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Summary 
 
The meniscus in the knee functions to absorb shock and transmit load within the 
joint.  Problems arise when the meniscus is injured or damaged as the meniscus’ 
healing potential is limited by the limited vascular supply extending only ~20% of 
the way through the mature meniscus.  Current treatment options are only 
effective at abating further degeneration and osteoarthritis due to altered joint 
mechanics.  Replacement of the meniscus has the potential to prevent the onset 
of osteoarthritis by restoring native joint mechanics. 
 
Here we aim to develop a decellularisation protocol for porcine medial meniscus 
with added bone blocks for easy fixation for use as a meniscal replacement.  
Menisci were decellularised using a low sodium dodecyl sulphate (SDS) method 
including freeze-thaw cycles, hypertonic, hypotonic and nuclease wash steps, as 
well as mechanical removal of cellular material.  Decellularised menisci were then 
characterised histologically, immunohistochemically, biochemically and 
biomechanically for successful decellularisation and compared to native 
meniscus. 
 
Histology revealed the absence of whole cells and nuclei from meniscus and 
bone, while quantification of DNA revealed ~96% and ~91% removal of DNA from 
meniscus and bone, respectively.  Immunohistochemical analysis showed 
retention of major structural collagens I, II and II; however there was complete 
removal of collagen IV and some loss of collagen VI.  Hydroxyproline assay 
showed retention of collagen and the collagen content of native meniscus was 
802.90 (± 52.95, 95% CL) mg.g-1 dry weight and for decellularised meniscus was 
935.35 (± 18.03, 95% CL) mg.g-1 dry weight, however there was a complete loss 
of GAGs from the decellularised matrices as revealed by Safranin O staining and 
quantified using dimethyl methylene blue assay (23.49 ± 8.63 μg.mg-1 vs. 0.30 ± 
0.47 μg.mg-1, 95% C.I.).  There was also a 51% reduction in calcium content of 
the decellularised bone blocks when compared to native bone blocks. 
 
Material properties of meniscus were obtained using uniaxial tensile and 
indentation testing with no significant differences observed between native and 
decellularised groups under tension although greater deformation was seen for 
decellularised samples under compression.  Unconfined compression of bone 
v  
however revealed a significant decrease in the compressive modulus and strength 
of decellularised bone blocks.  Differential scanning calorimetry revealed no 
significant differences in thermal stability between native and decellularised 
meniscus except for in the attachment region where collagen was mechanically 
manipulated prior to decellularisation.  Magnetic resonance imaging (MRI) also 
revealed no gross differences between native and decellularised bone and 
meniscus.   
Extract and contact cytotoxicity assays were used to determine biocompatibility of 
decellularised bone-meniscus-bone and residual SDS content determined using 
radio-labelled 14C SDS.  There was 0.289 μg.mg-1 of residual SDS in 
decellularised bone-meniscus-bone and assays showed no cytotoxicity to 3T3 and 
BHK cells.  The immunogenic galactose-α-1,3-galactose epitope could not be 
detected in decellularised meniscus by immunohistochemistry. 
 
In conclusion, a protocol for the successful decellularisation of porcine bone-
medial meniscus-bone has been developed which retains the structure and tensile 
properties of native meniscus and is non-cytotoxic.  Further investigation is 
required to determine whether loss of mechanical strength in the bone will prevent 
effective fixation in vivo. 
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Chapter 1. Introduction 
The menisci play a key role in the knee including load transmission, joint 
stabilization and shock absorption. They are a pair of semi-lunar 
fibrocartilaginous structures found between the femoral condyles and tibial 
plateau in the knee joint (Arnoczky et al., 1996; Fithian et al., 1990; Rath & 
Richmond, 2000).  Meniscal injury is common and can occur from both 
athletic events and activities of daily living. Treatment of meniscal injury will 
usually require surgery. Currently the most frequent orthopaedic procedure 
is arthroscopy which can represent up to 20% of all procedures in the United 
States (Renstrom & Johnson, 1990).  Until recently total meniscectomy was 
used to treat meniscal injury.  However, it is now known that this results in 
supra-physiological stress on the articular cartilage, which can eventually 
lead to knee damage and osteoarthritis. This has led to efforts in devising 
alternative treatments that avoid meniscectomy (McDermott & Amis, 2006; 
Lohmander et al., 2007).  The meniscus does have some ability to repair 
itself and is limited to the vascularised periphery (Arnoczky & Warren, 1982).  
This means that any damage suffered to the internal avascular regions is not 
repaired intrinsically, leading to further deterioration with time.  Therefore, 
alternative methods are necessary to facilitate meniscal healing.  Tissue 
engineering techniques aimed at regenerating menisci offer a promising 
solution, however there is very limited understanding in this field in 
comparison to other tissues (Hasan et al., 2013). 
 
1.1 The Knee Joint 
The knee joint is one of several synovial joints in the human body, 
characterised by the joint capsule surrounding the articulating surfaces of 
the joint and the presence of lubricating synovial fluid.   
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Figure 1.1:  Anterior view of the left knee joint.  Adapted from Hasan et al. 
(2013). 
The knee joint consists of four bones, which provide rigidity and structural 
support.  The femur, or thighbone, is attached to the tibia by ligaments and 
the knee capsule, running parallel to which is the fibula (Figure 1.1).  The 
patella, or knee cap, is located on the anterior face of the knee joint and 
articulates with the femur along the femoropatellar groove.  It is attached to 
both the quadriceps tendon, connecting it to the quadriceps femoris muscle, 
as well as the patellar tendon, which connects it to the tibia.  The articulating 
surfaces, the femoral condyles and tibial plateau, are covered in cartilage 
between which rest the menisci. 
 
1.1.1 Ligaments 
The knee joint is stabilised by four main ligaments (Figure 1.1): the anterior 
cruciate ligament (ACL), the posterior cruciate ligament (PCL), the lateral 
collateral ligament (LCL) and the medial collateral ligament (MCL) (Tham et 
al., 2008).  The ACL is attached to the lateral femoral condyle from where it 
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inserts itself into the midline of the tibia.  The main function of the ACL is to 
prevent anterior translation of the tibia with respect to the femur.  Other 
functions include prevention of excessive rotation of the tibia as well as 
limiting varus-valgus angulation and hyperextension of the knee (Tham et 
al., 2008).  During full extension of the knee the ACL is taut and extends 
parallel to the intercondylar roof notch. 
The PCL arises from the posterior intercondylar fossa of the tibia from where 
it crosses paths with the ACL, giving them a cruciform configuration and 
hence their names, to attach itself to the lateral aspect of the medial femoral 
condyle.  During full extension of the knee the PCL is lax and has a curved 
orientation (Tham et al., 2008). 
The LCL is attached to the lateral femoral condyle and runs to the lateral side 
of the fibular head.  The LCL has no attachments to the lateral meniscus and 
is the primary restraint to varus forces in the knee.  The MCL runs from the 
medial condyle of the femur, immediately below the adductor tubercle, to the 
medial surface of the tibia.  Unlike the LCL, it intimately adheres to the medial 
meniscus. 
The meniscofemoral ligaments run from the posterior horn of the lateral 
meniscus to the lateral aspect of the medial femoral condyle.  They are 
named based on their location in relation to the PCL.  The ligament of 
Humphrey runs anteriorly to the PCL, while the ligament of Wrisberg runs 
posteriorly.  Gupte and colleagues (2002) found a 93% incidence of these 
ligaments in a cadaveric study, with 50% revealing presence of both.  It is 
important to note this in order not to confuse the presence of these ligaments 
with pathology as they are not always present. 
 
1.1.2 Cartilage 
The articulating surfaces in the knee joint are covered in a smooth, white 
tissue known as articular cartilage, or hyaline cartilage.  As its name implies 
articular cartilage is imperative in the movement of one bone against 
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another.  Articular cartilage is composed of a large proportion of water, with 
the solid phase consisting of mainly type II collagen and aggrecan 
(Kempson, 1980).  This combination of collagen and aggrecan, through 
regulation of osmotic pressure, creates a swollen, hydrated tissue that 
resists compression. 
 
1.1.3 The Menisci 
The menisci are a pair of semi-lunar, fibrocartilage structures located 
between the femoral condyles and tibial plateau where they assist in load 
transmission and shock absorption (Figure 1.1).  The proximal surfaces of 
the menisci are in contact with the femoral condyles and are slightly concave 
in shape, as opposed to the distal surfaces which are slightly convex and in 
contact with the tibial plateau (McDevitt & Webber, 1990).  The meniscal 
surfaces are smooth, even when viewed by scanning electron microscopy 
(Ghadially, 1978).  The shape and smoothness of the menisci help 
accommodate the two articular surfaces with which they are in contact, 
ensuring smooth movement of the knee joint. 
The menisci are not identical in shape or in terms of their respective 
attachments.  The medial meniscus is C-shaped as opposed to the more O-
shaped lateral meniscus (Figure 1.2).  The medial meniscus is also smaller 
and less mobile than its counterpart, resulting in an increase in the possibility 
of injury.  The lateral meniscus is uniform in width from anterior to posterior, 
whereas the medial meniscus is wider near the posterior horn than the 
anterior horn.  In humans, the anterior and posterior horns of both menisci 
insert into the intercondylar fossa whereas in pigs the posterior horn of the 
lateral meniscus is attached to the femur.  The medial meniscus is more 
firmly anchored in place than the lateral meniscus due to a continuous 
attachment to the joint capsule via the MCL. 
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Figure 1.2:  Superior view of porcine tibial plateau showing meniscal 
attachments 
 
1.1.4 General Structure and Morphology of Menisci 
When first formed in the body both the medial and lateral menisci are 
completely vascular.  This initial vascularity diminishes rapidly with maturity 
to adulthood when ~10-30% of the meniscus is vascularised (Greis, 2002).  
This change in vascularity has been shown to be due to changes in the 
endostatin/cartilage XVIII level, which acts as an inhibitor to vascular in-
growth (Pufe et al., 2004).  Endostatin is present in homogenous 
concentrations throughout the meniscus in early development, but the levels 
in the inner two-thirds decrease with age, restricting vascularisation to the 
periphery of the meniscus.  The vascular supply to the menisci originates 
from the lateral medial genicular arteries, branches from which form the 
perimeniscal capillary plexus (PMCP). 
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Figure 1.3:  Meniscus collagen organization (Hasan et al., 2013).  Fibres are 
oriented randomly in the superficial (1) and lamellar (2) layers.  Circumferential 
fibres are present in the red zone (3) and white zone (4) deep portions with radial 
tie-fibres interspersed.  
Three distinct layers of the meniscus have been revealed using scanning 
electron microscopy: 
• A superficial fibril network covering the femoral and tibial surfaces 
• A lamellar layer 
• A central main layer 
As shown in Figure 1.3 the superficial fibril network is composed of a network 
of fibrils 10 µm wide with no specific orientation, that form a mesh contacting 
the femoral and tibial surfaces (1).  Beneath the superficial network is the 
lamellar layer (2).  The collagen fibrils located in the external circumference 
of the anterior and posterior segments are arranged in a radial direction.  In 
all other parts the collagen fibril bundles intersect at various angles.  The 
central main region is the main portion of the meniscus and is composed of 
collagen fibres in a circumferential orientation (3). 
The meniscus is more commonly divided into the following regions:  The 
meniscal horn towards the front of the knee known as the anterior region, 
the meniscal horn towards the back of the knee known as the posterior 
region, and between the anterior and posterior regions known as the middle 
region (Figure 1.4). 
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Figure 1.4:  Right medial meniscus showing meniscal regions. 
Further sub-divisions can be made when the meniscus is viewed in cross-
section.  The vascularised region attached to the capsule is known as the 
red zone, the avascular region known as the white zone, and the zone in 
between these two known as the red-white zone. 
 
1.2 Meniscal Cell Types 
Four morphologically different cell types have been identified in the menisci 
(Figure 1.5).  In the red vascularised margin, consisting mainly of 
fibrocartilage, cells have been shown to have a stellate appearance and 
numerous long thin cytoplasmic projections (Figure 1.5; (1)) (Hellio le 
Graverand et al., 2001).  Cells present in the deeper fibrocartilaginous 
region, which is less extensively vascularised, have been shown to have 
fewer projections, at most one or two (Figure 1.5; (2)), and the projections 
join cells from both these regions into sheets (Hellio le Graverand et al., 
2001).  In the avascular hyaline-like region of the menisci, cells have a more 
rounded morphology (Figure 1.5; (3)) and are said to be chondrocyte-like, 
with no projections (Hellio le Graverand et al., 2001).  The cells that line the 
aforementioned regions have been found to be fibroblast-like with fusiform 
morphology (Figure 1.5; (4)) (Hellio le Graverand et al., 2001).  It is this 
variation that has made it difficult to classify the cells in the menisci, and 
hence various terms have been used to describe them.  For example, 
fibroblast, chondrocyte, fibrocyte and fibrochondrocyte have all been used to 
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describe cells found within the menisci (Ghadially et al., 1978; Webber et al., 
1985; Hellio le Graverand et al., 2000; Pangborn & Athanasiou, 2005a).  In 
this review the cells will be termed meniscal fibrochondrocytes in order to 
avoid confusion. 
 
Figure 1.5:  The morphology and distribution of cell types in the menisci.  1) 
Cells in the red zone have many projections and include vascular cells, 2) cells in 
the red-white zone have fewer projections and have been termed 
fibrochondrocytes, 3) cells in the white zone are round with no projections and 
resemble chondrocytes, and 4) cells in the superficial layer are flattened and 
resemble fibroblasts. 
 
1.2.1 Biochemical Constituents 
Water has been shown to be the most abundant component of the menisci, 
constituting 70% of the total wet weight (Brindle et al., 2001), with the 
remaining 30% composed of organic matter (Figure 1.6).  Of this 30%, 
collagen accounts for 75% with proteoglycans, cells and adhesion 
glycoproteins forming the other 25% (Arnoczky et al., 1988; Fithian et al., 
1990; McDevitt & Webber, 1990). 
Collagen is the most abundant protein in the human body (Gloria et al., 2002) 
and it has been shown that type I collagen is the predominant meniscal 
1 
2 
3 
4 
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collagen, accounting for approximately 90% of all collagen present in the 
menisci (Sweigart et al., 2001).  A major type II collagen network is also 
present; however this network is not as extensive as the hybrid network 
found in articular cartilage that incorporates the proteoglycan aggrecan 
(Tanaka et al., 1999; Melrose et al., 2005).  Types III, IV, V and VI collagen 
have also been shown to be present in the menisci but at far lower 
concentrations (Tanaka et al., 1999; Melrose et al., 2005).  Cheung (1987) 
found the inner one-third of the bovine meniscus resembles hyaline cartilage, 
both in gross appearance and histology, whereas the outer two-thirds appear 
fibrocartilaginous.  The inner one-third comprises 10% of the wet weight of 
the whole meniscus with collagen accounting for 70% of the dry weight, 
compared to the outer two-thirds in which 80% of the dry weight is collagen 
(Cheung, 1987).  Collagen is not the only fibrillar component present in the 
meniscus.  Elastin, accounting for only 0.6% of the dry weight, plays an 
important role in the recovery of the meniscus from mechanical stresses 
(Hopker et al., 1986; Sweigart et al., 2001).  It is distributed throughout the 
meniscus, oriented in the direction of the collagen fibres, and the highest 
levels are found on the peripheral surfaces (Stapleton et al., 2008).  
 
Figure 1.6:  Composition of the meniscus 
Proteoglycans are large, negatively charged hydrophilic molecules 
composed of a protein core to which one or more glycosaminoglycans 
Water (70%) 
Organic 
Matter (30%) 
Collagen 
(~75%) 
Glycosaminoglycans 
(~15%) 
DNA (<2%) 
Adhesion 
Glycoproteins 
(<1%) 
Elastin 
(<1%) 
Inner Meniscus 
Type I (~40%) 
Type II (~60%) 
Outer Meniscus 
Type I (~99%) 
Chondroitin-6-sulfate (40%) 
Chondroitin-4-sulfate (~15%) 
Dermatan sulfate (~25%) 
Keratin sulfate (15%) 
Collagen type VI 
Fibronectin 
Thrombospondin 
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(GAGs) are covalently bound (McDevitt & Webber, 1990).  Proteoglycans 
are commonly separated by size into large and small groups.  Large 
proteoglycan molecules, such as aggrecan and perlecan, assist in the 
hydration of the meniscus and can entrain 50 times their weight in water 
(Sweigart et al., 2001).  Perlecan plays an important role in the organisation, 
stabilisation, and cellular attachment and migration within the meniscal 
extracellular matrix (Melrose et al., 2005).  Aggrecan, on the other hand, 
confers important load-bearing properties to the meniscus, and both 
perlecan and aggrecan have been shown to be immunolocalised to the tip 
of the white zone of the meniscus as well as around groups of rounded 
chondrocyte-like cells in the middle and white zone meniscus (Melrose et al., 
2005).  Smaller proteoglycans, such as biglycan and decorin, play important 
roles in load bearing as well as fibril organisation within the meniscus 
(Sweigart et al., 2001).  Work carried out by Scott et al. (1997) has shown 
biglycan as the most abundant small proteoglycan in the menisci, followed 
by decorin and finally fibromodulin.  Biglycan constitutes 53% of the 
proteoglycan content of the white zone of the porcine meniscus, 52% (w/w) 
of the red-white zone, and 38% of the red zone (Scott et al., 1997).  Decorin 
constitutes 23%, 28% and 32% of the white, red-white and red zones, 
respectively (Scott et al., 1997).  It has been suggested that the distribution 
and characteristics of small proteoglycans reflect regional adaptation due to 
functional demands within the meniscus (Scott et al., 1997).  GAGs only 
constitute a small fraction of total meniscal mass at 0.6-0.8% (Herwig et al., 
1984) of which 40% is chondroitin 6-sulphate, 20% is chondroitin 4-sulphate, 
20% is dermatan sulphate, 15% is keratan sulphate, and 3% hyaluronan 
(Herwig et al., 1984).  Dermatan sulphate was the predominant GAG chain 
identified on the small proteoglycans biglycan and decorin (Scott et al., 
1997).  Meniscal degeneration is shown to decrease GAG content as well as 
increase water content (Herwig et al., 1984). 
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1.2.2 Expression Profiles of Meniscal Cells 
Fibrochondrocytes from all regions of the meniscus work in cohort to produce 
the extracellular matrix molecules required for the meniscus to remain 
healthy and function properly.  The main types of collagen present in the 
meniscus are types I and II; however collagen III, IV, V and VI are also 
produced in lower concentrations (Melrose et al., 2005; Stapleton, 2008).  
The cells of the inner two thirds of the meniscus, which have a more rounded 
morphology, have been shown to synthesize greater levels of proteoglycans 
(Tanaka et al., 1999). Proteoglycan synthesis has been shown to be 
sensitive to transforming growth factor beta (TGF-β) in a dose-dependent 
manner (Tanaka et al., 1999), suggesting these cells have a chondrocytic 
phenotype.  Perlecan, a large proteoglycan expressed by cells with an oval 
or rounded morphology, has been shown to be localized in the white zones 
of the meniscus and strongly cell-associated (Melrose et al., 2005).  Levels 
of perlecan fall with age and degeneration of the meniscus (Melrose et al., 
2005).  Chondroitin sulphate is the most abundant GAG produced by 
meniscal cells followed by keratan sulphate (Gruber et al., 2008).   
Meniscal cells from different regions of the meniscus have different synthetic 
profiles and gene expression patterns.  Although type I collagen can be 
found throughout the bovine, canine and porcine meniscus (Kambic & 
McDevitt, 2005; Melrose et al., 2005; Upton et al., 2006a; Stapleton, 2008), 
type II collagen is more abundant in the white zone of the meniscus where it 
forms an organized network (Kambic & McDevitt, 2005; Melrose et al., 2005; 
Stapleton, 2008).  The cells in the white zone also stain positively for alpha 
smooth muscle actin (α-SMA) giving the cells a contractile phenotype, and 
hence they have been described as myofibroblasts (Mueller et al., 1999a).  
Mueller et al. (1999a) showed that α-SMA was present in ~10% of cells in 
normal meniscal tissue; however, during monolayer culturing of these cells 
α-SMA was present in all cells.  White zone cells can generally be 
characterised by their higher production of type II collagen and the 
proteoglycan aggrecan (Kambic & McDevitt, 2005; Verdonk et al., 2005a; 
Valiyaveettil et al., 2005).  Messenger ribonucleic acid (mRNA) levels of nitric 
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oxide synthase (NOS2), a pro-inflammatory enzyme implicated in protein 
biosynthesis in cartilage and the meniscus (Cao et al., 1998), has also been 
reported to be higher in the white zone of the porcine meniscus with levels 
similar to those for hyaline cartilage (Upton et al., 2006a).  Gene expression 
in the red zone more resembles that for fibrous tissues with increased mRNA 
levels for type I collagen and the proteases MMP2 and MMP3 (Upton et al., 
2006a). 
 
1.2.3 Effect of Biomechanical Stimulation on Protein Expression 
The production of the wide range of proteins in the meniscus is known to 
vary with age, injury and location in the tissue.  However, it is also true that 
mechanical stimulation can lead to variation.  Upton et al. (2006c) have 
shown using finite element modelling that different mechanical stresses are 
present for different regions of the meniscus.  Supplying a biaxial strain to 
the meniscus leads to cells in the white zone experiencing a 7% tensile strain 
in the direction of the collagen fibres and the elongated cells experiencing 
between 2 and 4% (Upton et al., 2006b).  Cells from all regions of the porcine 
meniscus have been shown to increase protein synthesis and nitric oxide 
production upon experiencing a biaxial strain (Upton et al., 2006c), however 
white zone cells produced more proteoglycans (Upton et al., 2006c). 
Static and dynamic loading conditions produced distinct gene expression 
patterns in cultures containing isolated porcine meniscal cells and have been 
found to differentially regulate mRNA levels for different proteins (Upton et 
al., 2003).  Dynamic compression led to a 2.1 fold decrease in the mRNA 
levels of decorin, a 4.0 fold decrease in type II collagen mRNA and an 
increase in nitric oxide production (Fink et al., 2001; Upton et al., 2006c).  
Static compression led to a 4.5-, 3.3- and 4.0-fold decrease in mRNA levels 
for decorin, type I collagen and type II collagen, respectively (Upton et al., 
2006c).  There was also an increase in the collagenase mRNA levels 
suggesting mechanical stimuli can regulate collagen levels (Upton et al., 
2006c).  Djurasovic et al. (1998) attempted to remove mechanical stimuli 
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from the meniscus to assess changes in aggrecan levels by immobilizing a 
limb at 90° flexion.  This led to a 5.5-fold decrease in the gene expression 
for aggrecan in the lower portion and a 2.0-fold decrease in the anterior 
section of the lateral meniscus. 
 
1.3 Biomechanical Properties and Functions of the 
Menisci 
Previous studies have shown that the menisci play important roles in joint 
stabilisation and load transmission (Shoemaker & Markolf, 1985; Fithian et 
al., 1990; Arnoczky et al., 1996; Rath & Richmond, 2000; Peña et al.; 2006).  
In order to successfully carry out these functions the menisci must withstand 
the different forces acting on them.  The conforming geometry of the menisci 
gives the first indication of their ability to deal with these forces.  The wedge 
shape increases the congruency between the femoral component and tibial 
plateau, allowing stable articulation between these surfaces.  Beaupré et al. 
(1986) suggested there was direct translation of compressive forces from the 
white zone wedge shape to tensile forces in the red zone through the 
meniscal fibres.  Both Shaffer et al. (2000) and McDermott et al. (2004) have 
measured human menisci with the lateral meniscus measuring ~32-36 mm 
anteroposteriorly and approximately 27-29 mm mediolaterally.  The medial 
meniscus measures in at ~40-46 mm and ~27 mm in the respective 
directions (Shaffer et al., 2000; McDermott et al., 2004).  In the 
circumferential direction the lateral meniscus is a little shorter than the medial 
at ~92 mm and ~99 mm, respectively (McDermott et al., 2004). 
 
1.3.1 Collagen Organization 
As previously mentioned (Section 1.2.3.1) the menisci are composed of 
three distinct layers: superficial, lamellar and central (Figure 1.3).  The 
collagen matrix in these layers is highly organized and imparts the necessary 
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characteristics required to aid the menisci in withstanding the forces acting 
on them.  Fibres in the superficial layer show no specific orientation and this 
is also true for fibres in the lamellar layer, noting the exception of radially 
oriented fibres in the anterior and posterior sections (Bullough et al., 1970; 
Skaggs et al., 1994; Peterson & Tillman, 1998).  The fibres in the bulk of the 
meniscus in the central portion mainly exhibit a circumferential orientation 
(Bullough et al., 1970; Aspden et al., 1985) along with a few radial fibres 
which begin at the periphery of the meniscus and travel into the central 
portion (Ghadially et al., 1983; Fithian et al., 1990; Skaggs et al., 1994).  The 
circumferentially oriented collagen fibres convert axial load into hoop 
stresses, dissipating it through the meniscus (Krause et al., 1976). 
 
1.3.2 Biphasic Behaviour 
As ~70% of a meniscus is composed of water, with cells and extracellular 
matrix constituting the remaining 30%, the menisci are considered as 
biphasic tissues (Favenesi et al., 1983; McDermott et al., 2008a).  Zhu et al. 
(1994) demonstrated that it is the interactions between the collagen fibres, 
negatively charged proteoglycans and water that imparts the biphasic 
(manifested through time-dependent viscoelastic) properties to the menisci.  
As load is applied to the meniscus, frictional drag forces help limit water flow 
as water is forced from the extracellular matrix absorbing some of the initial 
shock (McDermott et al., 2008a).  Once the load is released the negatively 
charged sulphate and carboxyl groups on the GAGs attract water back in to 
rehydrate the tissue (Fithian et al., 1990).  Finite element analysis has also 
revealed that the fluid phase initially appears to support a significant portion 
of the load (Spilker et al., 1992) due to the hydrostatic pressure developed, 
before further loading leads to transfer of the load from the fluid to the solid 
phase (McDermott et al., 2008a).  Using a non-invasive accelerometry 
method to detect bone vibrations resulting from gait it has been shown that 
the shock absorbing capacity of a normal knee is 20% higher than that of a 
pathological one (Voloshin & Wosk, 1983). 
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1.3.3 Material Properties 
The material properties of the meniscus govern its ability to function properly 
within the knee joint.  The meniscus has been described as an anisotropic 
tissue due to the directional variation in its material properties (Fithian et al., 
1990; Gabrion et al., 2005).  Previous studies have shown that samples of 
meniscal tissue taken from the central layer in the circumferential direction 
had much higher moduli than samples taken in the radial direction, whereas 
tissue samples taken from the randomly oriented superficial layer displayed 
no such differences (Bullough et al., 1970; Whipple et al., 1985; Proctor et 
al., 1989; McDermott et al., 2008a).   
 
1.3.4 Compressive Properties 
The compressive modulus, a measure of stiffness, and the permeability, a 
measure of the ease at which fluid flows through a material, are the two most 
discussed compressive properties in the literature.  DeHoll et al. (1999) 
assessed these two properties in bovine medial menisci using an automated 
creep indentation method and, although there were no differences in 
permeability, the aggregate modulus was found to be 50% and 91% higher 
in the anterior portion than the posterior and central portions, respectively.  
Confined compression creep testing and direct permeability testing found the 
mean water content of the meniscus to be 73.8%, with the mean aggregate 
modulus and permeability 0.41 MPa and 0.81 x 10-15 m4N-1s-1 (Proctor et al., 
1989), respectively.  The mean values for the aggregate modulus and 
permeability are displayed in Table 1.1.  Disparity in these results may have 
arisen from differences in curve-fitting and testing methods, from the 
biphasic theory applied by Proctor et al. (1989), an alternatively developed 
local optimization technique applied to the biphasic theory by Joshi et al. 
(1995), and the finite element analysis used by Sweigart et al. (2004). 
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Table 1.1: Compressive biphasic properties of the meniscus 
Reference Source Meniscus Aggregate Modulus (MPa) Permeability 
(10-15 m4 N-
1 s-1)    Anterior Central Posterior 
Proctor et 
al. (1989) Bovine Medial 0.38 0.40 0.49 0.81 
Joshi et al. 
(1995) Bovine Medial - - 0.11 3.6 
 Human Medial - - 0.22 2.0 
DeHoll et 
al. (1999) Bovine Medial 0.19 0.13 0.12 5.6 
Sweigart 
et al. 
(2004) 
Bovine Medial 0.19 0.13 0.12 5.6 
 Human Medial 0.16 0.11 0.10 1.8 
  
When bearing load the knee joint is subjected to compression and hence 
contact stresses.  The larger the contact area the smaller the contact 
stresses, and vice-versa.  Walker and Erkman (1975) showed using casting 
methods that under a 150 kg load the contact areas covered by the menisci 
were between 59 and 71%.  Another study showed that there was an 
increase in joint contact pressure of up to 235% after removal of menisci, 
due to concentration of load onto a much smaller joint contact area (Baratz 
et al., 1986).  The menisci, through optimisation of congruency between the 
femoral condyles and tibial plateau, increase the joint contact area and 
hence reduce joint contact stresses (Figure 1.7).  Fukubayashi and 
Kurosawa (1980) showed that meniscectomy reduces the contact area from 
115 mm2 to 52 mm2 while increasing peak contact pressure from 3 MPa to 
6 MPa.  In another study it was shown that a healthy knee can absorb up to 
52% of load exerted on it whereas a degenerate joint could only absorb 
around 24% (Hoshino & Wallace, 1987).  It has also been suggested that 
meniscectomy accelerates cartilage deformation by slowing recovery of 
cartilage due to the increased contact pressures (Song et al., 2008). 
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Figure 1.7:  Joint contact areas with and without menisci (McDermott and 
Amis, 2006).  A) The menisci improve congruency between the femoral condyles 
and the tibial plateau, increasing joint contact area and hence reducing contact 
pressure.  B) Removal of the meniscus reduces the joint contact area thereby 
increasing contact pressure. 
 
1.3.5 Tensile Properties 
It is clear from the literature that a standard method for testing the tensile 
strength of meniscal tissue is not available.  Sample geometry varies from 
the typical dumbbell shape specimens to the uniform width rectangular 
specimens.  However, the use of dumbbell shaped samples has no rationale 
in meniscal tensile testing due to the presence of non-continuous fibres 
present in the wider sections where splitting can occur (McDermott et al., 
2008a).  It is also evident that tissue specimen dimensions play a critical role 
in the tensile properties as described by Lechner et al. (2000).  Standard 
testing assumes that the material being tested is homogeneous, whereas 
meniscal tissue is composed of collagen fibres of varying diameters as well 
as weak matrix tissue (Petersen & Tillmann, 1998).  It was found that 27% 
of thinner samples failed prematurely during testing as opposed to only 17% 
of thicker samples (Lechner et al., 2000).  This suggests the thinner samples 
that were successfully tested had a higher proportion of collagen fibres, 
Meniscus 
Femoral 
Condyle 
Tibial 
Plateau 
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increasing the tensile modulus (Masouros et al, 2008).  A summary of tensile 
properties of meniscal samples of varying dimensions is shown in Table 1.2. 
Table 1.2: Tensile properties of the meniscus (Adapted from Masouros et al., 
2008) 
Reference Source Meniscus Geometry Sample 
Dimensions 
(mm) 
Tensile 
Modulus 
(MPa) 
Proctor et al. 
(1989)  
Bovine Medial Dumbbell 0.4 x 1.0 129 
Fithian et al. 
(1990)  
Human Medial  - 118 
Tissakht & 
Ahmed 
(1995)  
Human Medial Rectangular 1.5-2.0 x 
1.75-3.0 
83 
Goertzen et 
al. (1997)  
Bovine Medial Dumbbell 0.75 x 2.6 316 
Lechner et 
al. (2000)  
Human Medial Dumbbell 0.5 x 1.0 121 
   1.5 x 1.0 85 
    3.0 x 1.0 60 
 
Regional variations in the tensile properties of the meniscus have also been 
demonstrated.  The general trend in the medial meniscus appears to show 
that the stiffness for the anterior region is higher than that for the central and 
posterior regions (Fithian et al., 1990; Tissakht & Ahmed, 1995; Lechner et 
al., 2000; Chia & Hull, 2008; Bursac et al., 2009).  Lechner et al. suggested 
this was due to a greater density of collagen fibres in the radially thinner 
anterior horn of the medial meniscus imparting higher stiffness to the tissue.  
It has been shown that the lateral meniscus exhibits higher tensile moduli 
than the medial (Tissakht & Ahmed, 1995).  It has also been shown that there 
is a higher GAG content in the anterior medial meniscus than in the posterior 
or central regions, which results in a greater ability to resist compressive 
forces through hydrostatic pressure (Chia & Hull, 2008; Bursac et al., 2009). 
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1.3.6 Load Bearing and Transmission 
It has been well established that the menisci perform load bearing functions 
within the knee joint.  Forces acting on the knee during normal activities such 
as walking or climbing stairs can reach between 2.7 to 4.9 times bodyweight 
(Paul, 1976).  It has been suggested that the menisci bear anywhere 
between 45% and 75% of the load transmitted through the knee (Shrive, 
1974; Krause et al., 1976; Peña et al., 2006) and this is dependent on health 
of tissue as well as level of flexion.  As the knee flexes the contact area 
between the condyles diminishes by 4% for every 30° of flexion under a 150 
kg load (Walker & Hajek, 1972).  Without the menisci the contact areas 
decrease to between a third and a half, and subsequently stresses increase 
2 to 3 fold (Kurosawa et al., 1980).  When investigating load absorbing 
mechanisms in the knee, Hoshino and Wallace (1987) showed that the 
transmitted force increased by 180% in a replacement knee.  It was also 
found that the peak force transmitted increased as degeneration of menisci, 
cartilage and subchondral bone progressed.   
Even though the menisci are attached to the tibial plateau at the posterior 
and anterior horns a small amount of displacement occurs during flexion 
(Figure 1.8). This displacement allows the menisci to maintain congruency 
between the surfaces and optimise load bearing.  Using an MRI system 
these displacements have been measured revealing anterior horn 
displacement of 7.1 mm and 9.1 mm for medial and lateral menisci, 
respectively (Vedi et al., 1999).  The lateral meniscus is more mobile than 
the medial meniscus as it is not as tightly attached to the joint capsule.  Due 
to this immobilisation the medial meniscus is subjected to higher contact 
stresses which may contribute to an increased frequency of injury, 
particularly to the posterior horn. 
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Figure 1.8:  Transmission of load through the meniscus (Hasan et al., 2013). 
 
1.3.7 Stabilisation 
As well as playing a major role in load bearing, the menisci have been shown 
to assist in joint stabilisation.  Although the ACL plays the most important 
role in stabilising the knee joint (Levy et al. 1982), it has been shown that the 
menisci act as secondary stabilisers.  Levy et al. (1982) showed that 
although meniscectomy has no significant impact on stabilisation of normal 
knee joints, in ACL deficient knees the medial meniscus restricts 
displacement of the tibia, stabilising the knee joint.  They went on to suggest 
that when the ACL is disrupted, displacement of the tibia wedges the medial 
meniscal horn between the bones and prevents further displacement.  
Further work on meniscal stabilisation after ACL resection has shown that 
there is an increase of 197% in the forces within the medial meniscus (Allen 
et al., 2000).  It has also been shown that meniscectomy of the ACL deficient 
knee resulted in further anterior translation of the tibia. 
 
1.3.8 Lubrication and Tribology 
As the menisci are located between two articulating surfaces, it has been 
suggested that they play a role in joint lubrication.  Using a tribological 
simulation, McCann et al. (2009) studied the friction and wear of bovine knee 
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articular cartilage.  They found that meniscectomy increased peak contract 
stress under a 1000N load from 4.9 MPa to 17.1 MPa leading to an increase 
in frictional shear stress and biomechanical wear of the underlying cartilage.  
Lubricin (PRG4), a protein found in synovial fluid implicated in lubrication and 
anti-adhesion, has been detected on the meniscal surface, ligaments, 
synovium and cartilage using immunostaining techniques (Sun et al., 2006; 
Lee et al., 2008).  Lubricin was also detected within and near meniscal cells 
along the radial tie fibres and circumferential meniscal cells by Schumacher 
et al. (2005) who suggested that lubricin was synthesized and secreted by 
meniscal cells and may play a role in boundary lubrication.  It has been 
shown that synovial fluid lacking lubricin failed to reduce friction and 
increased wear in the knee joint (Jay et al., 2007).  These results were 
supported by Schmidt et al. (2007) who found that lubricin and hyaluronic 
acid contribute to low friction in a dose dependent manner, both individually 
and also in synergy.  Lubricin levels have also been shown to be affected by 
the onset of disease and degeneration (Teeple et al., 2008).  Lubricin levels 
were found to be lower in ACL-deficient knees leading to further 
degeneration of the joint (Teeple et al., 2008), and have been shown to be 
regulated by transforming growth factor beta 1 (TGF-β1), which enhances 
lubricin expression, and interleukin-1-beta (IL-1β), which reduces lubricin 
expression and is highly expressed in arthritic joints (Lee et al., 2008). 
 
1.4 Meniscal Injury and Degeneration 
Normal menisci are semi-lunar, fibrocartilage structures.  Deviations from 
this can occur in several ways including disease, degeneration, traumatic 
injury or abnormal development.  Abnormal development usually results in a 
discoid meniscus, where the white zone extends over the cartilage surfaces 
to either completely or partially cover them, forming a disc-like structure 
(Vandermeer & Cunningham, 1989).  The incidence of discoid menisci has 
been reported to be between 0.8 and 5% and can cause pain, clicking and 
limitation of joint motion (Vandermeer & Cunningham, 1989; Washington et 
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al., 1995).  The menisci are also affected by metabolic diseases such as 
calcium pyrophosphate crystal deposition, hemochromatosis and ochronosis 
which can cause calcification as well as discoloration of meniscal tissue 
(Bjelle, 1981).  These afflictions leave the menisci unable to function 
normally and, as they are due to systemic changes within the body, cannot 
be treated locally.  Other conditions such as degeneration and trauma can 
be treated as they directly affect the meniscus. 
 
1.4.1 Degeneration 
It is known that degeneration renders the menisci more prone to injury 
(Hough & Webber, 1990).  Osteoarthritis leads to degenerative changes in 
the menisci as well as the surrounding cartilage, and has been implicated in 
~75% of all meniscal tears and extrusions (Berthiaume et al., 2005; Lange 
et al., 2007).  Osteoarthritis affects the geometry of menisci, causing 
thickening of the medial posterior and lateral anterior horns.  This in turn can 
affect the biomechanics of the tissue leading to injury (Bamac et al., 2006).  
Adams et al. (1983) assessed the GAG content of menisci in beagles 
induced with osteoarthritis.  It was found one week after induction that the 
water content increased as the GAG content decreased, however after 15 
months the water content had returned to normal and the GAG content had 
reached elevated levels, suggesting stiffening of the tissue.  In another study 
it was shown that osteoarthritis leads to joint space narrowing (Sugita et al., 
2001).  This is due to radial displacement of the medial meniscus, which 
preserves this part of the tissue but compromises all other functionality, 
potentially leading to injury. 
 
1.4.2 Injury and Epidemiology 
The most common form of meniscal injury is mechanical failure of the tissue 
due to degeneration or trauma resulting in a tear.  Meniscal tears (Figure 
1.9) can be categorised into the following types: Longitudinal, horizontal, 
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radial, oblique and complex (Smillie, 1968; Greis et al., 2002; Boyd & Myers, 
2003; Schlossberg et al., 2007).  Longitudinal tears occur in a vertical 
direction and can vary in length from ~1mm to the length of the meniscus 
(Greis et al., 2002).  A variation of a longitudinal tear is known as the bucket 
handle tear and these occur when the tear spans the entire thickness of the 
meniscus, splitting a section mediolaterally (Greis et al., 2002; Schlossberg 
et al., 2007).  Oblique tears also occur in a vertical direction however these 
tears start from the white zone of the meniscus and slant inwards, and along 
with longitudinal tears have been shown to make up 81% of all tears (Greis 
et al., 2002).  Horizontal tears develop due to shear stresses generated by 
inferior and superior sections of the meniscus and are more common in 
elderly patients (Greis et al., 2002).  Radial tears are similar to oblique tears 
in that they begin at the edge of the white zone however radial tears extend 
radially towards the periphery and disrupt the meniscus’ ability to contain 
hoop stresses (Greis et al., 2002; Boyd & Myers, 2003).  Complex tears are 
composed of several different tears, associated with degeneration and 
incidence has been shown to increase with age (Greis et al., 2002; Boyd & 
Myers, 2003). 
The causes of meniscal injury can be divided into 3 types: sports injuries, 
non-sporting injuries, and unidentifiable injury.  Sporting injury is injury 
incurred through sporting activities and accounts for 32.4% of all meniscal 
injury with a mean age of ~33 years at time of injury (Drosos & Pozo, 2003).  
Non-sporting injuries account for 38.8% of all tears, the majority (71.9%) of 
which occur through daily activities, with a common cause cited as ascent 
from a squatting position (Drosos & Pozo, 2003).  The remaining 28.8% arise 
through unidentifiable injury (Drosos & Pozo, 2003).  Degenerative changes 
may be responsible for the occurrence of the non-sporting and unidentifiable 
injuries as these tend to occur with increasing age (~42 years of age) and 
require far less force than injuries occurring through sport (Drosos & Pozo, 
2003). 
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Figure 1.9:  Meniscal tears.  1) Longitudinal, 2) Bucket-handle, 3) Horizontal, 4) 
Radial, 5) Oblique, 6) Complex. 
Meniscal tears can reveal themselves through various symptoms.  Common 
symptoms include pain, a catching sensation, “giving way” and effusion 
(Choi & Victoroff, 2006).  Incidence of meniscal tears has been shown to be 
approximately 60-70 per 100,000 with 70-80% of tears occurring in males 
(Dandy, 1990; Greis et al., 2002).  Dandy (1990) showed that tears appear 
to be more common in the right knee with 56.5% of tears occurring in this 
location.  The majority of medial meniscal tears have been found to be 
longitudinal (75%) with horizontal tears (23%) second most common (Dandy, 
1990), whereas longitudinal tears constituted a smaller proportion of tears in 
the lateral meniscus (54%) and, oblique (15%)  and complex (15%) tears 
represented similarly large proportions (Dandy, 1990).  It has also been 
suggested that the meniscus is reliant on the ligaments of the knee as there 
is an increase in meniscal injury with ACL deficiency (Noyes et al., 1980; 
Allen et al., 2000; Greis et al., 2002).  Moglo and Shirazi-Adl (2002) showed 
that through to 30° of flexion the medial meniscus is subjected to higher 
loads and stresses in an ACL-deficient knee.  This suggests that the 
meniscus is heavily reliant on the ligaments of the knee to function properly 
and remain healthy. 
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1.4.3 Meniscectomy 
Total meniscectomy was used widely to treat meniscal injuries and defects 
however once meniscectomy had been described as “not totally innocuous” 
(Fairbank, 1948) repair of the meniscus was popularised.  Total 
meniscectomy has been shown to produce clinically good results 10 years 
after surgery (Perey et al., 1962) however it has since come to light that 
meniscectomy causes joint space narrowing, lowers the rate of regeneration, 
leads to an increase in the degenerative changes in the surrounding 
cartilage, and hence a higher incidence of osteoarthritis (Fairbank, 1948; 
Jackson, 1968; Cox et al., 1975; McGinity et al., 1977; Allen et al., 1984; 
Moon & Chung, 1988; Messner & Gao, 1998; Shelbourne & Dickens, 2007).  
These discoveries facilitated a switch to partial meniscectomy as the chosen 
form of treatment as well as surgical repair and implantation (Fairbank, 1948; 
Messner & Gao, 1998; Brindle et al., 2001) and partial meniscectomy is 
currently one of the most commonly performed arthroscopic procedures.  It 
preserves the load distribution characteristics of the meniscus (Burks et al., 
1997; Messner & Gao, 1998) with studies showing the amount of 
degeneration that takes place after partial meniscectomy is proportional to 
the amount of tissue resected during the procedure (Cox et al., 1975; Berjon 
et al., 1991; Burks et al., 1997; Andersson-Molina et al., 2002).  Although 
results are favourable when compared to total meniscectomy (Burks et al., 
1997; Shelbourne & Dickens, 2007), degeneration still occurs.  Restoration 
of meniscal tissue to its native state is most desirable and this can be 
achieved by promoting a healing response.  
 
1.4.4 Repair and Regeneration 
Surgery related to the meniscus accounts for around one million procedures 
a year in the United States of America alone (Rodkey et al., 1999; Cook et 
al., 2006) burdening health services in terms of time, expenditure and 
resources.  Many meniscal surgeries are secondary surgeries and so a 
reduction in the number of these surgeries would prove highly beneficial to 
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the health services providing them, allowing reallocation of resources to 
more urgent departments. 
The meniscus is not a homogeneous tissue hence its capacity for healing is 
limited.  As only the red zone is vascularised (Figure 1.10), general prognosis 
for healing is excellent in this area (Brindle et al., 2001).  Healing is poorest 
in the avascular white zone as there is no access to a blood supply or source 
of reparative cells (Arnoczky & Warren, 1983; Brindle et al., 2001).  Current 
repair techniques are only effective in the vascularised zone of the meniscus 
but fail to encourage healing in the avascular zone (Adams et al., 2005).  
Several methods have been devised to aid the healing of the meniscus, 
ranging from the creation of channels to introduce blood and reparative cells 
to tears; to suturing and resorbable scaffolds (Ghadially et al., 1986; Zhang 
et al., 1988; Gershuni et al., 1989; Fox et al., 1993; Zhang et al., 1995; Zhang 
& Arnold, 1996).  Trephination involves the creation of a channel from the 
vascularised zone to the tear (Zhang & Arnold, 1996) with use of this method 
resulting in very good results with Fox et al. (1993) reporting good results in 
90% of cases and Zhang et al. (1988) showing that trephination led to healing 
of all tears, either partially or fully.  Trephination provides an improved 
healing rate in the white zone compared to suturing alone (Zhang & Arnold, 
1996).  Suturing may stabilise a tear, however it does not encourage healing 
due to the lack of a blood supply (Zhang et al., 1995).  Other ways of 
introducing a blood supply and/or reparative cells to the site of injury are 
using a vascularised synovial flap or a fibrin clot (Ghadially et al., 1986; 
Arnoczky et al., 1988; Gershuni et al., 1989; Shirakura et al., 1997).  
Ghadially et al. (1986) created bucket-handle tears in the avascular zone of 
ovine menisci and repaired them using sutures alone or by introducing a flap 
of synovium to the tear.  Menisci that were sutured did not display any 
indication of healing; whereas the menisci repaired using synovium showed 
some healing.  These results are supported by another study in which 11 of 
35 menisci repaired using a free synovium flap were healed as opposed to 
none in the control groups (Shirakura et al., 1997).  Use of a fibrin clot in 
meniscal lesion repair has shown that it is possible to repair tears in the 
avascular zone using this method (Arnoczky et al., 1988).  Surgical 
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techniques range from arthroscopic to open repair (DeHaven et al., 1999).  
There are various alternatives to suturing available that work on the same 
premise.  The Meniscus Arrow (Bionx, Blue Bell, Pennsylvania), The 
Meniscal Dart (Arthrex, Naples, Florida), The T-Fix Suture Bar (Smith & 
Nephew, Endoscopy Division, Andover, Massachusetts), and The Clearfix 
Meniscal Screw (Johnson & Johnson) (DeHaven et al., 1999; Farng & 
Sherman, 2004). 
The nature of the repaired tissue must also be considered when critiquing a 
technique.  Ideal repair tissue should be as similar to native meniscal tissue 
histologically, morphologically and biomechanically as possible.  It has been 
shown that calcification increases with meniscal injury and may be a 
secondary symptom of degeneration (Noble & Hamblen, 1975).  Apoptosis 
also increases with meniscal degeneration or trauma and is seen in chondral 
tissues of patients with osteoarthritis (Uysal et al., 2008).  Repair tissue 
similar to normal meniscal repair tissue has been produced using a fibrin clot 
however it was dissimilar to normal meniscal tissue (Arnoczky et al., 1988).  
The biomechanical strength of meniscal repair tissue must also be 
considered.  Meniscus repaired using sutures or a fibrin clot had regained 
26% and 42.5% of its original strength for the suture and fibrin glue 
techniques, respectively.  A secondary area of weakness was also 
discovered in the peri-scar tissue in the line of the scar and this reduced in 
size after 12 weeks of healing (Roeddecker et al., 1994). 
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Figure 1.10:  Vascularisation of the meniscus.  The level of healing that takes 
place is proportional to the level of vascularisation in the meniscus.  Red represents 
vascularised tissue, with white representing avascular tissue.  
 
1.4.5 Replacement 
Replacement of the meniscus is more favourable than repair as it has a 
greater potential to protect the joint surfaces.  Transplantation also becomes 
an option when patients have suffered degenerative changes to the joint due 
to previous meniscectomy or when an irreparable tear is encountered.  There 
are two main types of meniscal transplantation: autogenous and allogeneic. 
1.4.5.1 Autogenous transplantation 
Autogenous transplantation refers to transplantation of tissue originating 
within the individual to whom it is to be applied.  The advantages of 
autogenous transplants are that they are not rejected by the immune system 
and there are no issues regarding transmission of infection.  Disadvantages 
include size limitations, longer time in surgery and cosmetic issues due to 
harvesting of tissue, and donor site morbidity.  Tissue has been sourced from 
a variety of locations including the patellar tendon (Kohn et al., 1992; 
Johnson & Feagin, 2000) and quadriceps (Kohn, 1993).  In order to assess 
the viability of autogenous transplantation, as well as provide a premise for 
allogeneic transplantation, Stone et al. (1995) carried out autogenous 
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transplantation of meniscal cartilage in dogs.  In this study the meniscus was 
excised and replanted and gross healing occurred in 50% of cases.  
Collagen abnormalities at the healing interface and within the tissue were 
noted and limping was seen in 79% of dogs.  Degenerative joint disease in 
the form of joint space narrowing and osteophyte formation was also seen in 
50% of dogs.  The method of fixation could have affected the results and 
fixation using bone plugs may improve outcomes as even though the 
replacement tissue was fresh and ideally sized it has been shown that 
fixation using bone plugs yields improved results compared to soft-tissue 
fixation (Paletta et al., 1997, Kim et al., 2012).  The authors went on to 
conclude that since a seemingly perfect model of meniscal replacement, 
where menisci were autogenous, fresh and perfectly matched in size, had 
failed to produce successful results, it was doubtful that studies using 
autografts and allografts would produce favourable results.  The same 
approach was repeated in an ovine model and showed autogenous 
transplants to have a protective effect on articular cartilage (Szomor et al., 
2000).  Studies on the potential of autografts for meniscal replacement are 
summarised in Table 1.3. 
Although the basis for autogenous transplantation is good, evidence 
indicates that this does not translate clinically.  Problems arise with the 
biomechanics of the grafted tissue as it is less able to withstand the forces 
encountered in the knee.  This may be due to insufficient remodelling and 
vascularisation, and in some cases shrinkage of the graft leading to 
exposure of cartilage surfaces resulting in continued degeneration.  Hence, 
meniscal autografts are not seen as a suitable replacement for menisci. 
1.4.5.2 Allogeneic transplantation 
Allogeneic transplants are grafts taken from genetically non-identical 
members of the same species.  Advantages of allogeneic transplants are 
that there is no donor site morbidity, they are cosmetically better and less 
time is spent in surgery as there is no need to harvest from the recipient.  
There are also no size limitations therefore revisions can be made depending 
on requirements during surgery (Prokopis & Schepsis, 1999).  As the 
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donated tissue is not genetically identical, there may be problems with 
immune rejection, and disease transmission is a possibility (Nemzek et al., 
1994; Tomford, 1995; Prokopis & Schepsis, 1999; Golshayan et al., 2007).  
It is also a more costly process than autogenous transplantation (Prokopis & 
Schepsis, 1999).  Historically disease transmission was a real concern in 
transplants especially as it is not always possible to detect viruses in 
transplanted material (Tomford, 1995).  Human immunodeficiency virus 
(HIV), syphilis, and hepatitis B and C are all transferable via transplantation.  
In a study carried out by Nemzek et al. (1994) of retroviral transmission in 
transplanted menisci and patellar ligaments, although there was no rejection 
of grafts, transmission of retrovirus occurred in all cases.  In order to address 
this issue sterilisation of tissue using gamma irradiation has been 
undertaken, however the dose required has been shown to produce 
detrimental changes in the viscous and elastic properties of the graft (Yahia 
et al., 1993; Vangsness et al., 2003).  Tissue banking services in the UK 
perform mandatory screening on all donated tissue for HIV, hepatitis C virus 
(HCV), hepatitis B virus (HBV) and syphilis.  Additional testing may be 
required for malaria, West Nile virus and Chaga’s disease (Section 20 - 
Tissue banking: selection of donors, Guidelines for the Blood Transfusion 
Services). 
Allografts described in the literature are fresh, fresh-frozen, cryopreserved 
and freeze-dried.  Various studies have been carried out using the different 
types in human and animal models, and these are summarised in Table 1.4 
and Table 1.5, respectively.  Rejection of grafts does not seem to be an issue 
with a low level immunological reaction reported at most (Rodeo et al., 2000).  
Fresh grafts have been reported to be superior due to the fact that viable 
cells are present and able to produce extracellular matrix once transplanted 
(Rodeo et al., 2000).  However it had already been shown that all donor cells 
are replaced by host cells after implantation (Jackson et al., 1993).  
Disadvantages of fresh grafts include difficulty in sizing, sterility and 
availability (Shelton, 2007).  They also produce the most pronounced 
immunologic reaction (Peters & Wirth, 2003).  Cryopreserved grafts maintain 
a viable cell population and so have been used as an alternative to fresh 
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grafts.  However, frozen grafts have been considered more favourable than 
cryopreserved grafts as freezing is less costly and there is less chance of 
transmission of infection due to loss of cell viability (Fabbriciani et al., 1997).  
The number of times a graft is frozen and thawed has been shown to have 
an effect on a meniscus’ ability to withstand compression (Lewis et al., 2008).  
Menisci subjected to a single freeze-thaw cycle have been shown to have a 
higher Young’s modulus than menisci that underwent four cycles of freezing 
and thawing (Lewis et al., 2008).  Freeze-drying leads to shrinkage and has 
an adverse effect on the biomechanical properties of grafts and is no longer 
recommended (Sekiya & Ellingson, 2006).  Since it has been shown that any 
remaining donor cells are gradually replaced by host cells (Arnoczky et al., 
1992; Jackson et al., 1993; Rodeo et al., 2000), it may be more important to 
maintain the extracellular matrix for a functioning transplant (Beaver et al., 
1992). 
It should also be noted that fixation methods, sizing, alignment of the joint, 
and patient selection are all critical in the success of a transplant.  Suture-
only fixation techniques, as opposed to bone-blocks in addition to sutures, 
can lead to increases in peak contact pressure and tears where sufficient 
healing has failed to take place (McDermott et al., 2008b).  Fixation plays an 
important role in the level of congruity achieved in the joint and is essential 
for function through development of hoop stresses upon loading, the 
mechanism by which the meniscus protects the articular cartilage 
(McDermott et al., 2004).  Bone-blocks may produce better clinical results 
(Rodeo et al., 2000), however accurate placement of these bony 
attachments is crucial to success, and inaccurate placement has been 
shown to produce unfavourable results (Szomor et al., 2000).  The size of 
the graft is also critical to achieving congruity, and this can be predicted 
accurately (5% mean error) from tibial plateau measurements (McDermott et 
al., 2004). 
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Table 1.3:  Meniscal autograft studies 
Reference Model Meniscus Autograft used Findings 
Jackson et 
al. (1992) 
Caprine Medial Meniscus Normal peripheral revascularisation and healing.  Water content increased by 6% 
and proteoglycan content increased. 
Kohn et al. 
(1992) 
Ovine Medial Patellar tendon Remodelling and revascularisation of tissue. Lower failure stress and tensile modulus 
compared to normal meniscus. Shrinkage of meniscus. Some degenerative changes 
Kohn 
(1993) 
Ovine Medial Infrapatellar fat pad 
Patellar tendon 
Lower tensile properties than in normal. 
Higher for tendon than fat pad graft. 
 Human  Quadriceps tendon No complications or further cartilage degeneration. 
Stone et al. 
(1995) 
Canine Medial Autogenous 
meniscus 
Gross healing in 50%.  Significant collagen organisation abnormalities.   
Bruns et al. 
(1998) 
Ovine Medial Perichondral tissue Remodelling of graft to resemble meniscus. Lower failure stress and tensile modulus 
compared to normal. Less intense revascularisation than in normal meniscus. 
Calcification in central meniscal regions. Menisci retained normal size 
Johnson & 
Feagin 
(2000) 
Human Lateral Semitendinosus 
tendon (4) 
Patellar tendon (1) 
Slight clinical improvement in one patient.   
Joint surface was not preserved. 
Szomor et 
al. (2000) 
Ovine Medial Autogenous 
meniscus (8) 
Allogeneic 
meniscus (8) 
Gross healing to periphery for all transplants.  Transplants reduced damage to 
articular cartilage when compared to meniscectomy.  Mild surface fibrillation and 
Fibrinoid degeneration. 
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There is much discussion as to what level of error is acceptable and further 
studies on the sensitivity of the knee joint to sizing errors is needed.  Various 
studies have shown that correction of joint alignment in addition to 
transplantation can aid the success of the procedure (Beaver et al., 1992; 
Garrett, 1993; van Arkel & de Boer, 1995; Cameron & Saha, 1997; Goble et 
al., 1999; Verdonk et al., 2005b), and it has been recommended that 
malalignment is corrected before any transplantation can take place (van 
Arkel & de Boer, 1995). 
 
1.4.6 Immunology 
To prevent rejection of allogeneic transplants, such as organ transplants, 
immunosuppressive drugs target the immune response non-specifically.  
Using this strategy lifelong administration may be required and can lead to 
susceptibility to infection, tumours and cardiovascular disease, among other 
side effects.  Therefore specific strategies allowing for the tolerance of 
allogeneic transplants without the need for immunosuppressant therapy 
need to be developed.  The major histocompatibility complex (MHC) is a 
large set of genes that is unique in each individual (except monozygotic 
twins) and plays an important role in the immune system.  Proteins encoded 
by the MHC genes are displayed on the surface of cells and the MHC 
molecules present foreign peptide antigens to be recognised by T cells which 
mediate the immune response.  The MHC in humans is known as the human 
leukocyte antigen (HLA) system.  HLA antigens are divided into three 
groups, class I, II and III.  Class I consists of A, B and C antigens which 
present peptides from within the cell; and class II consists of D (Dp, Dq and 
Dr) antigens which present peptides from outside the cell.  Recognition of 
mismatched-MHC antigens by T cells in allogeneic transplants leads to graft 
rejection.  T cells can initiate rejection of allogeneic transplants in three ways 
(Golshayan et al., 2007): directly, indirectly and semi-directly (Figure 1.11).   
It has been postulated that the meniscus is immunopriveliged.  Several 
studies have shown that there has been no rejection following allogeneic 
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meniscal transplantation (Milachowski et al., 1989; Garrett & Stevenson, 
1991; Ochi et al., 1993; de Boer & Koudstaal, 1994; Nemzek et al., 1994; 
van Arkel & de Boer, 1995; Fabbriciani et al., 1997).  There have also been 
cases where a low level immunological reaction has been encountered 
(Langer et al., 1978; Rodeo et al., 2000); however this has not affected the 
clinical outcome.  This may be due to the dense extracellular matrix which 
may act to protect the meniscal cellular antigens (Fabbriciani et al., 1997) or 
due to the lack of a blood supply which would be necessary for lymphocyte 
access.  Hence the likelihood of triggering an immune response is reduced. 
 
1.4.7 Xenotransplantation 
Xenogeneic meniscal transplantation is gaining popularity due to a 
potentially unlimited source of tissue.  Since the meniscus appears to be 
immunopriveliged, this will no doubt fuel this fire.  However, there are a 
number of issues that may prevent xenotransplantation translating to the 
clinic.  These include ethical, legal and religious reasons.  It has also been 
shown that using a cellular meniscus as a replacement can potentially lead 
to xenozoonoses.  In a study by Martin et al. (1998) it was shown that porcine 
endogenous retrovirus (PERV) mRNA was present after co-culture of human 
kidney cells with pig primary aortic endothelial cells, implying infection of 
human cells by PERV.  This may be overcome by the fact that it is possible 
to raise PERV-free pigs (Hammer, 2003) and also through removal of all 
cellular and nuclear material through decellularisation.  Pig menisci are the 
closest match to human menisci in terms of size, which is why there is more 
in the literature regarding pig immunogenicity than other animals.  
Hyperacute rejection has been shown to be a major problem for pig to 
primate organ transplantation (Galili et al., 1997; McPherson et al., 2000) 
and is due to presence of the Galactosyl-α(1,3)galactose (α-gal) epitope on 
cell membrane glycolipids and glycoproteins of lower mammals.  The α-gal 
epitope is not present in humans or Old World monkeys due to mutations of 
α1,3-galctosyltransferase, the enzyme responsible for producing α-gal.  
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Hyperacute rejection occurs due to the fact that humans naturally produce 
large titres of antibodies to α-gal, possibly due to constant exposure to 
intestinal bacteria which express epitopes which cross-react with the α-gal 
epitope. 
These antibodies bind to endothelial cells present in the donor graft resulting 
in complement-mediated hyperacute rejection.  Subsequent thrombosis in 
the graft vasculature then leads to graft hypoxia and death.  Anti-α-gal 
antibodies bound to xenograft cells can also mediate the destruction of 
xenograft cells by interacting with macrophages and natural killer cells via 
their Fc receptors leading to subsequent lysis of the graft cells.  This is known 
as the antibody dependent cellular cytotoxicity mechanism (Galili et al., 
1997).  Kasimir et al. (2005) showed that incomplete decellularisation which 
fails to remove the α-gal epitopes can lead to xenograft rejection.    This was 
supported in another study using mice negative for α-gal antibodies, in which 
Raeder et al. (2002) also showed that the α-gal epitope did not interfere with 
the ability of xenogeneic ECM to serve as a scaffold when there is a lack of 
an immune response. 
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Table 1.4:  Meniscal allograft studies in Humans 
Reference Meniscus 
(Number) 
Allograft type 
(Number) 
Findings 
Milachowski 
et al. (1989) 
Medial (11) 
 
 
Lateral (11) 
 
Freeze-dried and 
irradiated (8) 
Fresh-frozen (3) 
Freeze-dried and 
irradiated (8) 
Fresh-frozen (3) 
No adverse immunological reactions. Shrinkage seen in all cases with one meniscus 
completely destroyed at 2 years. Synovitis present in 4 patients with freeze-dried grafts. 
Complete healing in frozen menisci. Failures = 5 up to 14 years 
 
Garrett & 
Stevenson 
(1991) 
Medial (4) 
Lateral (2) 
Fresh Secure healing with horns anchored firmly. No sign of rejection or progression of 
degeneration. Pain and clicking noted in 3 cases. 
Garrett 
(1993) 
Medial (34) 
Lateral (8) 
Fresh (27) 
Cryopreserved (16) 
Healing of rim and lack of shrinkage present in 20 of 28 cases arthroscopically 
assessed. Degeneration of articular cartilage present. Failures = 8 up to 7 years 
De Boer & 
Koudstaal 
(1994) 
Medial (18) 
Lateral (7) 
Cryopreserved Revascularisation, recellularisation and healing present. Fewer cells in central areas.  
No rejection of grafts. 
Failures = 3 
Van Arkel & 
De Boer 
(1995) 
Medial (10) 
Lateral (15) 
Cryopreserved Healing and revascularisation present. Improved stability and function of joint. 
No inflammation or rejection. Failures = 3 due to malalignment up to 24 months 
Cameron & 
Saha (1997) 
Medial (37) 
Lateral (30) 
Fresh-frozen Peripheral healing and no shrinkage of graft. Improvements in function and pain. 
87% good to excellent results. Gross nonhealing evident in 3 patients. 
Failures = 7 up to 5 years 
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Verdonk 
(1997) 
Medial (23) 
Lateral (17) 
Fresh Slow in-growth of host cells up to 2 years with some donor cells surviving. 
Transient synovitis present in 4 cases but did not affect clinical outcome. 
Failures = 5 up to 6 years 
Carter (1999) Medial (39) 
Lateral (7) 
Cryopreserved Normal appearance. Good healing and repopulation with cells. Improvements in pain 
and function. Failures = 5 up to 5 years 
Goble et al. 
(1999) 
? (47) Cryopreserved Good healing and function in 71%. Pain reduced in 70% of cases. 80% viable meniscal 
tissue present in 57% of subjects. Shrinkage and accelerated graft wear evident. 
Failures = 11 up to 2 years 
Rodeo et al. 
(2000) 
Medial (17) 
Lateral (16) 
Fresh-frozen Allografts showed incomplete repopulation with cells derived from synovium. 
Low level immunological rejection but did not affect clinical outcome. 
Failures = 12 up to 47 months 
Stollsteimer 
et al. (2000) 
Medial (11) 
Lateral (12) 
Cryopreserved Improvement in pain and function. Shrinkage of graft to ~63% of normal meniscal size. 
Failures = 2 up to 69 months 
Rath et al. 
(2001) 
Medial (15) 
Lateral (7) 
 
Cryopreserved Complete healing to bed and revascularisation. Decrease in pain and improvement in 
function. Reduced cellularity in all grafts and reduced biochemical function. 
Failures = 8 up to 8 years 
Verdonk et 
al. (2005b) 
Medial (39) 
Lateral (61) 
Fresh Pain and function greatly improved. Effects remained in 70% of patients after 10 years. 
Failures = 21 up to 14 years 
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Figure 1.11:  Allorecognition pathways.  A) Direct pathway.  B) Indirect pathway.  
C) Semi-direct pathway (Adapted from Golshayan et al., 2007).  In the direct 
pathway allogeneic class II MHC on donor antigen-presenting cells (APCs) is 
recognised by CD4+ T helper cells.  Cytotoxic CD8+ T cells activated by the same 
APCs are then enlisted by these primed, allospecific helper T cells to impart an 
immune response.  The indirect pathway differs from the direct in that donor MHC 
molecules shed from the graft are picked up and processed by host APCs to be 
presented as peptides recognisable by helper T cells.  The semi-direct pathway 
involves aspects of both the direct and indirect pathways.  Donor MHC I molecules 
are acquired and presented to cytotoxic T cells as in the direct pathway by host 
APCs, which also present donor MHC class II molecules to helper T cells as in the 
indirect pathway.  In this way linked-help can occur as T cells are primed by the 
same APC.  
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1.5 Tissue Engineering of the Knee Meniscus 
A tissue engineered meniscal replacement conforming to the biological and 
biomechanical characteristics of native menisci prevent degeneration of the 
joint eradicating the need for further surgery or treatment thereby reducing 
the burden on health services and improve patients’ lives.  Many attempts 
have been made to tissue engineer a meniscus with limited success so far 
(Table 1.6 and Table 1.7).  It is very challenging to recapitulate the meniscus 
owing to its highly organized nature and heterogeneous cell population.  An 
ideal meniscal replacement has to be biocompatible, integrate with the 
surrounding tissue, allow neovascularisation, prevent degeneration of 
cartilage surfaces by remodelling in a timely manner whilst maintaining 
biomechanical and lubrication properties until regeneration has occurred and 
neo-tissue is able to withstand the biomechanical forces acting through the 
meniscus.  Ultimately, there are two strategies for engineering a meniscal 
replacement: a cell-based method in which scaffolds are seeded with cells 
before implantation or a cell-free method in which acellular scaffolds are 
designed to promote and support regeneration once implanted through the 
infiltration of endogenous cells from the surrounding tissue.  A variation of 
the cell-based method that is currently gaining momentum is the scaffold-
free approach in which stem cells or native meniscal cell types are cultured 
under specific conditions to produce meniscus-like ECM.  This aim with this 
approach is to eradicate the issues associated with the use of certain 
scaffolds such as adverse host responses, interference with cell-cell 
interactions and ECM alignment.  Biomechanically anisotropic tissue has 
been developed with collagen I, II and GAG deposition using articular 
chondrocytes and fibrochondrocytes in a  co-culture system utilising a 
meniscus-shaped mould (Aufderheide & Athanasiou, 2007).  The ideal 
approach for meniscal replacement has, however yet to be determined, with 
each method showing merit and impetus for further investigation. 
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Table 1.5: Animal meniscal allograft studies 
Reference Source Meniscus 
(Number) 
Allograft type 
(Number) 
Findings 
Milachowski 
et al. (1989) 
Ovine Medial 
(30) 
Freeze-dried (15) 
Irradiated (15) 
Complete healing, revascularisation and remodelling. No rejection. Less 
revascularisation in irradiated menisci. Grafts had lower tensile moduli when 
compared to normal menisci after 48 weeks. 
Arnoczky et 
al. (1992) 
Canine Medial 
(16) 
Fresh-frozen Repopulation with cells derived from synovium. Central core remained acellular at 
6 months. Remodelling of collagen network. No evidence of gross degeneration. 
Failures = None at 6 months 
Jackson et 
al.( 1992) 
Caprine Medial Fresh 
Cryopreserved 
Normal peripheral revascularisation and healing. Water content increased by 6% 
and proteoglycan content increased. Failures = None at 6 months 
Yahia et al. 
(1993) 
Lapine ? Fresh-frozen 
Irradiated 
Smaller effect on elastic stiffness than in irradiated grafts. No change in failure 
strength when compared to normal tissue. 
Adverse effect on viscous and elastic properties when irradiated. Lower Failure 
strength. 
Fabbriciani 
et al. (1997) 
Caprine Medial 
(30) 
Fresh-frozen (15) 
Cryopreserved (15) 
Healing at horns and periphery. No rejection. Grafts remodelled and 
revascularised at 1 year. 
Increase in water content and progressive decrease in GAG content. No 
differences noted between fresh-frozen and cryopreserved grafts. 
Szomor et 
al. (2000) 
Ovine Medial 
(28) 
Fresh Transplanted menisci less shiny than normal. Fibrinoid degeneration and areas of 
hypocellularity present. Failures = None at 4 months 
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The mechanical environment within the knee also needs to be considered 
when developing a tissue engineering strategy.  Whether the implanted 
material is a combination of cells and scaffold or scaffold alone it must be 
able to function under load without deforming or failing and provide the 
correct environment for cells to adhere and interact.  Certain cell types 
exhibit material-specific interactions dependent on material modulus with 
Engler et al. (2006) showing that mesenchymal stem cells, a cell source 
widely investigated in meniscal tissue engineering, commit to specific 
lineages dependent on matrix stiffness. 
 
1.5.1 Scaffold Based Meniscal Tissue Engineering 
Scaffold based approaches include the use of synthetic materials, naturally 
derived materials and acellular biological tissues (Table 1.6 and Table 1.7).  
Synthetic materials are easily processed, offer minimal batch to batch 
variability compared to naturally derived materials, and can have their 
mechanical and chemical properties tailored making them attractive options 
in generating a scaffold.  On the other hand, they lack the signalling cues 
present in naturally derived materials and can cause a mild immune 
response.  Interest in the use of synthetic materials for meniscal tissue 
engineering has declined following a period of intense investigation.    This 
may be due to evidence of adverse host responses (Veth et al., 1986; 
Klompmaker et al., 1996; Tienen et al., 2006) and failure to provide suitable 
environments for cellular ingrowth and matrix synthesis (Veth et al., 1986; 
Wood et al., 1990).  More recent studies, however, have shown some 
promise, possibly due to advances in biomaterials science and there are now 
approaches based on the use of advanced polymers such as poly L-lactic 
acid (PLLA), poly p-dioxanone (PPD), and polyurethane that are more 
biocompatible than polymers previously used.  Studies investigating 
acellular PLLA-PPD and PLLA scaffolds have shown regeneration of 
surgically created meniscal defects in animal models with integration to the 
native tissue (Testa Pezzin et al., 2003) and protection of cartilage surfaces 
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from damage (Cook & Fox, 2007).  Even so, synthetic materials will always 
induce a foreign body reaction and, if unchecked, the infiltration of cells and 
regeneration can be prevented by the formation of fibrotic scar tissue which 
can isolate the implant from the surrounding milieu.  Hence, produced from 
synthetic polymers have been coated in natural ECM components such as 
hyaluronan (Chiari et al., 2006).  The degradation rate can also be controlled 
to reduce the concentrations of inflammatory degradation products released 
by the scaffold. 
Various natural scaffolds have been investigated for tissue engineering the 
meniscus.  Collagen, decellularised menisci and small intestinal submucosa 
(SIS) have all been evaluated in an attempt to address meniscal 
regeneration (Cook et al., 2001; Reguzzoni et al., 2005; Bradley et al., 2007; 
Stapleton et al., 2008; Yamasaki et al., 2008).  Porcine small intestinal 
submucosa has been used in animal models of Achilles tendon repair to 
promote a regenerative response rather than a healing response where scar-
tissue is formed (Badylak et al., 1995).  After implantation SIS behaves as a 
temporary scaffold which degrades in 8 weeks having initiated a remodelling 
response (Badylak et al., 1995; Record et al., 2001; Gilbert et al., 2007).  It 
has been shown to improve limb function and reduce cartilage damage when 
used in repair of meniscal defects in dogs (Cook et al., 2006).  SIS has been 
used to treat avascular meniscal defects where it was shown to integrate 
well, produce an organized collagen matrix, and improve clinical function 
(Cook et al., 2001), however the repair tissue that was formed did not have 
significantly different Poisson’s ratio, permeability or shear modulus to the 
tissue formed when no treatment was applied (Welch et al., 2002).  SIS has 
also been shown to produce an unorganized matrix which resulted in 
increased degeneration of the cartilage surfaces when used to fill meniscal 
defects in rabbits (Bradley et al., 2007).  Currently SIS has been licensed as 
a clinical treatment for several applications other than meniscal repair. 
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Table 1.6:  In vitro meniscal tissue engineering 
Ref Material Model Cells, Growth 
Factors 
Study 
length 
Results 
Scaffold-based         
Balint et al. 
(2012)  
Collagen 
reinforced with 
p(DTD DD) 
Bovine - - Stiffness similar to ovine medial meniscus. Correlation between 
applied axial load and resultant circumferential tensile load. 
Ionescu et 
al. (2012)  
Poly-
caprolactone 
Bovine bFGF or TGF-β3 1 wk Addition of TGF increased integration strength 10-fold, increased 
GAG production with no change in collagen deposition.  Reduction 
seen when both added together. 
Decellularised Meniscus    
Maier et al. 
(2007) 
Decellularised 
meniscus 
Ovine 105 
fibrochondrocytes 
per mL 
4 wks Non-toxic.  Higher stiffness and compressive modulus to native 
meniscus. 
Stapleton et 
al. (2008) 
Decellularised 
porcine 
meniscus 
Porcine - - Complete cell removal.  No expression of xenogeneic epitope.  
Retention of histoarchitecture.  59.4% loss of GAGs.  Retention of 
biomechanical properties. Collagen I, II and III, and chondroitin 
sulphate present. 
Sandmann 
et al. (2009) 
Decellularised 
human 
meniscus 
Human - - Complete cell removal.  No significant differences in stiffness, 
residual force and collagen I, II and III histoarchitecture from native. 
Stabile et al. 
(2010) 
Decellularised 
ovine 
meniscus 
Ovine - - Complete removal of cellular material, ~55% reduction in DNA, 
maintenance of material properties, biocompatible, increased 
porosity. 
Cell-based           
Aufderheide 
& 
Athanasiou 
(2005)  
Agarose Leporine 2.5x107 
fibrochondrocytes 
per cm3, TGF-β1 
3 wks Cell death; individual cells of rounded morphology.  Aggregate 
modulus = ~10 kPa. 
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Puetzer et 
al. (2012)  
Alginate Bovine 50x106 meniscal 
cells per mL 
4-6 wks Increase of collagen bundle size with loading. Increase in GAG 
content with loading however this plateau`d except for in samples 
loaded then left static for 4 weeks where GAG plateau`d after 2 
weeks and sharply rose after 6 weeks.  Equilibrium modulus of 
samples increased with extended loading. 
Collagen           
Gruber et 
al. (2008)  
Collagen Human 105 
fibrochondrocytes 
per scaffold, 
TGF-β1 
2 wks Attachment of cells.  Presence of collagen I and II, and chondroitin 
sulphate.  Significant increase in proteoglycan production when 
exposed to TGF-β. 
Mueller et 
al. (1999b)  
Collagen I-
GAG 
Bovine 
or 
Canine 
1.8x107 
fibrochondrocytes 
per cm3 
3 wks Shrinkage to 54% of original size.  Fibroblast-like and chondrocyte-
like cells present which formed cellular capsule.  GAG and collagen 
production. 
  Collagen II-
GAG 
Bovine 
or 
Canine 
1.8x107 
fibrochondrocytes 
per cm3 
3 wks 12% shrinkage.  Cells distributed throughout scaffold.  Presence of 
collagen I and II, and GAGs. 
Hyaluronan         
Marsano et 
al. (2006)  
Hyaluronan Human 3.9x107 
fibrochondrocytes 
per cm3 in mixed 
flasks 
4 wks Bi-zonal tissue formation.  White zone rich in GAG and stiffer in 
compression. Red zone rich in collagen and stiffer in tension.  
Meniscus-like collagen organization. 
Tan et al. 
(2010)  
Hyaluronan-
Chitosan 
Murine 2x104 meniscal 
cells per well 
2 wks Collagen I/II + chondroitin sulfate surface triggered redifferentiation 
of dedifferentiated meniscal cells. 
Polymers           
Aufderheide 
& 
Athanasiou 
(2005)  
PGA Leporine 5x107 
fibrochondrocytes 
per cm3 
7 wks Cellularity increased; presence of collagen and GAGs.  Aggregate 
modulus = 2.6 ± 0.6 kPa. 
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Pangborn & 
Athanasiou 
(2005b)  
PGA Leporine 2.5x107 
fibrochondrocytes 
per cm3, TGF-β1 
3 wks Supports cell growth and ECM production.  TGF-β1 stimulated 
collagen and GAG synthesis. 
Aufderheide 
& 
Athanasiou 
(2007)  
PGA Bovine 50:50 articular 
chondrocytes and 
fibrochondrocytes
, 2.3x107 
8 wks Cell death; presence of randomly oriented collagen and GAGs. 
Tensile modulus = 16 ± 5 kPa in circumferential direction. 
Freymann 
et al. (2012)  
PGA-
hyaluronan 
Human 8.8x106 meniscus 
derived cells per 
scaffold 
3 wks Increase in matrix protein expression compared to control. 
Decrease in collagen X expression for all groups. Suggested 
redifferentiation of meniscus cells by scaffold. 
Fox et al. 
(2010)  
PGA-PLLA Equine 4x105 fibroblast-
like synoviocytes 
per cm3, bFGF, 
TGF-β1, IGF 
6 wks No integration of cell-scaffold construct to meniscal tissue.  No 
measurable collagen or GAGs.   
Baker et al. 
(2009)  
Polycaprolacto
ne 
Human 2.5x105 meniscus 
derived cells per 
scaffold 
10 wks Higher stiffness compared to unseeded scaffold. Reduced collagen 
and increased sGAG compared to native tissue. 
Mandal et 
al. (2011)  
Silk fibroin Human 0.8x106 BM-
MSCs per layer of 
scaffold, bFGF, 
TGF-β1 
4 wks Increase in collagen and GAG content.  Evidence for differentiation 
of MSCs to chondrogenic phenotype.  Doubling of compressive 
modulus in cultured scaffolds compared to scaffold alone. 
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The collagen meniscal implant, or CMI® (ReGen Biologics, Hackensack, NJ, 
USA), is a replacement composed of type I collagen and has been used to 
stimulate meniscal tissue ingrowth.  There are no storage or handling issues 
associated with collagen (Setton et al., 1999), and as collagen has 
maintained a highly preserved structure through evolution there is no 
antigenicity (van der Rest and Garrone, 1991).  Matrix characteristics such 
as porosity, pore size, permeability, shape and mechanical properties can 
also be adjusted in vitro (Setton et al., 1999).  In vivo studies in animals have 
shown that the CMI® promoted the in-growth of fibrochondrocytes and 
preserved the cartilage surfaces (Reguzzoni et al., 2005; Steadman & 
Rodkey, 2005).  However, it has also been shown that an unorganized and 
biomechanically unstable matrix is produced in patients using CMI® and it is 
therefore a poor substitute (Buma et al., 2007).  Collagen implants have had 
more success in vivo (Steadman & Rodkey, 2005) than decellularised 
menisci and SIS (Welch et al., 2002; Peretti et al., 2004).  Collagen and 
collagen-GAG composites, hyaluronan, and decellularised or devitalized 
meniscus are all currently under investigation as possible meniscal 
replacement or repair materials.  Varying degrees of success has been 
achieved with these with evidence of stem cell differentiation and ECM 
deposition in vitro, and integration and regeneration of defects in vivo.  
Decellularisation of porcine or human menisci to produce a natural scaffold 
has been gaining momentum in recent years (Maier et al., 2007; Stapleton 
et al., 2008; Sandmann et al., 2009).  Decellularisation aims to remove all 
immunogenic constituents of the tissue and provide an ideal structural 
framework for recellularisation either in vitro or in vivo.  Further work is 
required in this area to demonstrate practical feasibility. 
 
1.5.2 Cell Based Meniscal Tissue Engineering 
In vitro investigations into meniscal tissue engineering utilise natural, 
synthetic and combination biomaterials coupled with cells from various 
sources (Table 1.6 and Table 1.7).  In some cases cells are used to gauge 
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the biocompatibility of the chosen scaffold material as well as its ability to 
influence cell interaction and expression, although scaffold integration has 
been shown to be enhanced in preclinical studies which include a cell 
population with improved ECM deposition and organization (Angele et al., 
2008; Gu et al., 2012).  This may be because the remodelling response is 
accelerated as cells are already present and do not need to migrate into the 
scaffold (Gu et al., 2012).  Polyglycolic acid (PGA) has been investigated 
extensively as a synthetic scaffold for meniscal tissue engineering and has 
been reported to be biocompatible with a non-toxic degradation profile.  Cell 
proliferation, collagen synthesis and GAG production have all been shown 
to be improved when PGA scaffolds are compared to agarose scaffolds 
(Aufderheide & Athanasiou, 2005).  A study by Kang et al. (2006) using a 
meniscus-shaped PGA scaffold seeded with fibrochondrocytes before 
implantation demonstrated significant regeneration of fibrocartilage as well 
as zonal production of collagen I and II as seen in native menisci (Kang et 
al., 2006). 
Collagen based scaffolds have been shown to allow recellularisation and 
matrix production, with the addition of growth factors enhancing these 
properties (Gruber et al., 2008).  Cell behaviour has also been shown to be 
sensitive to collagen-GAG composites, with a collagen II-GAG composite 
promoting increased production of matrix components and reduced 
shrinkage as opposed to a collagen I-GAG composite (Mueller et al., 1999b).  
Hyaluronan has also shown promise as it can be used to produce bi-zonal 
tissue similar to meniscal tissue (Marsano et al., 2006). 
Fibrochondrocytes have been heavily investigated as a cell source for 
meniscal tissue engineering (Hidaka et al., 2002; Aufderheide & Athanasiou, 
2005; Pangborn & Athanasiou, 2005; Maier et al., 2007; Baker et al., 2009; 
Freymann et al., 2012).  Chondrocytes have also been well characterised 
and have been induced to produce meniscus-like ECM through manipulation 
of the culture conditions.  Other more readily available and easily procured 
cells have also been assessed for suitability in meniscal tissue engineering.  
These include various sources of stem cells (Horie et al., 2009; Zhang et al., 
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2009; Zellner et al., 2010; Mandal et al., 2011) which are yet to be 
understood in this application, as well as meniscal fibrochondrocytes or 
chondrocytes. However, stem cells have shown promise in producing a 
meniscus-like ECM.  Bone marrow derived mesenchymal stem cells have 
been shown to produce dense ECM containing type II collagen when seeded 
onto hyaluronan-gelatin composite scaffolds (Angele et al., 2008).  
Synovium-derived stem cells have been utilised in an injectable system for 
meniscal repair and have been shown to develop a gene expression profile 
which was more similar to meniscal cells than when bone marrow derived 
mesenchymal stem cells were used (Horie et al., 2009).  Investigations which 
have focussed upon the use of cells in combination with scaffolds or in self-
assembly approaches (Table 1.7) have, however, failed to articulate how the 
approach can be readily translated to routine clinical use. 
Practical and regulatory considerations will determine the successful 
translation to the clinic of scaffold-only or scaffold seeded with cells 
approach.   An ideal scaffold should have the appropriate mechanical 
properties to fulfil the load bearing and biotribological function of the 
meniscus immediately upon implantation whilst also encouraging the 
infiltration of a cell population to instigate regeneration.  Scaffold-only 
approaches could provide an off-the-shelf class III medical device at a 
relatively low cost making it accessible to a large number of patients.  
Approaches which include a living cell population may promote faster healing 
and regeneration compared to scaffold-only approaches however their use 
adds a level of complexity to the procedure.  Cells have to be harvested, 
most likely from an autologous source for immune-compatibility resulting in 
potential donor site morbidity, and cultured to obtain sufficient numbers for 
implantation.  This approach would be subject to additional regulatory 
requirements as it would be classed as an Advanced Therapy Medicinal 
Product (ATMP) and so a longer development life-cycle resulting  
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Table 1.7:  In vivo meniscal tissue engineering 
Ref Material Model Cells, Growth 
Factors 
Follow-
up 
Results 
Scaffold-based         
Carbon Fibre         
Veth et al. 
(1983)  
Carbon fibre Leporine - 17 wks None to partial repair in 43% with fibrosis in 57%.  
Fibrocartilage formation along carbon fibres. 
Veth et al. 
(1986)  
Carbon fibre-PLLA-
poly-urethane 
Canine - 19 wks Infiltration of vessels and neo-tissue.  Inflammation of 
synovium due to carbon fibre. 
Wood et al. 
(1990)  
Carbon fibre-
polyester 
Leporine - 26 wks Inflammation around polyester fibres.  Osteophyte 
formation and no cellular infiltration visible. 
CMI           
Stone et al. 
(1997)  
CMI Human - 3 yrs Repopulation by fibrochondrocytes.  Presence of 
unorganized and immature collagen fibres. 
Reguzzoni et 
al. (2005)  
CMI Human - 26 wks Implant healed to the meniscal capsule and stumps and 
displayed revascularisation and ECM production. 
Steadman & 
Rodkey 
(2005)  
CMI Human - 6 yrs Chondral surfaces protected with uniform ECM production 
and improvement in symptoms. 
Rodkey et al. 
(2008)  
CMI Human - 7 yrs Formation of repair tissue which appeared meniscus-like.  
Improvement in activity. 
Bulgheroni et 
al. (2010)  
CMI Human  2, 5 yrs Shrinkage of CMI but protection of chondral surfaces. 
Bone oedema was present in 13 patients. Two types of 
tissue formed after 5 years with increased cellularity and 
vascularity. 
Zaffagnini et 
al. (2011)  
CMI Human - 10 yrs Protection of cartilage surfaces with improvements from 
preoperative state 
Repair Materials         
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Tienen et al. 
(2006)  
Estane Canine - 26 wks Degenrative lesions formed on inner rim.  Integration seen 
at periphery with collagen I production and 
neovascularisation.  Neotissue had inferior mechanical 
properties compared to native meniscus. 
Kopf et al. 
(2010)  
Poly (ethylene, 
terephthalate) 
(Ethibond®) 
Ovine VEGF 8 wks No improvement compared to controls 
Reckers et al. 
(2009)  
Fibrin glue Leporine  4 wks Loosening of meniscus with cell infiltration impaired. 
Ishida et al. 
(2007)  
Gelatin hydrogel Leporine Platelet-rich Plasma 4, 8, 12 
wks, 
Protection of cartilage surfaces with Safranin O staining 
present after 12 weeks. 
Kobayashi et 
al. (2010)  
Meniscal fragments Leporine - 3, 6, 12 
wks 
Rough, meniscus-like tissue formed but thinner radially 
than native meniscus.  Thick synovium also formed. 
Reckers et al. 
(2009)  
Octyl cyanoacrylate 
suture 
Leporine - 4 wks Necrosis of transplanted menisci.  Suturing alone 
displayed best outcome. 
Polymers           
Testa Pezzin 
et al. (2003)  
PLLA-PPD Leporine   14 wks Some correctly aligned collagenous tissue formation with 
fibrochondrocyte infiltration. 
Chiari et al. 
(2006)  
Polycaprolactone-
Hyaluronan 
Ovine - 6 wks Soft tissue swelling in 4 cases (2 each) and both 
meniscectomies. Tissue ingrowth and vascularisation at 
periphery. Synovium regenerated. Graft extrusion and 
wrinkling. 
Tienen et al. 
(2006b)  
Polycaprolactone-
polyurethane 
Canine - 26 wks Fibrocartilage ingrowth.  Collagen I in peripheral fibrous 
zones and collagen II in central cartilaginous zones.  Small 
synovial reaction to polymer.  Giant cells and 
macrophages present. 
Welsing et al. 
(2008)  
Polycaprolactone-
polyurethane 
Canine - 24 mths Zonal tissue formation with thin fibrovascular rim and 
larger avascular cartilage-like inner zone. Collagen I, II and 
proteoglycans present. Fragmentation of scaffold. 
Cartilage degeneration similar to meniscectomy group. 
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Hannink et al. 
(2011)  
Polycaprolactone-
polyurethane 
Canine - 6, 24 
mths 
Cartilage degeneration seen at 6 months with further 
degeneration into calcified zone seen after 24 months. 
Cook and 
Fox (2007)  
poly-L-lactic acid Canine - 24 wks No articular cartilage damage. Complete healing (n = 2) 
and partial healing (n = 3) in avascular region of dogs 
receiving scaffold. No healing in controls. Load to failure 
was 52% for scaffold-treated menisci compared to intact 
menisci. Trephined menisci had zero strength. 
De Groot et 
al. (1997)  
poly-L-lactic acid 
and ε-caprolactone 
Canine - 26 wks Fibrocartilage ingrowth.  Formation of fibrocartilage linked 
to compressive modulus of scaffold. 
Klompmaker 
et al. (1992)  
Polyurethane Canine - 52 wks Formation of collagen I and II.  Giant cells, macrophages 
and lymphocytes present on polymer surface. 
Klompmaker 
et al. (1996)  
Polyurethane Canine - 28 wks Formation of collagen I and II.  Giant cells, macrophages 
and lymphocytes present.  Degeneration of cartilage. 
Brophy et al. 
(2009)  
Polyurethane Ovine -  Compressive modulus of 4.5 ± 1.3 MPa and 0.3 ± 0.1 MPa 
at 70% and 25% strain, respectively. Decreased mean 
contact area compared to intact knee. 
Galley et al. 
(2011)  
Polyurethane Ovine - 3, 6 and 
12 mths 
Tissue ingrowth into scaffold.  Lower equilibrium modulus 
than intact meniscus after 12 months. 
Verdonk et 
al. (2011)  
Polyurethane 
(Actifit®) 
Human - 24 mths Ingrowth of vascularised neomatrix. Protection of cartilage 
surfaces. Zonal tissue formation. 
SIS           
Cook et al. 
(2006)  
Small intestinal 
submucosa (SIS) 
Canine   3, 6, 12 
mths 
Mature repair tissue visible for SIS group.  Significantly 
lower articular cartilage damage than meniscectomy.  
Compressive moduli comparable to untreated group after 
12 months. 
Cell-based           
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Injectable 
Mizuno et al. 
(2008)  
- Murine 107 Synovium-
derived MSCs 
12 wks Formation of fibrocartilage time-dependent increase in 
collagen II expression. Stem cells appeared 
morphologically similar to meniscal cells. 
Horie et al. 
(2009)  
- Murine 5x106 Synovium-
derived MSCs 
2, 4, 8, 
12 wks 
Formation of fibrocartilage time-dependent increase in 
collagen II expression. Stem cells appeared 
morphologically similar to meniscal cells. Similar results 
with BM MSCs, however synovium derived stem cell 
genetic profile similar to meniscal cells 
Zhang et al. 
(2009)  
Calcium alginate 
gel 
Caprine BM MSCs 
transfected with 
IGF-1 
4, 8, 16 
wks 
Integration and formation of cartilage-like tissue. 
Chondrocyte-like cells present. Collagen I present.  
Self-assembled          
Aufderheide 
& Athanasiou 
(2007) 
Agarose wells Bovine 50:50 articular 
chondrocytes and 
fibrochondrocytes, 
2.3x107 cells 
8 wks Collagen fibre alignment with presence of collagen I and II, 
and GAGs.  Biomechanically anisotropic neotissue. 
Hoben et al. 
(2007) 
Agarose wells Bovine 50:50 co-culture of 
fibrochondrocytes 
and chondrocytes, 
2.75x107 cells each 
4 wks Presence of collagen I and II, and GAGs. 
      5.5x107 
fibrochondrocytes 
  Presence of collagen I and GAGs.  Significant contracture 
of construct. 
Meniscus           
Peretti et al. 
(2004) 
Decellularised 
meniscus 
Porcine Autologous 
chondrocytes 
9 wks Repair not homogeneous.  GAG production. 
Yamasaki et 
al. (2008) 
Devitalized 
meniscus 
Murine 2x105 BM MSCs 
per scaffold 
8 wks Expression of ECM.  Degeneration comparable to 
meniscectomised knees. 
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Weinand et 
al. (2009)  
Devitalized 
meniscus and 
woven PLGA mesh 
Murine Porcine 
chondrocytes at 1, 
2 and 5 million cells 
per mL 
12 wks Most homogeneous cell attachment found using dynamic 
oscillation. Integration of devitalized meniscus scaffold to 
surrounding tissue. 
Isoda & Saito 
(1998)  
Fibrin Leporine Fibrochondrocytes 8 wks Matrix production and cell proliferation 
Zellner et al. 
(2010)  
Hyaluronan-gelatin 
70:30 
Leporine 1.5x106 MSCs per 
scaffold 
12 wks Defects filled with dense ECM. Collagen II present. 
Integration to native meniscal tissue. 
Polymers           
Ibarra et al. 
(1997)  
PGA Murine 2.5x107 bovine 
fibrochondrocytes 
per mL 
16 wks Production of collagen and proteoglycan.  Matrix 
architecture similar to meniscal repair tissue. 
Hidaka et al. 
(2002)  
PGA Murine 2x107 bovine 
fibrochondrocytes 
per cm3 
8 wks Production of collagen and proteoglycan. Less extensive 
collagen network than normal meniscus. 
Kang et al. 
(2006)  
PGA-PLGA Leporine 2x106 meniscal 
cells per scaffold 
6, 10 
wks 
Fibrocartilage produced.  Time-dependent increase in 
collagen and proteoglycan content. Degeneration of tibial 
cartilage. 
Gu et al. 
(2012)  
PLGA Canine 1.5x107 canine 
myoblasts per 
scaffold, CDMP-2, 
TGF-β1 
12 wks Formation of cartilage-like regions with collagen I, II and 
aggrecan production. 
Kon et al. 
(2012)  
Polycaprolactone-
Hyaluronan 
Ovine 4x107 autologous 
chondrocytes per 
scaffold  
12 mths Osteoarthritis present in all groups.  Less severe in 
scaffold groups, both cell seeded and unseeded. Foreign 
body reactions present.  Hyaline-like matrix production in 
cell seeded constructs, with fibrous, GAG-rich matrix 
production in unseeded constructs. 
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in increased cost to the patient and/or health service provider thereby 
reducing availability to patients. 
An alternative avenue may be to harvest a population of cells during surgery 
which could be subjected to minimal manipulation and used in conjunction 
with the scaffold to enhance the regenerative properties of the implanted 
scaffold.  As no ex vivo manipulation is involved the device would still be 
regulated as a class III medical device, thereby remaining cost-effective and 
accessible to a larger number of patients. 
 
1.5.3 Conclusion 
Tissue engineering aims to create functional tissue with the potential for 
regeneration and growth.  The choice of scaffold for this purpose is crucial.  
The ideal scaffold should be biocompatible, biomechanically and 
geometrically suited to resist forces within the knee as healing progresses, 
non-immunogenic, and, if acellular, allow for endogenous cell population and 
vascularisation.  Although different materials have been investigated, an 
ideal conduit is yet to be developed.  Promising results have been obtained 
using both natural and synthetic materials.  Approaches which use a 
combination of cells and scaffold materials to recapitulate the meniscus prior 
to implantation are at a much earlier stage of development and there is little 
consideration of how these approaches might be translated to the clinic in 
the literature. 
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1.6 Aims and Objectives 
An acellular porcine medial meniscus has been developed which has great 
potential for clinical translation in the repair/ replacement of meniscal tissue. 
The biomimetic acellular scaffold may be implanted directly and regenerated 
by the recipients own endogenous stem cells or alternatively, it may be 
seeded with cells and used as a cellularised replacement. In order to 
produce a replacement that can be surgically implanted, the acellular 
meniscus should ideally retain bone plugs at either end (bone-meniscus-
bone graft).   
Proposed Methodology: 
a) Development of a method for effective decellularisation of the fresh 
porcine medial meniscus without compromising bony attachments. 
b) Comparison of fresh and decellularised porcine medial menisci by 
histological, immunohistochemical and biochemical methods. 
c) Biomechanical characterisation of the fresh and decellularised porcine 
medial meniscal tissue and bony attachments using simple compression 
and indentation tests. 
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Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 Equipment 
Details of the equipment and suppliers of the equipment used throughout 
this study are presented in Table 2.1. 
Table 2.1: Equipment used during the course of studies 
Equipment Model Supplier 
Aspirator Vacusafe Integra Biosciences 
Autoclave - - 
Balance GR200/GX2000 Jencons plc 
Bone Saw 310 EXAKT Technologies Inc 
Centrifuge Harrier 15/80  
Class II safety cabinet Heraeus 85 Kendro 
Cryomill Spex Sampleprep 
6770 
Fisher Scientific 
Dehydration and 
infiltration system 
510 EXAKT Technologies Inc 
Digital camera Evolution MP Colour Media Cybernetics 
Differential Scanning 
Calorimeter 
  
Filter paper Various Scientific Laboratory Systems 
Ltd 
Freezer (-25 °C) Electrolux 3000 Jencons plc 
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Freeze dryer LSBC50 Modulyo 
Fridge Electrolux ER8817 C Jencons plc 
Fume hood - Whiteley 
Gel Imaging System LOGIC 1500 Kodak 
Grinder 400 CS EXAKT Technologies Inc 
Haemocytometer Neubauer  
MNK-420-010N 
Fischer scientifiv 
Heating block - - 
Heated forceps Speci-leps Bios Europe 
Histology Cassettes  CMB-160-030R Thermo Fisher Scientific Ltd 
Histology water bath 3L Histology Leica Microsystems 
Hot plate E18.1 Raymond A Lamb 
Hot wax dispenser E66 wax dispenser Raymond A Lamb 
Incubator MCO-17A Sanyo 
Inverted microscope IX71 Olympus UK Ltd 
Light polymerization 
unit 
520 EXAKT Technologies Inc 
Linear variable 
differential transformer 
(LVDT) 
RDP DS-200H 
 
Electrosence  
 
Luminescence counter 
and liquid scintillation 
counter 
Packard TopCount 
NX 
Perkin Elmer 
Magnifying lamp D20251 Fisher Scientific 
Microscope Olympus BX51 Microscopes, Medical 
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Diagnostic Systems and 
Olympus Patient Systems Ltd 
(Olympus UK Ltd) 
Microtome RM2125RTR Leica Microsystems 
Magnetic Resonance 
Imager 
Bruker AVANCE II 
400 mHz 9.4T NMR 
Bruker 
Orbital shaker IKA KS 130 Basic Scientific Laboratory Systems 
Ltd 
PCR machine PCR Sprint Thermal 
Cycler 
Thermo Electron Corporation 
pH meter Jenway 3510 VWR International 
Piezo-electric force 
transformer 
060-1896-02 Electrosence 
Pipette Gilson Pipetman P2, 
P20, P200, P1000 
Anachem Ltd 
Pipette boy Acu classic Scientific Laboratory Systems 
Ltd 
Plate reader Multiskan Spectrum 
1500 
Thermo Fisher Scientific Ltd 
Precision adhesive 
press 
402 EXAKT Technologies Inc 
Shaking table IKA KS 130 Basic Jencons plc 
Slide holder  E102 Raymond A lamb  
Spectrophotometer Nanodrop ND-1000 Labtech Int 
Tensile testing 
machine 
3365 Instron 
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Tissue processor Leica TP 1020 Leica Microsystems 
Vacuum adhesive 
press 
401 EXAKT Technologies Inc 
Vortexer MS2 minishaker IKA 
Water bath Grant Jencons plc 
Water Pik Ultra Water 
Flosser 
WP100 WaterPik 
Water purifier  Option 7  ELGA 
 
2.1.2 Chemicals 
Details of the chemicals and the suppliers of the chemicals used 
throughout this study are shown in Table 2.2.  
Table 2.2: Chemicals used during the course of studies 
Chemical/Reagent Supplier 
Acetone  European Bios  
Acetic Acid  Thermo Fisher  Scientific Ltd  
Alcian Blue Bios Europe Ltd 
Ammonium oxalate Thermo Fisher Scientific Inc 
Anhydrous sodium hydrogen 
phosphate 
BDH Laboratory Supplies 
Aprotinin Mayfair house Leeds Teaching Hospital 
Pharmacy 
ATPLite-M assay PerkinElmer Ltd 
Bovine serum albumin Sigma-Aldrich Ltd 
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Calcium Chloride VWR International  
Calf thymus DNA Sigma-Aldrich Ltd 
Chloramine T Sigma-Aldrich Ltd 
Chondroitin sulfate Sigma-Aldrich Ltd 
Citric acid monohydrate Sigma-Aldrich Ltd 
DABCO Sigma-Aldrich Ltd 
DAPI Sigma-Aldrich Ltd 
Di-sodium hydrogen 
orthophosphate 
VWR International  
DPBSa Oxoid Ltd 
DPX mountant Bios Europe Ltd 
Eosin Thermo Fisher Scientific Inc 
Ethanol Thermo Fisher Scientific Inc 
Ethylenediaminetetraacetic acid 
(disodium salt) 
VWR International 
Fast green Sigma-Aldrich Ltd 
Foetal bovine serum Lonza 
Formic Acid  Sigma- Aldrich Ltd 
Glacial acetic acid VWR International 
Giemsa stain BDH Laboratory Supplies 
Glycerol Sigma-Aldrich Ltd 
Haematoxylin Bios Europe Ltd 
Hydrochloric acid Sigma-Aldrich Ltd 
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Hydrogen Peroxide Sigma- Aldrich Ltd 
ImmEdge Hydrophibic Barrier Pen Vector Laboratories 
Isopropanol Thermo Fisher Scientific 
L-Cystine hydrochloride Sigma- Aldrich Ltd 
Magnesium chloride VWR International 
Methanol Vichers Laboratories 
Miller’s staining kit Bios Europe Ltd 
Neutral buffered formalin Bios Europe Ltd 
Oxalic acid Thermo Fisher Scientific Inc 
p-dimethylbenzaldehyde Sigma-Aldrich Ltd 
Paraffin wax pellets Bios Europe Ltd 
PBS tablets Thermo Fisher Scientific Inc 
Peracetic acid Sigma-Aldrich Ltd 
Perchloric acid BDH Laboratory Supplies 
pH buffers Thermo Fisher Scientific Inc 
Potassium permanganate BDH Laboratory Supplies 
RNAase A Sigma-Aldrich Ltd 
Sirius red Raymond A Lamb Ltd 
Sodium acetate  Thermo Fisher Scientific Ltd 
Sodium azide  G Biosciences  
Sodium chloride VWR International 
Sodium di-hydrogen 
orthophosphate 
VWR International  
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Sodium hydroxide VWR International 
Trigene Scientific Laboratory Supplies Ltd 
Tris base Sigma-Aldrich Ltd 
Trypan Blue  Sigma-Aldrich Ltd 
Tween 20  Sigma-Aldrich Ltd 
Virkon Scientific Laboratory Supplies Ltd 
Xylene Bios Europe Ltd 
 
 
2.1.3 Cells 
The cell culture reagents used throughout this study are listed in Table 2.3 
and cell types and suppliers are listed in Table 2.4. 
Table 2.3: Cell culture reagents used during the course of the studies 
Reagent Supplier 
Dulbecco’s modified Eagle`s medium (DMEM) Lonza 
Fetal bovine serum (FBS) Lonza 
Glasgow’s minimal essential medium (GMEM) Sigma-Aldrich 
L-Glutamine (200 mM) Lonza 
Penicillin-streptomycin (5000 U.mL-1, 5000 U.mL-1) Lonza 
Trypsin-EDTA  Sigma-Aldrich 
Tryptose phosphate broth Sigma-Aldrich 
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Table 2.4: Cells used during the course of the studies 
Name Type Source Supplier 
3T3 Fibroblasts Murine European Collection of Animal 
Cell Cultures 
Baby Hamster 
Kidney (BHK) 
Fibroblasts Cricetine Health Protection Agency 
 
 
2.1.4 Antibodies 
Details of the antibodies used for investigations are presented in Table 2.5 
and Table 2.6.  The LabVision UltraVIsion ONE Detection System (Thermo 
Fisher Scientific) was used to visualise antibodies. 
Table 2.5: Primary antibodies 
Antigen Clone Antigen 
retrieval 
Isotype Working 
dilution  
Supplier 
α-gal M86 Proteinase K IgM 1:4 Enzo Life 
Sciences 
Collagen I - Proteinase K IgG 1:50 Millipore 
Collagen II COLL-II Proteinase K IgG 1:50 Millipore 
Collagen III - Proteinase K IgG 1:100 Abcam 
Collagen IV CIV22 Proteinase K IgG 1:4 Dako 
Collagen VI - Proteinase K IgG 1:50 AbD Serotec 
Osteocalcin 8H12F9H10 Proteinase K IgG2a 1:50 AbD Serotec 
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Table 2.6: Isotype control antibodies 
Isotype Source Supplier 
IgG1 Mouse Dako (X0931) 
IgG2a Mouse Dako (X0932) 
IgM Mouse Dako (X0942) 
 
2.1.5 Kits 
Kits used throughout the studies are listed in Table 2.7. 
Table 2.7: Kits used throughout the studies 
Kit Use Supplier 
LabVision UltraVIsion 
ONE Detection System 
Antibody visualisation Thermo Fisher Scientific 
DNeasy Blood & Tissue DNA extraction Qiagen 
 
2.1.6 Consumables 
2.1.6.1 Dissection instruments 
A size 22 scalpel handle, scissors and forceps were obtained from Seward 
Thackray.  Single-use size 22 scalpel blades were purchased from Thermo 
Fisher Scientific Ltd. 
 
2.1.6.2 Glassware 
Glassware (bottles, beakers and measuring cylinders) were cleaned by 
soaking overnight in Neutracon® detergent followed by washes in tap 
water and a final wash in distilled water. 
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2.1.6.3 Sterile plasticware 
Specimen containers (60 ml, 150 ml and 250 ml) were purchased from 
Scientific Laboratory Supplies Ltd.  Stripette® disposable pipettes were 
supplied by Sigma Aldrich Ltd. 
 
2.1.7 Stock solutions 
2.1.7.1 Phosphate buffered saline (PBS) 
One PBS tablet was dissolved in 100 mL of distilled water and kept at room 
temperature. 
2.1.7.2 Tris buffered saline (TBS) 
Tris solution (pH 7.6), 2M 25 ml was mixed with 50 ml 3M NaCl solution. 
The volume was made up to 1 L using distilled water. The pH of the 
solution was adjusted to pH 7.6.  The solution was sterilised by autoclaving 
and stored at room temperature. 
2.1.7.3 3T3 culture medium 
3T3 cells were cultured using Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (v/v) foetal bovine serum (FBS), 2mM L-
glutamine and 100 U.mL-1 each of penicillin and streptomycin. 
 
 
2.1.7.4 BHK culture medium 
BHK cells were cultured using Glasgow’s minimal essential medium 
(GMEM) supplemented with 5% (v/v) FBS, 2.5% (v/v) tryptone phosphate 
broth (TPB), 1 mM L-glutamine, and 100 U.mL-1 each of penicillin and 
streptomycin. 
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2.1.8 Decellularisation solutions 
2.1.8.1 Hypotonic buffer (10 mM tris, 2.7 mM EDTA, 10 KIU.mL-1 
aprotinin) 
Trizma base (1.21 g) and EDTA (1 g) were dissolved in 900 mL distilled 
water using a magnetic stirrer and stirrer bar.  The pH was then adjusted to 
8.0 – 8.2 by adding 6M hydrochloric acid or 6M sodium hydroxide drop 
wise, after which the volume was made up to 1 L using distilled water. 
2.1.8.2 SDS hypotonic buffer (0.1% (w/v) SDS, 10 mM tris, 2.7 mM 
EDTA, 10 KIU.mL-1 aprotinin) 
SDS (0.5 g) was added to hypotonic buffer (500 mL) using a magnetic 
stirrer and stirrer bar. 
2.1.8.3 Wash buffer (10 KIU.mL-1 aprotinin) 
One PBS tablet per 100 mL was added to distilled water to the volume 
required, to which aprotinin (10 KIU.mL-1) was added. 
2.1.8.4 Wash buffer with EDTA (2.7 mM EDTA, 10 KIU.mL-1 aprotinin) 
EDTA (0.1% w/v) was added to wash buffer. 
2.1.8.5 Nuclease solution (50 mM tris, 21 mM MgCl2, 50 µg.mL-1 BSA, 
50 U.mL-1 DNase, 1 U.mL-1 RNase) 
Trizma base (6.1 g) and magnesium chloride (2.0 g) were added to 80 mL 
of distilled water using a magnetic stirrer and stirrer bar and the pH 
adjusted to 7.5 – 7.7 using 6M hydrochloric acid or 6M sodium hydroxide.  
The volume was then made up to 990 mL with distilled water.  Immediately 
prior to use BSA (50 µg.mL-1), RNase (1 U.mL-1) and DNase (50 U.mL-1) 
were added and the solution used within 10 minutes. 
2.1.8.6 Hypertonic buffer (50 mM tris, 1.5 M sodium chloride) 
Sodium chloride (87.66 g) and tris (6.06 g) were added into 900 mL distilled 
water.  The pH was adjusted to 7.5 – 7.7 using 6M hydrochloric acid or 6M 
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sodium hydroxide.  The volume was then made up to 1000 mL using 
distilled water. 
2.1.8.7 Peracetic acid (PAA) solution (0.1% v/v) 
Peracetic acid solution (1.57 mL) was added to 500 mL of PBS solution 
and the pH adjusted to 7.2 – 7.5 using 6M hydrochloric acid or 6M sodium 
hydroxide. The solution was made fresh and used within 10 minutes.  
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2.2 Methods 
2.2.1 Basic techniques 
2.2.1.1 Measurement of pH 
The pH of solutions was measured using a Jenway 3020 pH meter.  
Calibration was carried out using standard solutions at pH 4, 7 and 10.  
The pH was altered using 6M hydrochloric acid or 6M sodium hydroxide 
and the pH was measured using temperature compensation. 
2.2.1.2 Microscopy 
Bright-field microscopy was carried out using an Olympus BX51 upright 
microscope.  Inverted microscopy was performed using an Olympus IX71 
inverted microscope.  Images were captured using an attached Evolution 
MP Colour digital camera controlled using cell^B® imaging software with 
correct Kohler illumination.  Fluorescence microscopy was carried out by 
illuminating fluorescently stained slides using a BX51-RFA fluorescent 
vertical illuminator and the same Olympus BX51 upright microscope.  
Images were captured using an attached Evolution MP Colour digital 
camera controlled using cell^B® imaging software.  
2.2.1.3 Moist heat sterilisation 
Solutions suitable for autoclaving were sterilised by autoclaving at 121 °C 
and 15 psi for 20 minutes with caps loosened slightly. 
2.2.1.4 Dry heat sterilisation 
Items were wrapped in foil and placed in an oven and held at a 
temperature of 180 °C for 4 hours. 
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2.2.2 Dissection 
2.2.2.1 Equipment 
Equipment used to dissect menisci and bone-meniscus-bone are listed in 
Table 2.8. 
Table 2.8: Dissection equipment 
Equipment Size Supplier 
Bench top clamp - Irwin 
Hand saw - - 
Scalpel handle Size 4 Scientific Laboratory Supplies Ltd 
Rat tooth forceps - Seward Thackray 
Curved scissors - Seward Thackray 
 
2.2.2.2 Dissection method 
Porcine right hind legs from female white pigs (~6 months old, 75kg) were 
obtained from the abattoir (J. Penny, Rawdon, Leeds) within 24 hours of 
slaughter.  Menisci and bone-meniscus-bone were obtained as shown in 
Figure 2.1.  Incisions were made in the porcine knee to isolate the knee 
joint capsule (A).  The patella was then removed by cutting through the 
patella tendon and down into the intercondylar fossa (B).  Incisions were 
made in order to separate the femur from the tibia and this exposed the 
tibial plateau and menisci (C).  If retrieving only meniscus, then the medial 
meniscus was obtained at this stage by cutting through the meniscal horns.  
If dissecting bone-meniscus-bone the lateral meniscus was cut at the horns 
(D) leaving the top of the tibial plateau and medial meniscus intact.  The 
top of the tibial plateau was sawn off (E) with ~2 cm of bone remaining to 
the surface (F).  Rat tooth forceps were used to remove connective tissue 
and separate the meniscus from the PMCP (G).  The tibial plateau was 
then clamped and the lateral region of the tibial plateau removed (H).  This 
flat edge enabled improved clamping of the remaining sample and so 
70 
further portions of bone were removed using a saw to leave a single  
segment of bone to which the meniscus was attached (I, J).  At this point, 
rat tooth forceps were again employed to remove tissue from around the 
attachment sites of the medial meniscus, including remaining portions of 
the ACL and PCL (K).  The bone was then sawn through the middle and 
separated into individual bone blocks (L).  These were cut to ~10 mm x 10 
mm x 15 mm (M, N) and excess blood removed by washing in PBS (O).  
Menisci were then stored at -20 °C in sterile plastic pots containing PBS 
soaked filter paper. 
 
Figure 2.1: Dissection of bone-meniscus-bone. 
 
71 
2.2.3 Tissue preparation 
2.2.3.1 Fixation 
Meniscus was cut into pieces no more than 4 mm in thickness along the 
radial axis and bone was cut into pieces measuring 3 mm x 11 mm x 15 
mm and placed in labelled histocassettes.  These were then either 
immersed in 10% (v/v) neutral buffered formalin for 48 hours if destined for 
histology or immersed in zinc fixative for 16 hours if destined for 
immunohistochemistry.  Zinc fixative solution (pH 7.4) was comprised of 5 
g.L-1 zinc acetate, 5 g.L-1 calcium acetate, and 0.5 g.L-1 zinc chloride. 
2.2.3.2 Decalcification 
Samples of previously fixed bone were decalcified in 125 g.L-1 EDTA under 
agitation at 37 °C.  EDTA was changed every other day and decalcification 
assessed using the calcium oxalate test. 
2.2.3.3 Calcium oxalate test 
Reagents: 
• Citric-Phosphate buffer 
o 7.5 g.L-1 citric acid 
o 4.0 g.L-1 anhydrous sodium hydrogen phosphate 
• Saturated ammonium oxalate solution 
Samples (0.5 mL) were taken of solutions being used to decalcify bone and 
placed into bijouxs.  Citrate-phosphate buffer (1 mL) and saturated 
ammonium oxalate solution (2.5 mL) were added to each sample and 
mixed by inverting.  Samples were left undisturbed for 20 minutes after 
which they were checked for precipitate formation.  Presence of a 
precipitate indicated the presence of calcium ions in the sample and 
incomplete decalcification. 
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2.2.3.4 Lyophilisation 
Tissue was cut into ~1 mm3 pieces using a scalpel and weighed into 
bijouxs.  Lids were left slightly loose and bijouxs containing samples were 
placed in a freeze-drier (Thermo, ModulyoD) at -50 °C, 0.15 – 0.2 bar, and 
freeze dried to constant weight. 
2.2.3.5 Homogenisation 
Freeze-dried tissue was placed in a Spex Sampleprep cryomill and 
comminuted to a fine powder by mechanical disruption for five minutes. 
2.2.3.6 Acid hydrolysis 
Tissue samples were hydrolysed to break down proteins to their constituent 
amino acids for subsequent determination of hydroxyproline.  Samples 
(100 mg) were added to SureSeal polypropylene tubes and 5 mL of 6M 
hydrochloric acid added.  Tubes were then sealed and wrapped in parafilm 
to avoid evaporation, and incubated in a heating block at 120 °C for 6 
hours.  Samples were then neutralised using 6M sodium hydroxide. 
2.2.3.7 Papain digestion 
Reagents: 
• Digestion solution 
o 1250 U papain 
o 0.788 g.L-1 L-cysteine hydrochloride 
o 1.8612 g.L-1 EDTA 
o PBS 
Lyophilised samples were digested using papain for subsequent 
quantification of sulphated glycosaminoglycans.  Samples (50 mg) were 
incubated in papain digestion solution (5 mL) at 60 °C in a water bath for 
72 hours until fully digested. 
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2.2.4 Histological techniques 
2.2.4.1 Paraffin embedding 
Menisci were cut radially into 10 slices approximately 4 mm in width.  Each 
slice was then placed into 50 mL 10% (v/v) NBF for 48 hours prior to being 
placed into cassettes for dehydration using an automated tissue processor.  
The programme used immersed the slices sequentially into the following 
reagents: 10% (v/v) NBF for 1 hour (this step was omitted when zinc 
fixative was used), 70% (v/v) ethanol for 1 hour, 90% (v/v) ethanol for 1 
hour, 100% (v/v) ethanol for 2 hours 20 minutes, 100% (v/v) ethanol for 3 
hours 20 minutes, 100% (v/v) ethanol for 4 hours 20 minutes, xylene for 1 
hour, xylene for 1 hour 30 minutes, xylene for 2 hours, molten wax for 1 
hour 30 minutes, molten wax for 2 hours, and molten wax for 2 hours.  
Once this had finished the slices were taken and placed into wax moulds 
and covered in molten wax then left to solidify.  The wax moulds were then 
removed and any excess wax trimmed using a forceps handle. 
2.2.4.2 Sectioning of wax-embedded tissue blocks and slide preparation 
Blocks were sectioned using a microtome set to cut at a width of 6 µm and 
a cutting angle of 4°.  Sections were transferred to a water bath (45 °C) 
using forceps and a soft brush and then transferred onto SuperFrost Plus 
slides.  These were then placed onto a hot plate (55 °C) to facilitate 
adhesion to the slide and dry the sections. 
2.2.4.3 Dewaxing and rehydration of paraffin embedded sections 
Slides were placed in two pots of xylene for ten minutes each before being 
transferred to three pots of absolute ethanol for three, two and two minutes, 
respectively.  Slides were then immersed in 70% (v/v) ethanol for two 
minutes and then transferred to running tap water for three minutes. 
2.2.4.4 Dehydration and mounting of stained slides 
Slides were placed in 70% (v/v) ethanol for five seconds before being 
transferred to three pots of absolute ethanol for one, two and three minutes 
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respectively.  They were then transferred to two pots of fresh xylene for ten 
minutes each after which sections were mounted using a single drop of 
DPX mountant and covered using a cover slip.  Slides were then left to dry 
inside the fume hood for a minimum of three hours. 
2.2.4.5 Resin embedding 
Fixed bone was dehydrated in a graded ethanol series (0%, 20%, 40%, 
60%, 80%, 100%) before infiltration of Technovit resin in a graded resin-
ethanol series (20:80, 40:60, 60:40, 80:20, 100:0).  Once infiltration 
reached 100:0 stage samples were placed under vacuum in 100% resin for 
seven days.  Samples were then removed from vacuum and placed in 
moulds and immersed in resin to be photo-cured under UV light over 24 
hours.  Once cured resin blocks were removed from moulds and attached 
to slides using cement. 
2.2.4.6 Sectioning of resin-embedded tissue blocks and slide 
preparation 
Slides with resin blocks were ground down to the sample using an 
automatic grinder.  An additional slide was glued to the exposed face to 
sandwich the resin block between two slides.  The cemented side was 
attached to the slide holder of the bone saw (EXACT) by vacuum and set 
400 μm from the secondary slide.  A slice was then cut and ground down in 
increments to 20 μm and section thickness was confirmed using a digital 
micrometer.   
 
2.2.5 Histological staining 
2.2.5.1 Alcian Blue – Glycosaminoglycans 
Reagents: 
• 10 g.L-1 Alcian blue – pH 2.5 
• 525 mM Acetic acid 
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• Eosin 
Slides containing paraffin embedded sections were dewaxed and 
rehydrated before a brief initial wash in 3% (v/v) acetic acid.  Slides were 
then immersed in 1% (w/v) alcian blue for 15 minutes after which each 
slide was blotted dry using tissue paper.  The slides were subsequently 
immersed in eosin for one minute before dehydration and mounted for 
viewing. 
2.2.5.2 Haematoxylin and eosin – Cell morphology and histoarchitecture 
Reagents: 
• Haematoxylin 
• Eosin 
Slides were dewaxed and rehydrated before immersion into pre-made 
haematoxylin solution for one minute.  Slides were then transferred to 
running tap water until the water ran clear after which they were immersed 
in eosin for three minutes.  Slides were then dehydrated and mounted. 
2.2.5.3 Safranin O – Proteoglycans 
Reagents: 
• 1 g.L-1 Safranin O 
• 0.2 g.L-1 Fast green 
• 1.21 M Acid alcohol 
• 175 mM Acetic acid 
• Haematoxylin (Weigart’s) 
Sections were dewaxed and rehydrated before immersion in Weigart’s 
haematoxylin for three minutes.  This was followed by a wash in running 
tap water for 10 minutes before differentiation in acid alcohol for one 
minute.  A 5 minute rinse in running tap water followed after which sections 
were immersed in fast green for five minutes.  This was rinsed off using a 
76 
10-15 second rinse in acetic acid before immersion in safranin O solution 
for 4 minutes and finally dehydration and mounting. 
2.2.5.4 Sirius red/Miller’s elastin – Collagen and Elastin 
Reagents: 
• 50 g.L-1 Potassium permanganate 
• 10 g.L-1 Oxalic acid 
• 1 g.L-1 Sirius red 
Slides were dewaxed and rehydrated then immersed into 5% (w/v) 
potassium permanganate for five minutes.  Each slide was then rinsed 
using distilled water before immersion into 1% (w/v) oxalic acid for two 
minutes.  Slides were then rinsed using distilled water, first for one minute 
then for four minutes.  They were then transferred to 70% (v/v) ethanol for 
one minute followed by immersion in 95% (v/v) ethanol for one minute.  
Slides were then stained using Miller’s stain for one hour after which they 
were transferred to 70% (v/v) ethanol until they ran clear.  Slides were then 
transferred to 95% (v/v) ethanol for one minute, rinsed in tap water for two 
minutes, then stained using Weigart`s haematoxylin for ten minutes.  They 
were then rinsed again, firstly using tap water for one minute followed by 
distilled water for 30 seconds.  Slides were then stained using picro Sirius 
red for one hour, rinsed using distilled water and blotted dry using tissue 
paper, before being dehydrated and mounted. 
2.2.5.5 4',6-diamidino-2-phenylindole (DAPI) – DNA 
Reagents: 
• DAPI dye solution 
o 1.211 g.L-1 Tris base 
o 0.3724 g.L-1 Disodium ethylenediaminetetraacetic acid 
o 5.8 mg.L-1 Sodium chloride 
o 1 mg.L-1 DAPI dye 
o pH adjusted to 7.4 before use 
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Dewaxed and rehydrated slides were placed into a slide holder and stained 
using DAPI dye solution in the dark and at room temperature for 10 
minutes followed by three washes using PBS for ten minutes each.  
Sections were then mounted using a glass cover slip and 1,4-
diazabicyclo[2.2.2]octane (DABCO):glycerol (1:9) mountant.  Sections were 
then viewed using ultra violet microscopy under a DAPI filter. 
2.2.5.6 McNeal’s Tetrachrome – Bone 
Reagents: 
• 0.25 M Formic Acid 
• McNeal’s Tetrachrome 
• 6.87 M Glycerol 
• 12.04 M Methanol 
• 0.05 g.L-1 Toluidine Blue 
• 0.1 g.L-1 Methylene Blue 
• 0.16 g.L-1 Azure A Eosinate 
• 0.02 g.L-1 Methyl violet 
• 1 g.L-1 Basic Fuchsin 
Slides were etched by immersion in ethanol followed by formic acid for 10 
minutes each.  Distilled water was then used to rinse the slides before 
immersion into 10% McNeals Tetrachrome for five minutes.  Excess stain 
was then removed by washing in running tap water.  This was followed by 
a dip in 70% (w/w) ethanol and immersion in basic fuchsin for 30 seconds.  
Slides were finally washed in tap water and allowed to air dry for two hours. 
2.2.5.7 Safranin O – Proteoglycans 
Reagents: 
• 1 g.L-1 Safranin O 
• 0.2 g.L-1 Fast green 
• 1.21 M Acid alcohol 
• 175 mM Acetic acid 
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• Haematoxylin (Weigart’s) 
Sections of native and decellularised meniscus were dewaxed and 
rehydrated before immersion in Weigart’s haematoxylin for three minutes.  
This was followed by a wash in running tap water for 10 minutes before 
differentiation in acid alcohol for one minute.  A 5 minute rinse in running 
tap water followed after which sections were immersed in fast green for five 
minutes.  This was rinsed off using a 10-15 second rinse in acetic acid 
before immersion in safranin O solution for 4 minutes and finally 
dehydration and mounting.  Stained sections were viewed using an upright 
microscope under bright-field illumination. 
 
2.2.6 Biochemical Assays 
2.2.6.1 Collagen 
Reagents: 
• Assay buffer 
o 33.25 g.L-1 Citric acid 
o 140 mM Acetic acid 
o 80 g.L-1 Sodium acetate-3-hydrate 
o 20% (v/v) Propan-1-ol 
o Distilled water 
• Ehrlichs reagent 
o Propan-1-ol 
o 150 g.L-1 p-dimethylbenzaldehyde 
o 60% (v/v) Propan-1-ol 
o 2.77 M Perchloric acid 
o Distilled water 
• 14.1 g.L-1 Chloramine T solution 
Collagen content was determined using the hydroxyproline assay.  
Homogenised and lyophilised meniscus tissue samples of known weight 
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were added to SureSeal polypropylene tubes and hydrolysed using 5 mL of 
6M hydrochloric acid at 120 °C for 6 hours in a heating block (Section 
2.2.3.6).  Hydrolysed samples were neutralised using 6M sodium hydroxide 
and the volume recorded. Standard and test solutions (50 µL) were added 
to wells of a 96-well flat-bottomed plate.  Chloramine T solution (50 μL) was 
added to each well and placed on a shaker for two minutes at 60 rpm 
followed by addition of 100 μL of Ehrlich’s reagent to each well and 
incubation at 56 °C in a water bath for 45 minutes.  Plates were then read 
at 570 nm in a plate reader and absorbance values converted to 
hydroxyproline concentration by linear regression from the standard curve. 
The hydroxproline content of the tissue samples was calculated and then 
multiplied by 7.14 to obtain collagen content 
2.2.6.2 Glycosaminoglycans (GAGs) 
Reagents: 
• Dimethylmethylene blue dye 
o 16 mg.L-1 Dimethyl methylene blue 
o 2 g.L-1 sodium formate 
o 0.2% (v/v) formic acid 
o 0.5% (v/v) ethanol 
• Assay buffer 
o 68.5 mM sodium di-hydrogen orthophosphate 
o 31.5 mM di-sodium hydrogen orthophosphate 
Quantification of GAGs was performed colorimetrically using the 
dimethylmethylene blue (DMB) assay.  Lyophilised samples of known 
weight were digested using 5 mL of papain (Section 2.2.3.7) and then 
diluted in assay buffer (1:10, 1:50, 1:100).  Concurrently, assay standards 
were made up from chondroitin sulphate and assay buffer (0, 3.125, 6.25, 
12.5, 25, 50, and 100 µg.mL-1).  Each sample and standard (40 µL) were 
added to three wells each of a flat-bottomed 96-well plate along with 250 
µL of DMB dye and gently shaken for 2 minutes on a plate shaker.  Plates 
were then placed in a plate reader and optical density read at 525 nm.  A 
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standard curve was plotted from the chondroitin sulphate standards and 
linear regression performed to interpolate the sample GAG concentrations. 
The GAG content of the tissue was then calculated in µg.mg-1.  
2.2.6.3 Quantification of meniscus DNA content 
Reagents: 
• DNeasy kit 
Menisci were cut into ~1 mm3 pieces and weighed into 2 mL micro-
centrifuge tubes (25 mg for fresh and 150 mg for decellularised).  For fresh 
menisci, 180 μL buffer ATL and 20 μL proteinase K (>600 mAU.mL-1) from 
a DNeasy kit (Qiagen) were added and samples were incubated at 56 °C in 
a water bath overnight.  The volumes of buffer ATL and proteinase K were 
doubled for decellularised menisci.  Samples were retrieved and DNA 
purified using the mini-spin columns provided in the DNeasy kit to a final 
volume of 400 μL.  Purified samples were then assayed at 260 nm using a 
NanoDrop 1000 spectrophotometer (Thermo Scientific). 
 
2.2.6.4 Quantification of bone DNA content 
Reagents: 
• DNeasy kit 
• Digestion buffer: 
o 10 g.L-1 SDS 
o 125 g.L-1 (w/v) EDTA 
o 10% (v/v) Proteinase K (>600 mAU.mL-1) 
Bone blocks were cut into ~2 mm3 pieces and freeze-dried to constant 
weight prior to comminution using a cryomill.  Samples were then weighed 
into 2 mL micro-centrifuge tubes (25 mg for fresh and 100 mg for 
decellularised).  For all samples, 1520 μL of digestion buffer was added 
and samples were incubated at 56 °C in a shaking incubator overnight to 
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agitate samples.  A further 80 μL of proteinase K was then added and 
samples were once again incubated at 56 °C in a water bath for 3 hours.  
Samples were retrieved and DNA from 400 μL of each digest was purified 
using a single mini-spin column to a final volume of 400 μL resulting in four 
columns per sample.  Final eluants were pooled together and assayed at 
260 nm using a NanoDrop 1000 spectrophotometer (Thermo Scientific). 
 
2.2.7 Immunohistochemistry 
2.2.7.1 Antigen retrieval 
Antigen retrieval was performed using proteinase K (Dako, 20 mg.mL-1) 
digestion of zinc-fixed paraffin wax embedded sections.  Drops of 
proteinase K solution were used to cover the entire section and left at room 
temperature for 20 minutes before rinsing with TBS to terminate the 
reaction. 
2.2.7.2 Immunohistochemical staining 
Reagents: 
• TBS pH 7.6 
• TBS containing 0.05 % (v/v) Tween 20, pH 7.6 
• Antibody diluent: 
o TBS (pH 7.6)  
o 0.1 g.L-1 Sodium azide 
o 0.1 g.L-1 Bovine serum albumin (BSA).  
o The pH was adjusted to pH 7.6  
• 3% (v/v) hydrogen peroxide (H2O2):  
o 30 % (v/v) H2O2 
o PBS pH 7.6 
• Lab Vision Ultravision Detection System 
Paraffin wax embedded sections were dewaxed and rehydrated (Section 
2.2.4.3) prior to antigen retrieval.  Peroxidase blocking was then performed 
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by immersion in 3% (v/v) H2O2 for 20 minutes at room temperature and 
washed in distilled water.  A hydrophobic pen was used to ring the 
sections, which were then washed once by immersion in TBS and drops of 
V block solution (Ultravision Detection kit) were placed on each section for 
10 minutes.  Sections were then washed twice using TBS for 10 minutes 
on a plate rocker before incubation with the primary antibody (50 µL) which 
was diluted in PBS to the working concentration (Table 2.5) for one hour in 
a moist environment.  Isotype control antibodies were diluted to the same 
protein concentration as primary antibodies, while a negative control was 
also employed where antibody diluent (50 µL) was used instead of an 
antibody.  Subsequent washing in TBS containing Tween, and TBS (twice 
for 10 minutes each) preceded incubation with HRP polymer solution 
(Ultravision Detection kit) for 30 minutes at room temperature in the dark.  
Slides were again washed using TBS containing Tween and TBS (twice for 
10 minutes each) after which 3,3’-diaminobenzidine (DAB) plus chromagen 
(50 µL) was added to each section and left to allow the colour to develop 
for 10 minutes.  The reaction was terminated by washing the slides in slow 
running tap water following which sections were counterstained using 
haematoxylin and dehydrated and mounted as already described. 
 
2.2.8 Cell culture 
Cell culture was performed in a class II microbiological safety cabinet 
2.2.8.1 Cell counting 
Cell suspensions were diluted to the desired level using PBS and 10 µL of 
trypan blue was added to 90 µL of diluted cell suspension.  Samples were 
transferred to a haemocytometer and visualised under an inverted-
microscope for counting.  Four grids were counted and the total divided by 
four to obtain an average count.  Live cells appeared clear while dead cells 
appeared blue due to infiltration of trypan blue through cell membranes.  
The following formula was used to calculate cell density: 
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𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑑𝑑𝐶𝐶𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 = 𝑇𝑇𝑇𝑇𝑑𝑑𝑇𝑇𝐶𝐶 𝑐𝑐𝑇𝑇𝑐𝑐𝑑𝑑𝑑𝑑
𝐺𝐺𝐺𝐺𝑑𝑑𝑑𝑑𝑑𝑑
× 104  × 𝐷𝐷𝑑𝑑𝐶𝐶𝑐𝑐𝑑𝑑𝑑𝑑𝑇𝑇𝑑𝑑 𝑓𝑓𝑇𝑇𝑐𝑐𝑑𝑑𝑇𝑇𝐺𝐺 
2.2.8.2 Cell resurrection from frozen  
Cryovials were retrieved from liquid nitrogen storage and thawed for 2 
minutes in a water bath at 37 °C, or until all ice crystals had melted.  The 
vial contents were then transferred to a falcon tube and 10 mL of pre-
warmed cell culture medium was added over the course of a minute.  The 
cell suspension was then centrifuged at 150 g for 10 minutes and 
resuspended in 15 mL of pre-warmed medium and added to a T75 flask.  
The flask was incubated at 37 °C and in an atmosphere of 5% (v/v) CO2 in 
air with the first medium change occurring the following day and 
subsequent medium changes every 2-3 days until passage at 
approximately 80% confluence. 
2.2.8.3 Passage 
Flasks were removed from the incubator and the cell monolayer washed 
using 10 mL of PBS without calcium and magnesium.  Trypsin-EDTA (2 
mL) was added and the flask incubated at 37 °C for 5 minutes or until all 
cells had detached from the culture surface.  Cell culture medium was 
added in a 3:1 ratio to the Trypsin-EDTA to terminate the reaction.  The 
suspension was then transferred to a centrifuge tube and centrifuged at 
150 g for 10 minutes.  The supernatant was aspirated from the tube without 
dislodging the cell pellet and 10 mL of culture medium was added.  The cell 
pellet was resuspended by gentle trituration using a 5 mL pipette and a 
sample taken for counting (Section 2.2.8.1).  Cells were then seeded into 
T75 flasks at 2 x 104 cells.cm-2 and incubated at 37 °C and in an 
atmosphere of 5% (v/v) CO2 in air. 
 
2.2.9 Numerical analysis 
All numerical analysis within this study was performed using Microsoft 
Office Excel 2007. 
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2.2.9.1 Confidence limits 
In order to present data as the mean ± 95% confidence intervals (C.I.), data 
was analysed using the ‘Descriptive Statistics’ function of the ‘Data 
Analysis’ add-on within Microsoft Office Excel 2007 using α=0.05.   
𝑚𝑚𝐶𝐶𝑇𝑇𝑑𝑑 =  Σ𝑥𝑥
𝑑𝑑
 
𝜎𝜎 =  � Σ𝑥𝑥2
𝑑𝑑 − 1 
𝑆𝑆𝑆𝑆 = 𝜎𝜎
√𝑑𝑑
 
95% C. I. = 𝑆𝑆𝑆𝑆 𝑥𝑥 𝑑𝑑 𝑣𝑣𝑇𝑇𝐶𝐶𝑐𝑐𝐶𝐶 
where, 
x  value 
n  sample size 
σ  standard deviation 
SE standard error 
2.2.9.2 Statistical analysis 
To compare the means of two groups the student’s t-test was used, with an 
analysis of variance (ANOVA) used when more than two groups were 
compared.  The minimum significant difference (MSD), calculated using the 
T-method was used to differentiate between individual group means (Sokal 
& Rohlf, 1981) with p values smaller than 0.05 considered significant. 
Standard error = �𝜎𝜎12
𝑑𝑑1
+ 𝜎𝜎22
𝑑𝑑2
  
Critical value = 𝑄𝑄𝑄𝑄[𝑘𝑘, 𝑣𝑣] 
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𝑀𝑀𝑆𝑆𝐷𝐷 = 𝑆𝑆𝑆𝑆 × 𝐶𝐶𝐺𝐺𝑑𝑑𝑑𝑑𝑑𝑑𝑐𝑐𝑇𝑇𝐶𝐶 𝑣𝑣𝑇𝑇𝐶𝐶𝑐𝑐𝐶𝐶 
where, 
α  p = 0.05 
k  number of groups 
v degrees of freedom = n - 1 
2.2.9.3 Arcsin transformation 
As many biological variables do not meet the assumptions of parametric 
statistical tests, it is sometimes necessary to transform the data so that it 
fits these assumptions better.  In order to accurately compute 95% 
confidence intervals and perform statistical analysis values presented as 
proportions or percentages, values were first transformed to arcsin.  Back 
transformation was performed for presentation. 
2.2.9.4 Linear regression 
To interpolate sample concentrations from standard curves linear 
regression was applied.  The gradient of the linear portion of a standard 
curve was determined and used to calculate concentrations from optical 
density values obtained for samples (Figure 2.2). 
 
Figure 2.2: Linear regression of standard curve. 
 
O
D
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Chapter 3. Decellularisation of bone-meniscus-
bone 
3.1 Introduction 
Decellularised natural tissue matrices retain the natural organization and 
cell signalling cues present in extracellular matrix, and if taken from a 
xenogeneic source are readily available making them ideal candidates for 
meniscal replacement.  Investigations of synthetic materials for meniscal 
replacement has so far yielded limited success with integration and 
promotion of matrix formation however cartilage degeneration has also 
been noted (Kang et al., 2006; Galley et al., 2011).  The use of natural 
materials for meniscal replacement has also shown some success with 
improvements shown from the pre-operative state using the CMI 
(Zaffagnini et al., 2011).  The majority of studies, however, focus on the 
repair of meniscal defects over total replacement thereby circumventing the 
challenges associated with anatomical fixation of the meniscus.  Repair 
tissue formed from the treatment of defects has been shown to be 
mechanically inferior to native meniscal tissue (Tienen et al., 2006).   
It is hypothesised that the decellurisation of a readily available xenogeneic 
meniscus incorporating bone blocks for ease of fixation will produce a 
meniscal replacement with the natural cell signalling cues and 
biomechanical properties of the native meniscus.  Porcine tissue is readily 
available through abattoirs and the porcine meniscus is anatomically 
similar to human meniscus. 
Several methods exist for the removal of cells from tissues however the 
level of decellularisation varies between groups.  Ideally, for total 
decellularisation to be achieved 100% of cellular material should be 
removed since cellular remnants have been implicated in the tissue 
remodelling outcome through modulation of macrophage phenotype 
(Brown et al., 2009; Nagata et al., 2010). 
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Methods for decellularisation usually comprise a combination of physical, 
chemical and biological methods.  Physical methods are included to allow 
reagents in the subsequent steps to penetrate the tissue effectively.  
Chemical reagents are used to solubilise and wash out cellular material 
with enzymes used to target specific matrix-protein interactions and clear 
nuclear material.  Final wash steps are usually incorporated to remove 
process reagents to avert host cytotoxicity. 
 
3.1.1 Chemical agents 
3.1.1.1 Acids and bases 
Acids and bases work through the hydrolytic degradation of biomolecules, 
solubilising cellular components.  Peracetic acid is included as a 
disinfection step towards the end of decellularisation protocols and has 
been shown to remove residual nucleic acids without damaging the 
extracellular matrix (Hodde et al., 2007).  Bases are also used to remove 
hair from porcine dermis but can remove growth factors and adversely 
impact the mechanical properties (Reing et al., 2010) by cleavage of 
collagen fibrils (Gorschewsky et al., 2005).   
3.1.1.2 Solvents 
Solvents act to lyse cells by dehydration and can solubilise lipids.  They 
have been reported to effectively remove cells from dense tissue whilst 
also having a disinfectant action, however solvents may also precipitate 
proteins and crosslink collagen (Reing et al., 2010; Lumpkins et al., 2008; 
Dong et al., 2009).  Deeken et al. utilised tributyl phosphate, which forms 
stable complexes with metals, to decellularise porcine diaphragm tendon 
showing retention of collagen architecture and mechanical properties.   
3.1.1.3 Detergents 
Detergents have been widely used in the decellularisation of tissues.  They 
can be split into ionic, non-ionic, and zwitterionic detergents.  Anionic 
88 
 
detergents, such as sodium dodecyl sulfate (SDS), solubilise cell and 
nuclear membranes and can also denature proteins.  SDS has been shown 
to effectively remove cell and nuclear material but can also remove GAGs 
and growth factors, and damage collagen fibres (Reing et al., 2010; 
Lumpkins et al., 2008; Stapleton et al., 2008; Deeken et al., 2011).  This is 
especially true at high SDS concentrations with studies decellularising with 
1% (w/v) SDS reporting fragmentation and swelling of collagen fibres 
(Bodnar et al., 1986; Courtman et al., 1994) while 0.1% (w/v) SDS has 
been shown to effectively decellularise porcine heart valves without 
negatively impacting the ECM (Booth et al., 2002).  Other anionic 
detergents of note are sodium deoxycholate and Triton X-200.  Sodium 
deoxycholate has been used to decellularise porcine bladder (Brown et al., 
2009), porcine adipose tissue (Brown et al., 2011) and porcine pulmonary 
valves (Cebatori et al., 2010), showing mixed results with effective removal 
of lipids (Brown et al., 2011) but unsuccessful removal of all cells and DNA 
(Partington et al., 2013) whilst also proving difficult to wash out resulting in 
cytotoxicity (Cebatori et al., 2010).  Hudson et al. (2004) showed Triton X-
200 to be more efficacious in decellularising thin tissues but when 
compared to other detergents tissue treated with Triton X-200 showed 
greater damage. 
Non-ionic detergents disrupt DNA-protein and lipid-protein interactions 
(Seddon et al., 2004).  Triton X-100 has been extensively studied for its 
ability to solubilise proteins and is gentler than SDS.  This allows for 
protein-protein interactions to be sustained, however it is only efficient in 
decellularising thin tissues (Reing et al., 2010; Yang et al., 2009; Guo et al., 
2010).  Zwitterionic detergents have also been reported to decellularise thin 
tissues with only mild disruption of the extracellular matrix (Hudson et al., 
2004).  They are generally more damaging to proteins than ionic and non-
ionic detergents as they incorporate aspects of both other types of 
detergent (Seddon et al., 2004). 
 
 
89 
 
3.1.1.4 Hypertonic and hypotonic agents 
Osmotic shock has also been used to lyse cells by employing hypotonic 
reagents (Cox and Emili et al., 2006; Stapleton et al., 2008), while 
hypertonic solutions dissociate DNA from proteins (Xu et al., 2007).  These 
agents are not effective at removing cellular remnants from tissue and are 
usually used in combination protocols to enhance the action of detergent 
and enzymatic steps (Stapleton et al., 2008; Yang et al., 2009). 
 
3.1.2 Biological agents 
3.1.2.1 Enzymes 
Enzymes are employed in a decellularisation protocol for the highly specific 
removal of cellular or matrix components.  Nucleases are used to aid in the 
removal of nuclear material from tissues by cleaving DNA and RNA.  Cells 
need to be lysed to allow access of the enzymes to the nuclear material 
therefore nuclease steps are incorporated towards the end of a protocol.  
For more effectual fragmentation and hence more efficient removal of DNA, 
non-restriction endonucleases such as Benzonase may be used (Petersen 
et al., 2010).  Utilisation of other enzymes is dependent on the requirement 
to retain extracellular matrix components.  Trypsin treatment may show 
improved GAG retention compared to detergents (Grauss et al., 2005) 
however prolonged exposure leads to disruption of collagen and hence 
compromises the mechanical properties of natural matrices (Yang et al., 
2009).  Decellularisation of ovine meniscus using trypsin and collagenase 
has been shown to result in partial digestion and loss of GAGs from the 
matrix which resulted in a mechanically stiffer tissue (Maier et al., 2007).  
Contrary to this, using a 0.05% trypsin solution in a combination protocol to 
decellularise rabbit meniscus Stabile et al. (2010) found no statistically 
significant differences in the tensile and compressive properties between 
untreated and decellularised meniscus. 
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3.1.2.2 Non-enzymatic agents 
Chelating agents such as ethylenediaminetetraacetic acid (EDTA) and 
ethylene  glycol tetraacetic acid (EGTA) work by chelating Ca and Mg 
ions and are therefore useful in disrupting cell-matrix interactions (Klebe, 
1974) and inhibition of metalloproteinases (Booth et al., 2002).  They are 
used to protect the ECM from damage by endogenous proteases released 
by the disruption of cells due to other decellularising agents (Booth et al., 
2002; Deeken et al., 2010; Reing et al., 2010), along with serine protease 
inhibitors such as aprotinin (Booth et al., 2002; Stapleton et al., 2008) and 
phenylmethylsulfonyl fluoride (PMSF), which is only suitable for research 
purposes due to its highly toxic nature and limited half life (Woods & 
Gratzer, 2005). 
 
3.1.3 Physical methods 
Aside from applying chemical and biological agents, tissues can be 
subjected to physical treatments to aid decellularisation.  Freeze/thaw 
cycles lyse cells by the generation of intercellular ice crystals and can also 
increase the penetration of reagents by creating space within the matrix 
(Gulati et al., 1988; Stapleton et al., 2008; Brown et al., 2009).  Ice crystals 
can also have a deleterious effect on tissues by disrupting or fracturing the 
ECM.  Direct removal of cells or tissues through hydrostatic force or 
mechanical abrasion can also be used to enhance decellularisation 
however application of force can directly damage the ECM (Freytes et al., 
2008).  Other physical methods that have been used in decellularisation 
include changes in pressure, which can be used to burst cells and facilitate 
the removal of cellular material (Funamoto et al., 2010), and 
electroporation whereby cell membranes are disrupted by a pulsed 
electrical field (Phillips et al., 2010).  Again, both of these methods have the 
potential to damage the ECM. 
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3.1.4 Work leading to the current study 
Initial work within the group on decellularisation aimed to develop a method 
for decellularisation of heart valves.  Booth et al. (2002) investigated 
various detergents including 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS), SDS, sodium deoxycholate, Triton-X, and 
Tween 20 and found that only SDS and sodium deoxycholate provided 
effective decellularisation of porcine aortic valves and patella tendon (US 
Patent 7354749, 2008).  SDS at 0.03-0.1% (w/v) was utilised in these 
studies to minimise damage to the matrix and prevent cytotoxicity from 
potential retention, whilst protease inhibitors, EDTA and aprotinin, were 
also included to negate damage from endogenous proteases released 
during the process and preserve the ECM.  This method was then adapted 
for the decellularisation of porcine meniscus (Stapleton et al., 2008) where 
there is a real clinical need for a meniscal replacement as the meniscus 
lacks the ability to repair itself owing to its avascular nature and current 
repair and replacement techniques only delay the onset of osteoarthritis.  
Again, this incorporated a low SDS concentration solution as well as 
protease inhibitors, however additional steps were required due to the 
dense nature of the meniscus.  Freeze-thaw cycles and an optional 
ultrasonication step were included to allow more effective diffusion of 
reagents into the tissue.  A successful protocol was developed (US Patent 
20100152852) however surgical attachment of the meniscal implant to the 
patient knee was still an issue as soft tissue fixation leads to the formation 
of mechanically inferior repair tissue.  Therefore, it was hypothesised that 
the incorporation of bone blocks would allow easier fixation while 
maintaining anatomical positioning and maintenance of mechanical 
integrity. 
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3.2 Aims and objectives 
3.2.1 Aims 
The aim of the work presented within this chapter was to develop a 
protocol for the effective decellularisation of porcine bone-medial 
meniscus-bone. 
3.2.2 Objectives 
• To develop a decellularisation protocol for the removal of cellular 
and nuclear content from porcine medial meniscus and bone 
attachments while retaining native histoarchitecture 
• To characterise the native and decellularised porcine bone-medial 
meniscus-bone using: 
• Histology for cellular and nuclear content and visualisation of the 
histoarchitecture  
• Extraction and quantification of DNA content  
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3.3 Methods 
3.3.1 Decellularisation 
3.3.1.1 Meniscus – Original method from Stapleton et al. 
The decellularisation treatment initially applied to the porcine medial 
meniscus (Figure 3.3.1) was based on the method described in Stapleton 
et al. (2008).  Menisci (n = 3) were dissected from porcine knees less than 
24 hours after slaughter and subjected to decellularisation.  Treated 
menisci were then retrieved and prepared as described in Sections 2.2.3 
and 2.2.4 for H&E (Section 2.2.5.2) and DAPI (Section 2.2.5.5) staining to 
observe changes to meniscal histoarchitecture and detect residual nuclear 
material.  The solutions used were prepared as described in Section 2.1.7.  
For all steps sterile 150 mL containers were used and 100 mL of each 
solution was used per meniscus.  Shaking tables were set at 320 rpm 
except for the nuclease step, which was at 80 rpm, and the final wash 
buffer steps which were carried out at 160 rpm.  Menisci underwent three 
freeze/thaw cycles during which they were frozen at -20 °C for 3 hours, or 
until fully frozen, and defrosted at room temperature for 4 hours, or until 
fully defrosted.  Specimens were then processed through three freeze/thaw 
cycles while immersed in hypotonic buffer (10 mM tris, 10 KIU.mL-1 
aprotinin).  Menisci were then washed using hypotonic buffer at 4 °C for 24 
hours, hypotonic buffer at 37 °C for 24 hours, SDS hypotonic buffer (0.1% 
(w/v) SDS , 10 mM tris, 10 KIU.mL-1 aprotinin) at 45 °C for 24 hours twice.  
These steps were repeated twice in the order stated.  This was followed by 
three washes in wash buffer (PBS, 10 KIU.mL-1 aprotinin) at room 
temperature for 24 hours each, and three further washes in nuclease 
solution (50 mM tris, 21 mM MgCl, 50 µg.mL-1 BSA  50 U.mL-1 DNAase , 1 
U.mL-1 RNAase) at 37 °C for three hours each.  The menisci were then 
washed using wash buffer with EDTA (2.7 mM EDTA, 10 KIU.mL-1 
aprotinin) at room temperature for 12-16 hours, hypertonic solution for 24 
hours at 37 °C, wash buffer with EDTA at room temperature for 12-16 
hours before disinfection using PAA solution for three hours at 27 °C.  The 
following steps were carried out aseptically inside a class II cabinet.  The 
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disinfected menisci were then washed using wash buffer with EDTA at 45 
°C for 24 hours, wash buffer with EDTA at 37 °C for 24 hours, and five 
washes in wash buffer with EDTA at 4 °C for 24 hours. 
 
Figure 3.3.1: Original decellularisation method 
3.3.1.2 Meniscus – Method 1 
Decellularisation was identical to the original method (Section 3.3.1.1) 
except all reagents were prepared without EDTA.  Steps that were 
changed from the original method are highlighted in red in Figure 3.3.2.  
Menisci (n = 3) were dissected from porcine knees less than 24 hours after 
slaughter and subjected to decellularisation.  Treated menisci were then 
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retrieved and prepared as described in Sections 2.2.3 and 2.2.4 for H&E 
(Section 2.2.5.2) and DAPI (Section 2.2.5.5) staining. 
 
Figure 3.3.2: Decellularisation method 1 
3.3.1.3 Meniscus – Method 2 
Menisci (n = 6) were dissected from porcine knees less than 24 hours after 
slaughter and subjected to decellularisation.  Treated menisci were then 
retrieved and three were prepared as described in Sections 2.2.3 and 2.2.4 
for histology.  The remaining three menisci were assayed for residual DNA 
as described in Section 2.2.6.3.  Decellularisation was identical to Method 
1 (Section 3.3.1.2) with the addition of an extra cycle of hypotonic buffer at 
4 °C for 24 hours, hypotonic buffer at 37 °C for 24 hours, SDS hypotonic 
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buffer at 45 °C for 24 hours and hypotonic buffer at 45 °C for 24 hours prior 
to the three washes in wash buffer preceding nuclease treatment.  Steps 
changed from method 1 are highlighted in red in Figure 3.3.3. 
 
Figure 3.3.3:  Decellularisation method 2 
3.3.1.4 Meniscus – Method 3 
Menisci (n = 6) were dissected from porcine knees less than 24 hours after 
slaughter and subjected to decellularisation.  Treated menisci were then 
retrieved and three were prepared as described in Sections 2.2.3 and 2.2.4 
for histology.  The remaining three menisci were assayed for residual DNA 
as described in Section 2.2.6.3.  Decellularisation was identical to Method 
1 (Section 3.3.1.2) except that the three 24 hour washes in wash buffer 
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preceding the nuclease treatment were split into six 12 hour washes in 
wash buffer to aid removal of SDS from the tissue prior to the nuclease 
step.  Steps changed from method 2 are highlighted in red in Figure 3.3.4. 
 
Figure 3.3.4:  Decellularisation method 3 
 
3.3.1.5 Bone-meniscus-bone 
Bone-meniscus-bone (BMB; n = 6) was dissected from porcine knees less 
than 24 hours after slaughter and subjected to decellularisation.  Treated 
BMB’s were then retrieved and menisci removed from the bone by sharp 
dissection.  Three were prepared as described in Sections 2.2.3 and 2.2.4 
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for histology with the remaining three assayed for residual DNA as 
described in Section 2.2.6.3.  Bone (n = 3) was fixed (Section 2.2.3.1) and 
embedded in resin (Section 2.2.4.5) for histology (Section 2.2.5.6).  The 
remaining bone (n = 3) was assayed for residual DNA (Section 2.2.6.4).  
The solutions used were prepared as described in Section 2.1.7.  For all 
steps menisci with bone (BMB) were placed in individual 250 mL 
containers and 150 mL of each solution was used per BMB.  Shaking 
tables were set at 320 rpm except for the nuclease step, which was at 80 
rpm, and the final wash buffer steps which were carried out at 160 rpm.  
Collagen fibres were teased apart at the attachment site using a scalpel, 
rat-tooth forceps and a magnifying lamp in order to allow diffusion of 
solutions into the enthesis (Figure 3.3.5) after which the bone was treated 
using a water flosser (Figure 3.3.6) and PBS to remove bone marrow from 
the bone attachments. 
 
 
 
Figure 3.3.5: Introduction of incisions to the attachment site to aid diffusion of 
decellularisation reagents. 
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Figure 3.3.6: Waterpik.  PBS stored in the reservoir was pumped through the nozzle at 
high velocity to clear trabecular bone of bone marrow. 
 
BMB were then subject to three freeze/thaw cycles during which they were 
frozen at -20 °C for three hours, or until fully frozen, and defrosted at room 
temperature for 4 hours, or until fully defrosted.  Specimens were then put 
through three freeze/thaw cycles while immersed in hypotonic buffer (10 
mM tris, 10 KIU.mL-1 aprotinin).  Menisci were then washed using 
hypotonic buffer at 4 °C for 24 hours, hypotonic buffer at 42 °C for 24 
hours, SDS hypotonic buffer (0.1% (w/v) SDS , 10 mM tris, 10 KIU.mL-1 
aprotinin) at 42 °C for 24 hours and hypotonic buffer at 42 °C for 24 hours.  
These steps were repeated twice in the order stated.  This was followed by 
three washes in wash buffer (PBS, 10 KIU.mL-1 aprotinin) at 4 °C for 24 
hours each, and three further washes in nuclease solution (50 mM tris, 21 
mM MgCl2, 50 µg.mL-1 BSA  50 U.mL-1 DNAase , 1 U.mL-1 RNAase)  at 37 
°C for three hours each.  The menisci were then washed using wash buffer 
at 4 °C for 12-16 hours, hypertonic solution (50 mM tris, 1.5 M sodium 
chloride) for 24 hours at 42 °C, wash buffer at 4 °C for 12-16 hours before 
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disinfection using 0.1% (v/v) peracetic acid  solution for three hours at 27 
°C.  The following steps were carried out aseptically inside a class II 
cabinet.  The disinfected menisci were washed using wash buffer at 42 °C 
for 24 hours twice, followed by wash buffer at 4 °C for 24 hours, and this 
cycle was repeated a further four times.  Steps changed from method 3 are 
highlighted in red in Figure 3.3.7. 
 
 
Figure 3.3.7:  Bone-meniscus-bone decellularisation protocol 
 
 
x3 
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3.3.2 Tissue sampling for histology 
Native and decellularised menisci (n = 3) were cut radially into ten Sections 
and prepared for Sectioning as described in Section 2.2.4.1.  Each slice 
was then sectioned with one in every ten sections selected for staining.  
Both bone attachments from three native and decellularised bone-
meniscus-bone were cut into three pieces measuring 3 mm x 11 mm x 15 
mm and prepared for cutting and grinding as described in Sections 2.2.3.1 
and 2.2.4.5.  Two slices measuring ~400 µm thick were taken from each 
resin block and ground down to ~20 µm as described in Section 2.2.4.6 
prior to staining. 
 
3.3.3 DNA extraction and quantitative analysis  
Native and decellularised menisci (n = 3) were cut into five slices along the 
radial axis: anterior horn (AH), anterior middle (AM), middle (M), posterior 
middle (PM), and posterior horn (PH).  Each slice was then cut into ~1 mm3 
pieces with four samples taken from each slice and processed as 
described in Section 2.2.6.3.  Both bone blocks from each native and 
decellularised bone-meniscus-bone were separated into bone and enthesis 
pieces and then cut into ~2 mm3 pieces.  The entire bone block was 
processed as described in Section 2.2.6.4 with four samples taken from 
each bone block and enthesis. 
3.3.3.1 Validation of DNA assay 
Sections of bone stained with H&E were used to validate the bone DNA 
assay.  Three squares (10 µm) were placed randomly onto the image and 
any cells falling within or touching the squares were counted.  Sections 
were taken from resin embedded samples and so a section thickness of 20 
µm was assumed.  Cell counts were averaged to obtain the cell density 
within bone samples and this used in conjunction with an average DNA 
content of 6 pg per cell to obtain the average DNA content in bone.  A bone 
density of 0.2 – 2 g.cm-3, depending on location within the bone, was then 
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assumed and multiplied with the section volume to obtain the section mass.  
The average DNA content in bone was then divided by the section mass to 
obtain the DNA concentration of bone.  This was calculated as ~1000 ng of 
DNA per mg of bone. 
 
3.3.4 Qualitative analysis of DNA 
3.3.4.1 Polymerase chain reaction (PCR) 
DNA extracted from native and decellularised bone-meniscus-bone 
(Sections 2.2.6.3 and 2.2.6.4) was used to amplify collagen I, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and β-actin genes 
using PCR.  Upstream and downstream primers were designed using 
Primer3 (Untergrasser et al., 2012) from sequences available on the 
Nucleotide database (NCBI).  Primers (1 µL) for each gene were mixed 
with 2x PCR Master Mix (25 µL; Promega, UK), nuclease-free water (22 
µL) and sample DNA (1 µL) in a PCR tube.  Tubes were then spun down in 
a microcentrifuge to ensure all reagents were mixed.  Tubes were then 
placed in a thermal cycler and the following program run: 
Initial Denaturation 95 °C  3 minutes 
Denaturation  95 °C  30 seconds 
Annealing   56 °C  30 seconds  35 cycles 
Extension   72 °C  30 seconds 
Final Extension  72 °C  10 minutes 
End 
 
3.3.4.2 Primers 
Primers for porcine GAPDH, Collagen I and β-actin were obtained from X 
and are described below. 
Porcine GAPDH: 
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• Upstream primer  GGGCATGAACCATGAGAAGT 
• Downstream primer  AAGCAGGGATGATGTTCTGG 
• Product size   230 base pairs 
Predicted Sequence 
GGGCATGAACCATGAGAAGTATGACAACAGCCTCAAGATCATCAGCA
ATGCCTCCTGTACCACCAACTGCTTGGCACCCCTGGCCAAGGTCATC
CATGACAACTTCGGCATCGTGGAAGGACTCATGACCACAGTCCATGC
CATCACTGCCACCCAGAAGACTGTGGATGGCCCCTCTGGGAAACTGT
GGCGTGATGGCCGAGGGGCTCTCCAGAACATCATCCCTGCTT 
 
Collagen I: 
• Upstream primer  TAGCCCTGTCTGCTTCCTGT 
• Downstream primer  TGCAGTTTTGGTTTTTGGTC 
• Product size   243 base pairs 
Predicted Sequence 
TAGCCCTGTCTGCTTCCTGTAAACTCCCTCCGCCCCAATCTGGCTCCC
TCCCACCCAACCCAATTGCCCCTGACCCTGGAAACAAACAAACACCC
CAAACGGAAACCCCCCCAAAAGCCAAAAAATGGGAGACAATTTCACAT
GGACTTTGGAAAATATTTTTTTCCTTTGCATTCATCTCTCAAACTTAGTT
TTTAAATCTTTGACCAACTGAACTGAACATGACCAAAAACCAAAACTGC
A 
 
β-actin: 
• Upstream primer      ACGTGGACATCAGGAAGGAC 
• Downstream primer     ACATCTGCTGGAAGGTGGAC 
• Product size   210 base pairs 
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Predicted Sequence: 
ACGTGGACATCAGGAAGGACCTCTACGCCAACACGGTGCTGTCTGGC
GGGACCACCATGTACCCCGGCATCGCCGACAGGATGCAGAAGGAGA
TCACGGCCCTGGCGCCCAGCACCATGAAGATCAAGATCATCGCCCCT
CCCGAGCGCAAGTACTCCGTGTGGATCGGGGGCTCCATCCTGGCCT
CGCTGTCCACCTTCCAGCAGATGT 
3.3.4.3 Agarose gels 
Reagents 
• 40 g.L-1 Agarose in tris/acetate/EDTA (TAE) buffer 
• 0.00005% (v/v) SYBR SAFE DNA gel stain 
Agarose gels were made by adding agarose in TAE buffer to a final 
concentration of 40 g.L-1.  The mixture was placed in an Erlenmeyer flask 
and heated in a microwave for one minute or until all the agarose had 
dissolved.  The mixture was then cooled to ~60 °C before the gel was cast 
by pouring the agarose solution into a gel casting tray and allowing it to set. 
3.3.4.4 Gel electrophoresis 
PCR products were run through 4% (w/v) agarose gels at 12 V over 30 
minutes to separate and identify DNA fragments.  Quick-Load PCR marker 
(Bolabs) was run concurrently as a size reference (Table 3.1).    
Table 3.1: Quickload PCR marker (2 kb) 
Fragment Size (base pairs) Mass (ng) 
1 2000 100 
2 800 40 
3 400 20 
4 200 10 
5 100 5 
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3.4 Results 
3.4.1 Evaluation of decellularisation 
The degree of decellularisation for each method was determined initially 
using histological methods and later by extraction and quantification of 
residual DNA (Figure 3.4.6) with comparisons to native meniscus and 
bone.  Haematoxylin and eosin staining displayed cell nuclei, cytoplasm 
and extracellular matrix and DAPI staining revealed DNA.  Serial sections 
of decellularised menisci were taken with representative images shown in 
Figure 3.4.3 to Figure 3.4.8.   
3.4.1.1 Original method 
On gross inspection meniscus decellularised using the original method 
developed by Stapleton et al. (2008) appeared white in colour with a glossy 
appearance.  No obvious changes to the structure or size of the menisci 
were observed. 
 
Figure 3.4.1:  Native porcine meniscus (left) and decellularised porcine meniscus 
(right). 
H&E staining of native meniscus (Figure 3.4.2) revealed cells located 
throughout the tissue with varying densities depending on region.  Cells in 
the white zone existed in small groups within lacunae and had a round 
morphology (Figure 3.4.2 A) while cells located in the superficial zone 
appeared to have a more elongated appearance (Figure 3.4.2 B).  A 
synovium could also be seen measuring ~5 µm in thickness on the 
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outermost surface with a thicker layer of collagen fibres (~100 µm) running 
parallel to the surface just underneath.  The red-white zone displayed the 
lowest cell density with cells showing a less rounded morphology than 
those in the white zone but with one or two projections (Figure 3.4.2 C).  
Large collagen fibre bundles with orientation and structure synonymous 
with radial tie fibres could also be seen distributed through the red-white 
zone.  Areas densely populated with cells characteristic of vasculature 
were evident in the red zone, containing cells with many projections (Figure 
3.4.2 D).  Decellularisation using the original method resulted in complete 
removal of cellular material from all zones except the white zone as shown 
by H&E staining (Figure 3.4.3).  Staining revealed the introduction of 
spaces within the ECM of decellularised meniscus however general 
histoarchitecture was retained.  The synovium was lost however the 
superficial layer remained intact (Figure 3.4.3 C).  Use of the original 
method to decellularise menisci (n = 3) resulted in incomplete 
decellularisation of the tissue.  The white zone displayed some staining 
present in lacunae suggesting the presence of cell debris.  Upon further 
investigation using DAPI staining it was revealed that the staining was 
apparently due to presence of dsDNA and was present in all decellularised 
menisci.  Therefore, the original method was unsuccessful in 
decellularising porcine medial menisci. 
3.4.1.2 Method 1 
Menisci were subjected to the original decellularisation protocol with EDTA 
removed from all wash solutions to determine what effect this have since it 
was not desirable to include EDTA in a process for the subsequent 
decellularisation of bone-meniscus-bone.  Whole porcine menisci (n = 3) 
were subject to the decellularisation process and the extent of 
decellularisation evaluated by histology and DAPI staining of tissue 
Sections (Figure 3.4.4).  H&E staining revealed the retention of matrix 
histoarchitecture throughout the meniscus with radial tie fibers present in 
the red-white and red zone regions (Figure 3.4.4 A and E).  There was also 
an absence of nuclear material in the red, superficial and red-white zones 
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however there was some haematoxylin staining in the white zone (Figure 
3.4.4 G).  DAPI staining suggested that this was dsDNA whilst also 
verifying the absence of dsDNA from all other regions (Figure 3.4.4 H).  
Therefore Method 1 did not successfully decellularise porcine medial 
meniscus. 
 
Figure 3.4.2: H&E staining of native porcine meniscus showing the white (A), 
superficial (B), red-white (C), and red (D) zones.  Magnification 200x unless stated, 
Images are representative of the results obtained from n = 3 menisci. 
 
3.4.1.3 Methods 2 and 3 
A further six medial menisci were subject to decellularisation using 
methods 2 and 3. Introduction of the extra detergent cycle in method 2 as 
described in Section 3.3.1.3 resulted in similar results to Method 1 (Figure 
3.4.4).  The red zone was clear of cellular staining with spaces visible 
between the matrix where vascular cells existed previously (Figure 3.4.5 
A).  Again, the synovium was not present however the superficial layer was 
intact (Figure 3.4.5 C).  The red-white zone did not display any staining for 
cellular remnants but radial tie fibres were visible suggesting retention of 
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ECM structure (Figure 3.4.5 E).  The white zone was stained weakly by 
eosin and several round spaces were visible.  Some eosin staining was 
present in these spaces previously occupied by cells in the white zone 
(Figure 3.4.5 G), suggesting the presence of cellular debris from the 
collapse of lacunae (Kheir et al., 2011).  As no haematoxylin staining was 
present it was deduced that there was no dsDNA present.  
Decellularisation using method 3 yielded almost identical results to method 
2.  Collagen structures were preserved, but as with the previous methods 
the synovium was lost (Figure 3.4.5 D).  A similar level of eosin staining 
was seen in the white zone (Figure 3.4.5 H) compared to method 2 
however the matrix appeared to retain its structure better.  Both methods 
were successful in removing all nuclear material from porcine menisci with 
no nuclear staining present upon histological assessment.  Staining also 
revealed retention of histoarchitecture however there was removal of the 
synovial membrane and the introduction of spaces between collagen fibres.  
DNA was quantified for method 3 menisci as this appeared to be an 
effective decellularisation protocol.  Samples were taken from throughout 
the tissue to ensure removal of DNA from the entire meniscus.  This 
revealed regional variations in DNA content (Figure 3.4.6) however none of 
these were statistically significant (p>0.05).  The mean DNA content of 
native porcine meniscus was 960.19 ± 61.32 ng.mg-1 dry weight of tissue 
and 41.83 ± 11.88 ng.mg-1 dry weight of tissue for decellularised porcine 
meniscus, equating to a 95.64% reduction in total DNA. 
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Figure 3.4.3: Radial Sections of decellularised meniscus (original method) stained with H&E and DAPI.  A) H&E staining of decellularised meniscus 
red zone B) DAPI staining of decellularised meniscus red zone C) H&E staining of decellularised meniscus superior surface D) DAPI staining of decellularised 
meniscus superior surface E) H&E staining of decellularised meniscus red-white zone F) DAPI staining of decellularised meniscus red-white zone G) H&E 
staining of decellularised meniscus white zone (400x) H) DAPI staining of decellularised meniscus white zone (100x).  Magnification 200x unless stated, 
Images are representative of the results obtained from n = 3 menisci. 
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Figure 3.4.4: Radial Sections of decellularised meniscus (method 1) stained with H&E and DAPI.  A) H&E staining of decellularised meniscus red zone 
(20x) B) DAPI staining of decellularised meniscus red zone C) H&E staining of decellularised meniscus superior surface (20x) D) DAPI staining of 
decellularised meniscus superior surface E) H&E staining of decellularised meniscus red-white zone (20x) F) DAPI staining of decellularised meniscus red-
white zone G) H&E staining of decellularised meniscus white zone (400x) H) DAPI staining of decellularised meniscus white zone (400x).  Magnification 200x 
unless stated, Images are representative of the results obtained from n = 3 menisci. 
111 
 
 
Figure 3.4.5: Radial Sections of decellularised meniscus (method 2 and 3) stained with H&E.  A)  Method 2 meniscus red zone B) Method 3 meniscus 
red zone C) Method 2 meniscus superior surface D) Method 3 meniscus superior surface E) Method 2 meniscus red-white zone F) Method 3 meniscus red-
white zone G) Method 2 meniscus white zone H) Method 3 meniscus white zone.  Magnification 200x unless stated, Images are representative of the results 
obtained from n = 3 menisci. 
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Figure 3.4.6: DNA content of native and decellularised meniscus by 
spectrophotometric analysis of extracted DNA at 260 nm.  Data presented as mean (n 
= 3) ± 95% C.I.  AH – anterior horn, AM – anterior-middle, M – middle, PM – posterior-
middle, PH – posterior horn.  The data was analysed using two one-way ANOVA`s for 
native and decellularised menisci and this revealed no significant variation in the data. 
3.4.1.4 Decellularisation of bone-meniscus-bone 
The protocol for decellularising bone-meniscus-bone was adapted from 
method 3 with additional steps incorporated to aid decellularisation of bone 
attachments.  The initial freeze-thaw cycles were followed by mechanical 
manipulation of the attachment site to introduce space between the 
collagen fibre bundles which would improve process reagent access to the 
enthesis region.  Bone attachments were also treated using a waterpik at 
this stage to remove bone marrow, again to improve access for process 
reagents.  The volume of solution in each pot was also increased from 100 
mL to 150 mL given the increased size and weight of tissue equating to 8-9 
mL per gram of tissue, with all steps carried out at either 4 °C or 42 °C, 
except for the nuclease and sterilisation steps, to limit microbial growth.  
The change from 45 °C to 42 °C incubations was enforced when 
temperature monitoring of incubators revealed temperature fluctuations up 
to 48 °C when set at 45 °C, which could potentially cause denaturation of 
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meniscal ECM.  Setting the temperature at 42 °C meant the temperature 
could only reach a maximum of 45 °C. 
Decellularisation did not appear to alter the size and geometry of porcine 
bone-meniscus-bone (Figure 3.4.7).  Decellularised samples appeared to 
have a more glossy appearance and were less red in colour when 
compared to native porcine bone-meniscus-bone.  Cartilage surfaces were 
smooth and intact, while the bone appeared white suggesting removal of all 
marrow.  The bone attachments were soft to the touch and seemed to have 
lost some of their mechanical stiffness when pressed. 
 
Figure 3.4.7: Native porcine bone-meniscus-bone (left) and decellularised porcine 
bone-meniscus-bone (right). 
As seen with the previous methods, H&E staining of menisci revealed 
retention of major histoarchitecture however the synovial membrane was 
removed (Figure 3.4.8).  Decellularisation appeared to be successful in the 
meniscus with no nuclear staining present in any region (Figure 3.4.8).  
Bone attachments were stained using a modified McNeal’s tetrachrome 
stain after embedding in resin, as traditional decalcification may have 
provided false negative results.  McNeal’s tetrachrome staining of native 
bone displayed the distinct layers present within the attachment site: the 
ligamentous attachment and its insertion point (Figure 3.4.9 A and B), the 
transition to trabecular bone (Figure 3.4.9 C and D), and the dense 
enthesis (Figure 3.4.9 E and F).  Cells which appeared oval in shape were 
present between the collagen fibers in the ligamentous attachment with 
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more spindle shaped cells also found in the associated vasculature.  
Pockets of fat were also seen throughout the attachment site.  Cells in the 
bone were usually solitary surrounded by mineralised matrix with bone 
marrow and its associated cells present in the trabecular space.  The 
enthesis was composed of dense mineralised matrix with small pockets of 
bone marrow and a layer of calcified cartilage towards the tibial surface.  
The decellularisation protocol was successful in removing whole cells and 
nuclei from the bone attachment with no nuclear staining present in any of 
the regions (Figure 3.4.9 B, D and F).  Spaces appeared between the 
collagen fibers of the ligamentous attachment however this was expected 
given the mechanical manipulation during the process.  Otherwise the 
attachment appeared to be unchanged from the native samples. 
Residual DNA was quantitated by extraction using a DNeasy kit and 
spectrophotometric analysis using a NanoDrop 1000 (Figure 3.4.10).  
Entire menisci were cut into ~1 mm3 pieces and freeze-dried prior to 
comminution using a cryomill.  This ensured homogenisation and mixing of 
menisci allowing representative sampling of the whole meniscus.  Samples 
(25 mg for native and 100 mg for decellularised) were then processed as 
described in Section 2.2.5.3.  Native meniscus contained 803.8 ± 20.0 
ng.mg-1 whereas decellularised meniscus contained 26.7 ± 2.4 ng.mg-1 (dry 
weight) which equates to a >96% reduction.  The DNA content of porcine 
bone was slightly higher at 1371.8 ± 38.5 ng.mg-1 (dry weight) with a >91% 
reduction in DNA observed in decellularised tissue which contained 124.9 ± 
6.0 ng.mg-1 (dry weight). 
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Figure 3.4.8: Radial Sections of native and decellularised meniscus (bone-meniscus-bone) stained with H&E.  A) Native meniscus red zone B) 
Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native meniscus red-white zone F) 
Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 200x unless stated.  Images 
are representative of the results obtained from n = 3 menisci. 
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Figure 3.4.9: Sections of native and decellularised bone block stained with McNeal’s Tetrachrome.  A) Native ligament B) Decellularised ligament C) 
Native trabecular bone D) Decellularised trabecular bone E) Native enthesis F) Decellularised enthesis.  Magnification 100x unless stated.  Images are 
representative of the results obtained from n = 3 menisci. 
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Figure 3.4.10:  DNA content of native and decellularised bone-meniscus-bone 
following extraction and spectrophotometric analysis at 260 nm.  Data presented as 
mean (n = 3) ± 95% C.I.  Statistical analysis performed using student’s t-test (* p<0.05). 
 
3.4.2 Qualitative analysis of DNA 
PCR was used to determine the presence of functional genes for GAPDH, 
β-actin and collagen I in native and decellularised bone-meniscus-bone.  A 
representative agarose gel is shown in Figure 3.4.11.  Functional genes 
were amplified in DNA extracted from native porcine bone-meniscus-bone 
with clear bands for GAPDH, β-actin and collagen I.  A clear band localised 
around 600 base pairs (bp) was seen for DNA extracted from native 
porcine meniscus and bone and amplified using primers for GAPDH.  No 
band was seen in the corresponding lanes for DNA extracted from 
decellularised porcine meniscus or bone.  DNA from native meniscus and 
bone amplified using primers for β-actin also displayed clear bands, this 
time around 300 bp.  Again, there was no visible band for decellularised 
meniscus or bone.  The same pattern was repeated for DNA amplified 
using primers for collagen I, with clear bands present for native samples 
0
200
400
600
800
1000
1200
1400
1600
Meniscus Bone
D
N
A,
 
ng
.m
g-
1
dr
y 
w
ei
gh
t
Native
dCelled
* * 
118 
 
and no band for decellularised samples.  There was also no band visible 
for the blank reaction. 
 
Figure 3.4.11:  Gel electrophoresis of genes expanded from native and 
decellularised porcine bone-meniscus-bone.  1) Native meniscus GAPDH, 2) Native 
meniscus β-actin, 3) Native meniscus Collagen I, 4) Decellularised meniscus GAPDH, 5) 
Decellularised meniscus β-actin, 6) Decellularised meniscus Collagen I, 7) Blank, 8) DNA 
ladder, 9) Native bone GAPDH, 10) Native bone β-actin, 11) Native bone Collagen I, 12) 
Decellularised bone GAPDH, 13) Decellularised bone β-actin, 14) Decellularised bone 
Collagen I. 
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3.5 Discussion 
Multiple strategies have been investigated in the search for a suitable 
meniscal replacement.  Both natural and synthetic materials have been 
evaluated as potential scaffolds to promote the regeneration of meniscal 
tissue.  Other approaches have tried to develop scaffold-free methods for 
growing replacement meniscal tissue as well as decellularisation of 
allogeneic or xenogeneic meniscus.  The approach evaluated in this study 
focused on the decellularisation of xenogeneic meniscus and bone 
attachments to remove immunogenic material in order to create a potential 
replacement.  The bone attachments will be vital to the function of the 
acellular scaffold following implantation as they provide a relatively simple 
mechanism for the fixation of the scaffold in the knee joint whilst 
maintaining the anatomic relationship between the anterior and posterior 
meniscal horns.  It has been shown that grafts’ incorporating bone plugs 
restore contact mechanics close to normal (Alhalki et al., 1999) and 
termination of the collagen fibres in the bone allow retention of mechanical 
integrity as hoop stresses can still be generated. 
Freeze/thaw cycles were included at the start of the decellularisation 
process as a means of separating the dense ECM by creating ice crystals, 
which enhances the diffusion of decellularisation solutions.  Repeated 
freezing and thawing was also useful in lysing cells located deep within the 
meniscus.  The subsequent wash steps in hypotonic buffer were included 
to further lyse cells.  This was followed by incubation in 0.1% (w/v) SDS in 
hypotonic buffer to solubilise and facilitate removal of cell fragments.  The 
use of SDS has been scrutinized as it is potentially toxic.  Higher 
concentrations of SDS have been reported to cause damage to collagen in 
studies of the decellularisation of other tissues.  However, these studies 
used 1% (w/v) SDS (Bodnar et al., 1986; Courtman et al., 1994) whereas 
only 0.1% (w/v) SDS was used here resulting in no signs of damage to the 
ECM.  It has also been postulated that the damage observed in previous 
studies was not attributable to SDS but to proteases released through cell 
lysis (Booth et al., 2002).  The potential for such damage to occur was 
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negated in this study by the incorporation of the protease inhibitor aprotinin.  
It must also be noted that aprotinin is stable at the higher temperatures 
used during the process, due to its tertiary structure.  Wash steps in 
DPBSa were then included to remove solubilised cell remnants from the 
previous steps and SDS as this may have inhibited the activity of 
nucleases in the subsequent step.  In order to digest nucleic acids, DNase 
and RNase were included.  This would also reduce sites of calcification 
associated with the phosphate groups on nucleic acids in the clinical 
application.  Menisci were then washed using hypertonic buffer and DPBSa 
to wash out any remaining solubilised cellular material followed by 
disinfection using PAA.  The numerous final washes in DPBSa were 
incorporated to remove all traces of potentially cytotoxic process reagents 
as well as any cellular remnants. 
Initial assessment of the decellularisation method developed by Stapleton 
et al. (2008) (original method, 3.3.1.1) was carried out on meniscus without 
the bone attachments to gauge the effectiveness of the protocol once 
EDTA had been removed from decellularisation reagents.  Previous studies 
had revealed softening of bone blocks owing to the inclusion of EDTA in 
the decellularisation solutions.  Haematoxylin and eosin staining of native 
and decellularised meniscus was performed to assess the level of 
decellularisation achieved by the original method and method 1, and to 
compare matrix changes.  This revealed an absence of cellular residue in 
the red, red-white and superficial zones.  However, nuclear material, 
determined by DAPI staining, was visible in the white zone (Figure 3.4.3).  
The failure of the original method to decellularise meniscus may have been 
due to intricacies in the protocol not described in the SOP suggesting the 
process was not robust.  Method 1 was employed to assess the impact of 
EDTA on decellularisation.  EDTA was removed from all process reagents 
and this yielded almost identical results to the original method with nuclear 
material present in the white zone of decellularised menisci (Figure 3.4.4).  
This suggested that removing EDTA from process reagents would not have 
an adverse effect on decellularisation.  As neither method was able to 
achieve complete decellularisation of porcine meniscus, it was 
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hypothesised that the SDS treatment was insufficient in solubilising and 
removing cellular material or that residual SDS was inhibiting nuclease 
activity.  Therefore, to achieve complete decellularisation, Method 1 was 
adapted to include an extra cycle of hypotonic buffer at 4 °C for 24 hours, 
hypotonic buffer at 37 °C for 24 hours, SDS hypotonic buffer at 45 °C for 24 
hours and hypotonic buffer at 45 °C for 24 hours prior to the three washes 
in wash buffer preceding nuclease treatment was added (method 2, 
Section 3.3.1.3).  This was because there were whole cell nuclei remaining 
in the tissue suggesting insufficient cell lysis.  SDS also acts to aid the 
removal of cellular detritus.  In parallel an adapted protocol incorporating 
six 12 hour washes in wash buffer to aid removal of SDS from the tissue 
prior to the nuclease step instead of three 24 hour washes (method 3, 
Section 3.3.1.4) was also tested.  It was hypothesised that residual SDS in 
the tissue was affecting nuclease activity thereby preventing complete 
digestion of nuclear material.  Therefore it was postulated that extra 
changes of wash buffer would help reduce residual SDS concentrations 
and improve nuclease activity.  Both protocols proved successful in 
decellularising porcine meniscus, however as staining revealed cellular 
remnants in menisci treated using method 2 it was decided that method 3 
would be carried forward.  Also, the inclusion of further SDS wash steps 
could damage the ECM and lead to cytotoxicity, whereas method 3 was 
slightly more economical as wash buffer is less expensive and the length of 
the decellularisation process remained unchanged. 
Decellularisation of bone-meniscus-bone followed the same process as 
method 3, however, slight alterations were made and steps added to aid 
decellularisation of the bone blocks.  The volume of solutions was 
increased to match the increased mass, EDTA was removed from all 
solutions, bone blocks were treated using a water flosser to remove bone 
marrow and prevent clotted blood in the trabecular space from forming a 
barrier to penetration and collagen fibers were teased apart at the 
attachment site to aid diffusion of reagents into the enthesis in both the 
superior and inferior directions. 
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The initial level of decellularisation was determined using H&E staining in 
the meniscus and McNeal’s Tetrachrome staining in bone.  While histology 
of the meniscus was fairly straightforward due to available expertise within 
the group, methods for staining bone without prior decalcification were not 
available.  Decellularised bone was not decalcified as the decalcification 
process can remove cells from the tissue possibly resulting in a false 
negative.  Hence, it was decided to embed bone in resin as this would 
preserve the decellularised bone completely allowing for accurate 
determination of decellularisation.  Initially, a method for staining resin 
embedded bone using H&E was attempted however this resulted in 
ineffective staining of both cells and ECM.  Several adaptations were made 
and a method incorporating an initial step to remove a layer of resin 
allowing the staining solutions access to the sample proved successful in 
staining native porcine bone but not decellularised porcine bone possibly 
due to interactions between the solvent used and residual decellularisation 
reagents.  Next staining was attempted with Sanderson’s Rapid Bone stain 
however this also was unsuccessful as although bone matrix was stained 
no cellular staining was seen even on native tissue controls.  Finally, a 
staining protocol using McNeal’s Tetrachrome was identified and this 
revealed complete removal of whole cells from both these regions as well 
as retention of gross matrix architecture. 
To further verify removal of cellular material, DNA was extracted using the 
DNeasy kit and quantified using spectrophotometry.  Again, a method for 
analysis of bone was not available and so had to be developed as the 
protocol for soft tissue was not able to successfully extract DNA from bone.  
Successful extraction was achieved by incorporating SDS and EDTA into 
the digestion solution to decalcify and solubilise bone resulting in the 
release of cells surrounded by mineralised matrix and allowing subsequent 
digestion by proteinase K.  Results revealed >96% removal of DNA from 
meniscus and >90% removal of DNA from bone blocks.  Crapo et al. 
(2011) suggested that decellularised matrices should aim to reduce the 
level of dsDNA to below 50 ng.mg-1 of dry weight in order to prevent 
adverse host reactions.  The quantification method used in this study 
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detected ssDNA and so was more sensitive than those outlined as a 
standard for decellularised tissues.  Even so, the decellularisation protocol 
reduced the ssDNA content of meniscus to 26.7 ± 2.4 ng.mg-1 (dry weight) 
which is well below the quoted standard. 
It is crucial to assess the level of DNA removal from decellularised matrices 
and whether any remaining DNA is functional.  PCR was used to determine 
the presence of functional DNA in decellularised bone-meniscus-bone.  
DNA was extracted as described in Sections 2.2.6.3 and 2.2.6.4 and 
amplified for target genes GAPDH, β-actin and collagen I.  GAPDH, an 
enzyme involved in carbohydrate metabolism, and β-actin, a component of 
the cell cytoskeleton, were selected as they are ubiquitous in cell DNA.  
Collagen I was selected as it is expressed in abundance by 
musculoskeletal cells, and so all target genes are reliable markers for 
residual functional DNA.  Results indicated the presence of all target genes 
in samples extracted from native tissue and an absence in samples 
obtained from decellularised bone-meniscus-bone.  PCR products had a 
predicted size of 230 bp, 210 bp and 243 bp for GAPDH, β-actin and 
collagen I, respectively.  However, actual PCR product size for GAPDH 
was ~500 bp and for β-actin was ~300 bp.  This may have been due to the 
presence of both exons and introns in DNA extracted whereas primers 
were designed from mRNA which only includes exons.  The Collagen I 
PCR product size was as expected. 
The results presented in this chapter describe the successful 
decellularisation of porcine bone-meniscus-bone.  Matrix geometry and 
architecture were preserved and total DNA was reduced to >90% for both 
soft and hard tissue portions.  Further investigations into specific changes 
to the matrix are detailed in the next chapter. 
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Chapter 4. Characterisation of decellularised 
porcine bone-meniscus-bone 
4.1 Introduction 
In Chapter 3, a process for the production of an acellular porcine bone-
meniscus-bone scaffold was described. It was important to determine how 
the decellularisation process and reagents affected the ECM of 
decellularised bone-meniscus-bone as this will impact its in vivo efficacy.    
The impact of various decellularisation reagents have been discussed in the 
previous chapter.  Histology, immunohistochemistry, and biochemical 
assays were used to compare native and decellularised bone-meniscus-
bone composition, while differential scanning calorimetry and magnetic 
resonance imaging provided information on structural changes that may 
have taken place. 
 
4.1.1 Meniscal matrix components 
Tissues can be separated into two components: the cells, which maintain 
homeostasis and produce the ECM, which, in turn provides support to the 
cells and the mechanical function of the tissue.  Meniscal ECM is mainly 
composed of collagen with proteoglycans, GAGs and elastin making up the 
remainder.  These constituents form highly organised structures that allow 
the meniscus to withstand forces transmitted through the knee firstly by the 
attraction and retention of water by GAGs which creates a Donnan osmotic 
pressure allowing the fluid phase to bear the initial load before radial 
displacement of the meniscus leads to the generation of hoop stresses as 
the collagen fibres act in tension. 
4.1.1.1 Collagen 
Collagen is used to describe proteins forming a triple helix consisting of 
polypeptide chains.  Although the different types of collagen display diverse 
structures they all comprise a right-handed triple helix composed of three α 
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chains (Kuhn, 1986).  The organic matter present in the meniscus is 
composed of ~80% collagen with fibrillar collagens in abundance.  The inner 
region is hyaline-like and has a high proportion of type II collagen although 
type I still accounts for 40% of inner region organic matter.  The outer region 
however is composed almost entirely of collagen type I (~99%).  The triple 
helix in collagen I is heterotrimeric and formed from two α1(I) chains and one 
α2(I) chain, whereas three α1(II) chains comprise the homotrimeric collagen 
II triple helix (Gelse et al., 2003).  Type I collagen provides tensile strength 
in tendons and, post-calcification, torsional stiffness in bone.  Collagen II is 
predominantly found in hyaline cartilage, however it is also present in the 
nucleus pulposus of intervertebral discs and corneal epithelium (von der 
Mark, 1999).  Collagen III consists of three α1(III) chains and is usually found 
associated with collagen I in elastic tissues (von der Mark, 1981).  Collagen 
IV is found on the basement membrane where it provides major structural 
support and binds other ligands such as laminin to form supramolecular 
architectures (Poschl et al., 2004).  Collagen VI is found in the pericellular 
matrix and anchors the cell membrane to the ECM (Sardone et al., 2013) 
where it provides protection from compressive loading.  It is also involved in 
cell-matrix signalling (Fraser et al., 2006) and has been found in bone growth 
plates where it plays a role in remodelling (Keene et al., 1991). 
4.1.1.2 Proteoglycans 
Proteoglycans are found in meniscal ECM and consist of multiple 
glycosaminoglycan (GAG) chains covalently bound to a core protein, and so 
more resemble polysaccharides than proteins.  Aggrecan is the major 
proteoglycan in the meniscus, however perlecan, decorin, biglycan and 
fibromodulin are also present (Melrose et al., 2005).  As described in Chapter 
(1) proteoglycans are hydrophilic in nature and this restricts the flow of water 
within the meniscus thereby contributing to the ability of the meniscus to 
withstand compressive forces, as described by the biphasic theory (Mow et 
al. 1980). 
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4.1.1.3 GAGs 
Glycosaminoglycans are linear polysaccharides containing a characteristic 
repeating disaccharide unit comprised of an amino sugar and uronic acid.  
Common GAGs are chondroitin sulphate, dermatan sulphate, keratan 
sulphate and hyaluronic acid.  GAGs, with the exception of hyaluronic acid, 
are bound to a proteoglycan core protein through serine residues.  
Hyaluronic acid is, however, able to bind to aggrecan through a link protein 
forming large aggregating complexes that are highly negatively charged thus 
able to occupy a larger hydrodynamic space. 
 
4.1.2 Bone matrix 
The basic building block of bone is the mineralized collagen I fibril.  The 
mineral component is dahllite, a carbonated apatite, which forms thin plate-
shaped crystals.  There are also over 200 non-collagenous proteins present 
in bone and the most abundant of these is osteocalcin (Hauschka et al., 
1989), however these only make up <10% of the total protein content.  Water 
is the other major constituent of bone and plays a major role in bone 
mechanical properties as dry bone has been shown to have altered 
mechanical properties to wet bone (Currey, 1990).  Bone can be separated 
into cortical, or compact, and cancellous, or trabecular, bone.  Long bones, 
such as the femur, have a cortical shell and a cancellous interior.  The tibia 
is an example of a long bone and has a layer of hyaline cartilage covering 
the articulating surfaces.  The medial meniscus is anchored to the superior 
surface, the tibial plateau, via the meniscal horns allowing it to dissipate load 
through the generation of circumferential hoop stresses.  Collagen fibres 
extend into the enthesis of the tibial plateau where they terminate and are 
secured in place by the mineralised matrix.  The medial meniscus is attached 
in the same way in both humans and pigs, only to the tibial plateau.  
However, the lateral meniscus in pigs is attached to the femoral condyle at 
the posterior horn and the tibial plateau at the anterior horn, whereas in 
humans it is only attached to the tibial plateau.   
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4.2 Aims and objectives 
4.2.1 Aims 
The aim of the work described in this chapter presented was to characterise 
decellularised porcine bone-meniscus-bone in comparison to native tissue. 
 
4.2.2 Objectives 
• To qualitatively compare native and decellularised porcine bone-
meniscus-bone composition using immunohistochemistry to 
investigate the presence of the major collagens.. 
• To quantitatively determine the total collagen, GAG, and calcium 
content of native and decellularised porcine bone- meniscus-bone. 
• To determine thermal stability of native and decellularised porcine 
bone-meniscus-bone using differential scanning calorimetry 
• To determine the structure of native and decellularised porcine bone-
meniscus bone using 9.4T magnetic resonance imaging. 
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4.3 Methods 
4.3.1 Experimental approach 
To complete the studies described in this chapter it was necessary to dissect 
and decellularise a further 7 bone-meniscus-bone. 
• Sections of meniscus obtained for histology as described in Chapter 
(3) section 3.2.2 were also used for histology in this chapter. 
• Four porcine bone-meniscus-bone samples were decellularised using 
the method described in Chapter (3) Section 3.3.1.5.  Decellularised 
bone-meniscus-bone was stored on PBS-soaked filter paper at -20 
°C prior to use.  These samples were used for quantification of 
calcium in bone with unused bone blocks (n = 2) used for MRI. 
• Three porcine bone-meniscus-bone samples were decellularised 
using the method described in Chapter (3) Section 3.3.1.5.  
Decellularised bone-meniscus-bone was stored on PBS-soaked filter 
paper at -20 °C prior to use.  These samples were used for thermal 
analysis using differential scanning calorimetry. 
 
4.3.2 Quantification of calcium in porcine bone 
Samples of native and decellularised porcine bone (~1 g; n = 4) were dried 
at 95 °C for five days after which they were digested in a microwave using 4 
mL nitric acid and 1 mL hydrogen peroxide.  The digest was then diluted 1 
in 10 using 18 megohm distilled water in polypropylene tubes.  Samples were 
diluted 1 in 46 using 2% (v/v) nitric acid prior to analysis using ICP-MS.   A 
commercially available standard solution (Merck) was used to test accuracy 
of measurements.  Work was carried out at the UK Centre for Tissue 
Engineering, University of Liverpool. 
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4.3.3 Thermal analysis 
Native and decellularised bone-meniscus-bone (n = 3) was split into five 
regions for sampling: white, red-white, horns, enthesis and bone.  Samples 
of ~10 mg were taken from each region and dehydrated in a graded ethanol 
series (0%, 20%, 40%, 60%, 80%, 100%, 100%, 100%) by immersion for 
one hour in each solution.  Ethanol was removed from samples using a 
vacuum centrifuge for 30 minutes.  Samples were then heated to 200 °C at 
10 °C per minute in a differential scanning calorimeter with a blank chamber 
used as the reference.  Data was generated as temperature (°C) vs heat flow 
(W/g) and denaturation enthalpy (ΔH) was calculated as the area under the 
transition peak. 
 
4.3.4 Magnetic Resonance Imaging 
4.3.4.1 Meniscus 
Native and decellularised menisci (n = 2) were prepared by slicing in a radial 
direction to produce slices ~5mm thick.  Samples were placed in a universal 
(diameter = 25 mm) with tissue paper in the bottom to create a flat surface.  
MR images of the menisci were obtained using a 9.4T Bruker AVANCE II 
400 MHz laboratory NMR system using a 3D-FLASH (3D Fast Low Angle 
Shot) sequence with a scan duration of 25 hours and 56 minutes.  A total of 
100 slices were taken using a matrix size of 512 x 512 pixels with 59 µm 
spatial resolution in the matrix plane and spatial resolution of 90 µm in the 
slice direction.  The repetition time (TR) was 38 ms, the echo time (TE) was 
4.3 ms, and the flip angle (FA) was 15°.  A total of 48 averages of each slice 
were taken to produce the final image. 
4.3.4.2 Bone 
Native and decellularised bone (n = 2) were prepared by removing the 
meniscus at the horns by sharp dissection.  Whole bone blocks were placed 
in a universal (diameter = 25 mm) with tissue paper in the bottom to create 
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a flat surface.  MR images of the bone were obtained using a 3D-FLASH 
sequence with scan duration of 54 hours and 28 minutes.  A total of 210 
slices were taken using a matrix size of 512 x 512 pixels with 59 µm spatial 
resolution in the matrix plane and spatial resolution of 90 µm in the slice 
direction.  The repetition time (TR) was 38 ms, the echo time (TE) was 4.3 
ms, and the flip angle (FA) was 15°.  Again, a total of 48 averages were 
taken. 
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4.4 Results 
4.4.1 Histological characterisation 
4.4.1.1 Proteoglycans 
Sulphated glycosaminoglycans such as chondroitin and dermatan sulphate 
were stained in histological sections of fresh and decellularised porcine 
meniscus using Safranin O (Figure 4.4.1).  In the native meniscus this 
revealed very little staining in the red zone which was mainly associated with 
blood vessels, with no staining present in the superficial region.  Extensive 
staining was seen throughout the hyaline-like inner region however no 
staining was seen in the red-white zone.  Decellularised porcine meniscus 
tissue exhibited no staining in any region suggesting that decellularisation 
removed the GAGs from the tissue. 
 
4.4.2 Immunohistochemical characterisation 
4.4.2.1 Collagen I 
Collagen I distribution in native and decellularised porcine meniscus was 
investigated by immunohistochemical staining (Figure 4.4.2).  Isotype and 
negative (no antibody) controls did not display any staining (Appendix A).  
Collagen I was shown to be present throughout the native meniscus with 
positive staining of cells especially in the superficial and red-white zones. 
Less positive staining was seen around cells in the white zone.  The level of 
staining appeared to remain unchanged post-decellularisation. Collagen I 
staining of the attachment site and bone showed the presence of collagen I 
throughout the bone and attachment (Figure 4.4.3).  The crimp could be seen 
on the collagen fibres making up the attachment itself with some staining 
also present in cells residing between the fibres.  Staining was also present 
on the mineralised portion of the trabecular bone but not in the cells making 
up the bone marrow.  Cells residing in the trabecular space within the 
enthesis however did display collagen I staining as did the
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Figure 4.4.1:  Radial sections of native and decellularised meniscus (bone-meniscus-bone) stained with Safranin O.  A) Native meniscus red zone B) 
Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native meniscus red-white zone F) 
Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 100x unless stated.  Images 
are representative of the results obtained from n = 3 menisci.
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enthesis.  The attachment area of the decellularised meniscus appeared to 
lose its structure with no crimp visible in the collagen fibres.  The mineralised 
trabeculae and enthesis displayed the same intensity of staining as in the 
native bone. 
4.4.2.2 Collagen II 
No staining was seen with antibody isotype and negative [no antibody] 
controls (Appendix A).  Collagen II was also present throughout the entire 
native meniscus and was also seen localised to cells mainly in the white zone 
but also in the red and red-white zones, however no cellular staining was 
seen in the superficial layer (Figure 4.4.4).  The staining intensity again 
remained unchanged post-decellularisation of the meniscus however there 
was more intense staining in the white zone.  Collagen II stained slightly less 
intensely in native attachment than collagen I however there was more 
intense staining in cells in this region (Figure 4.4.5).  Cells in the trabeculae 
and enthesis also stained positively for collagen II and there was some 
staining present in the bone marrow.  Weak staining was present in the 
mineralised portions of the trabecular bone and enthesis.  The intensity of 
staining did not appear to change in the decellularised specimens.   
4.4.2.3 Collagen III 
A similar pattern emerged when the tissues were examined 
immunhistochemically for collagen III (Figure 4.4.6) which was also present 
throughout the entire meniscus and localised to cells, although to a lesser 
number of cells than collagen II.  There was an absence of staining on the 
inner tip in decellularised meniscus but no other changes in staining intensity 
or pattern were observed between native and decellularised menisci.  
Collagen III staining was present in the native attachment between the 
collagen fibres and localised to cells, with stronger staining present around 
the vasculature (Figure 4.4.7).  There was weak staining visible in the bone 
marrow and mineralised matrix within the trabeculae and enthesis.  Staining 
was weak in the decellularised attachment and was 
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Figure 4.4.2:  Immunohistochemical staining of radial sections of native and decellularised meniscus using antibody against collagen I.  A) Native 
meniscus red zone B) Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native 
meniscus red-white zone F) Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 
40x unless stated.  Images are representative of the results obtained from n = 3 menisci. 
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Figure 4.4.3:  Immunohistochemical staining of anteroposterior sections of native and decellularised bone block using antibody against collagen I.  
A) Native attachment B) Decellularised attachment C) Native trabecular bone D) Decellularised trabecular bone E) Native enthesis F) Decellularised enthesis.  
Magnification 200x unless stated.  Images are representative of the results obtained from n = 3 bone blocks. 
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Figure 4.4.4:  Immunohistochemical staining of radial sections of native and decellularised meniscus using antibody against collagen II.  A) Native 
meniscus red zone B) Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native meniscus 
red-white zone F) Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 100x unless 
stated.  Images are representative of the results obtained from n = 3 menisci. 
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Figure 4.4.5: Immunohistochemical staining of anteroposterior sections of native and decellularised bone block using antibody against collagen II.  
A) Native attachment B) Decellularised attachment C) Native trabecular bone D) Decellularised trabecular bone E) Native enthesis F) Decellularised enthesis.  
Magnification 200x unless stated.  Images are representative of the results obtained from n = 3 bone blocks. 
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Figure 4.4.6: Immunohistochemical staining of radial sections of native and decellularised meniscus using antibody against collagen III.  A) Native 
meniscus red zone B) Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native 
meniscus red-white zone F) Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 
20x unless stated.  Images are representative of the results obtained from n = 3 menisci. 
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Figure 4.4.7: Immunohistochemical staining of anteroposterior sections of native and decellularised bone block using antibody against collagen 
III.  A) Native attachment B) Decellularised attachment C) Native trabecular bone D) Decellularised trabecular bone E) Native enthesis F) Decellularised 
enthesis.  Magnification 200x unless stated.  Images are representative of the results obtained from n = 3 bone blocks. 
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mainly associated with fat remaining in the tissue.  Staining was very weak 
in the trabecular bone however remained unchanged in the enthesis. 
4.4.2.4 Collagen IV 
Native menisci stained for collagen IV (Figure 4.4.8) showed weak staining 
localised to cells throughout the entire meniscus as well as strong staining 
associated with the vasculature.  This revealed an extensive network of 
microvasculature in the menisci extending from the outer region well into the 
inner region with larger vessels present in the outer region reducing in size 
as they extend in towards the inner region.  There was no staining present 
in any of the regions for decellularised samples.  Collagen IV stained 
predominantly around the vasculature of the attachment with very strong 
staining along vessel walls, however there was also some staining of cells 
present between the collagen fibres (Figure 4.4.9).  This was also true for 
the bone with some staining of cells in the bone marrow and further staining 
of blood vessels in the enthesis.  As with the meniscus, once decellularised 
there was no collagen IV staining visible in any of the regions.  No staining 
was seen with the antibody isotype and negative [no antibody] controls. 
4.4.2.5 Collagen VI 
No staining was seen with antibody isotype and negative [no antibody] 
controls.  Collagen VI staining was evident in the native menisci, again 
localised to the cell population with more intense staining around the 
vasculature and synovial membrane.  Cells in all regions stained strongly for 
collagen VI, especially those in the superficial layer.  Staining intensity 
decreased in decellularised menisci with some staining present in the outer, 
superficial and central regions, and no staining present in the inner region.  
On gross inspection of decellularised sections there appeared to be a border 
of weaker staining surrounding the section with intensity increasing towards 
the centre of the section.  The attachment stained positively for collagen VI 
with strong staining of the cells and within the matrix (Figure 4.4.9).  Cells 
were also stained in the trabecular bone and 
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Figure 4.4.8:  Immunohistochemical staining of radial sections of native and decellularised meniscus using antibody against collagen IV.  A) Native 
meniscus red zone B) Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native 
meniscus red-white zone F) Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 
20x unless stated.  Images are representative of the results obtained from n = 3 menisci. 
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Figure 4.4.9:  Immunohistochemical staining of anteroposterior sections of native and decellularised bone block using antibody against collagen 
IV.  A) Native attachment, magnification 200x B) Decellularised attachment, magnification 200x C) Native trabecular bone D) Decellularised trabecular bone 
E) Native enthesis F) Decellularised enthesis.  Magnification 100x unless stated.  Images are representative of the results obtained from n = 3 bone blocks. 
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Figure 4.4.10: Immunohistochemical staining of radial sections of native and decellularised meniscus using antibody against collagen VI.  A) Native 
meniscus red zone B) Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native meniscus 
red-white zone F) Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 100x unless 
stated.  Images are representative of the results obtained from n = 3 menisci.   
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Figure 4.4.11: Immunohistochemical staining of anteroposterior sections of native and decellularised bone block using antibody against collagen 
VI.  A) Native attachment B) Decellularised attachment C) Native trabecular bone D) Decellularised trabecular bone E) Native enthesis F) Decellularised 
enthesis.  Magnification 200x unless stated.  Images are representative of the results obtained from n = 3 bone blocks. 
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Figure 4.4.12: Immunohistochemical staining of anteroposterior sections of native and decellularised bone block using antibody against osteocalcin.  
A) Native attachment B) Decellularised attachment C) Native trabecular bone D) Decellularised trabecular bone E) Native enthesis F) Decellularised enthesis.  
Magnification 100x unless stated.  Images are representative of the results obtained from n = 3 bone blocks. 
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enthesis as well as in the bone marrow however the trabeculae were 
negative for collagen VI unlike the enthesis where there was some staining.  
Staining was much weaker in decellularised attachment and this was also 
seen in the enthesis.  There was no staining present in the trabeculae. 
4.4.2.6 Osteocalcin 
No staining was seen with antibody isotype and negative [no antibody] 
controls.  Osteocalcin stained positively in the native meniscal attachment 
with extensive staining throughout, particularly surrounding the vasculature 
and cells.  This was also seen in the native trabecular bone and enthesis 
with cells staining very positively for osteocalcin, including in the bone 
marrow.  Staining was less positive in the decellularised attachment however 
was not affected in the trabecular bone or enthesis where the matrix was 
stained as intensively as in native specimens.   
 
4.4.3 Biochemical characterisation 
4.4.3.1 Collagen 
Collagen content of native and decellularised meniscus and bone was 
determined using hydroxyproline assay (Figure 4.4.14).  Dried soft-tissue 
samples were acid hydrolysed prior to assay with bone samples decalcified 
prior to hydrolysis.  In order to ensure the accuracy of the data, it was first 
necessary to determine the time taken for complete hydrolysis of samples. 
Samples of meniscus were therefore hydrolysed for up to eight hours and 
the hydroxyproline content determined at two hour intervals. This showed 
that hydrolysis for 6 hours was sufficient (Figure 4.4.13). This was therefore 
applied to the samples of meniscus and bone to be tested.  Values obtained 
for hydroxyproline content were converted to collagen content.  The collagen 
content of native meniscus was 802.90 (± 52.95, 95% C.I.) mg.g-1 dry weight 
and for decellularised meniscus was 935.35 (± 18.03, 95% C.I.) mg.g-1 dry 
weight.  The values were not significantly different (student`s t-test; p>0.05).  
Native bone had a collagen content of 391.42 (± 39.51, 95% C.I.) while 
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decellularised bone contained 501.52 (± 100.01, 95% C.I.) mg.g-1 dry weight.  
Again the means were not significantly different (student`s t-test; p>0.05). 
 
Figure 4.4.13: Hydroxyproline concentrations from investigation of acid hydrolysis 
duration.  Data presented as mean (n = 3) ± 95% C.I.  Statistical analysis was performed 
using ANOVA (* p<0.05 compared to all other groups). 
 
Figure 4.4.14: Collagen content of native and decellularised bone-meniscus-bone by 
hydroxyproline assay.  Data presented as mean (n = 3) ± 95% C.I.  Statistical analysis 
was performed using student’s t-tests which revealed no significant difference in the total 
collagen content of the meniscus or bone before and after decellularisation (p>0.05). 
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Glycosaminoglycan content of native and decellularised meniscus was 
analysed using DMMB assay.  Dried soft-tissue samples (n = 3) were 
digested using papain prior to assay.  The time taken for complete digestion 
of samples was determined through investigation of incubation with papain 
digestion solution for up to 4 days.  DMMB assay was performed every 24 
hours and the results showed complete digestion after 72 hours (Figure 
4.4.15).  Therefore, samples of meniscus were digested for 72 hours prior to 
DMMB assay.  The mean GAG content of native meniscus (Figure 4.4.16) 
averaged over all regions was 23.49 (± 8.63, 95% C.I.) mg.g-1 dry weight and 
for decellularised meniscus was 0.30 (± 0.47, 95% C.I.) mg.g-1 dry weight.  
The values were significantly different when analysed by student’s t-test (p< 
0.05).  Regional analysis of GAG content was also undertaken with the 
meniscus separated into inner, outer and attachment regions.  The mean 
GAG content of native inner meniscus was 64.80 (± 1.06, 95% C.I.) mg.g-1 
dry weight and for decellularised inner meniscus was 3.73 (± 14.34, 95% 
C.I.) mg.g-1 dry weight.  Again the means were significantly different 
(student`s t-test; p< 0.05);.  The mean GAG content of native outer meniscus 
was 20.75 (± 5.56, 95% C.I.) mg.g-1 dry weight and for decellularised outer 
meniscus was 0.19 (± 0.53, 95% C.I.) mg.g-1 dry weight.  The means were 
significantly different (student`s t-test; p< 0.05);.  The mean GAG content of 
native attachment was 7.88 (± 0.02, 95% C.I.) mg.g-1 dry weight and for 
decellularised attachment was 0.00 (± 0.00, 95% C.I.) mg.g-1 dry weight. 
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Figure 4.4.15: GAG concentrations from investigation of papain digestion 
duration.  Data presented as mean (n = 3) ± 95% C.I.  Statistical analysis was performed 
using ANOVA (* p<0.05 compared to all other groups). 
 
Figure 4.4.16: GAG content of native and decellularised meniscus by DMMB assay.  
Data presented as mean (n = 3) ± 95% C.I.  Statistical analysis performed using student’s 
t-tests which revealed significant differences in the total GAG content between different 
regions of the meniscus before and after decellurisation (* p<0.05). 
4.4.3.3 Calcium 
Bone samples were dried and dissolved in hydrochloric and nitric acid 
followed by analysis using inductively-coupled plasma mass spectrometry 
for quantification of calcium (Figure 4.4.17).  Native bone had a calcium 
concentration of 26.61 (± 5.15, 95% C.I.) mg.g-1 dry weight compared to 
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13.015 (± 3.37, 95% C.I.) mg.g-1 dry weight for decellularised bone.  Means 
were found to be significantly different when compared by student’s t-test (p 
< 0.05). 
 
Figure 4.4.17: Calcium content of native and decellularised bone by ICP-MS.  Data 
presented as mean (n = 4) ± 95% C.I.  Statistical analysis was performed using student’s 
t-test (* p<0.05). 
 
4.4.4 Thermal analysis 
4.4.4.1 Differential scanning calorimetry 
Differential scanning calorimetry was used to compare the thermal stability 
of native and decellularised bone-meniscus-bone.  Samples were taken from 
inner, outer, attachment, enthesis, and bone regions from three native and 
three decellularised bone-meniscus-bone and heated to 200 °C.  Broad 
peaks were evident on all thermograms corresponding to collagen 
denaturation.  Results are summarised in Figure 4.4.18 and Figure 4.4.19.  
Native samples had denaturation temperatures (TD) of 74.43 (± 8.03, 95% 
C.I.), 65.48 (± 7.72, 95% C.I.), 76.13 (± 17.00, 95% C.I.), 60.52 (± 12.10, 
95% C.I.), and 51.43 (± 4.58, 95% C.I.) °C for inner, outer, attachment, 
enthesis and bone regions, respectively.  Decellularised samples had 
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denaturation temperatures of 65.58 (± 13.66, 95% C.I.), 59.87 (± 7.06, 95% 
C.I.), 53.39 (± 4.23, 95% C.I.), 61.39 (± 6.56, 95% C.I.), and 50.27 (± 1.11, 
95% C.I.) °C for inner, outer, attachment, enthesis and bone regions, 
respectively.  There were no significant differences between native and 
decellularised samples with the exception of the attachment which had a 
significantly lower denaturation temperature for the decellularised samples 
compared to native samples (student`s t-test; p < 0.05). 
 
Figure 4.4.18: DSC thermograms of native and decellularised bone-meniscus-bone.  
N = native, D = decellularised, RW = red-white, W = white, B = bone, E = enthesis, and A = 
attachment.  Images are representative of n = 3 samples. 
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Figure 4.4.19: Denaturation temperatures of native and decellularised bone-
meniscus-bone by DSC.  Data presented as mean (n = 3) ± 95% C.I.  Statistical analysis 
was performed using student’s t-test for each region (* p<0.05 when compared to native 
tissue). 
 
4.4.5 Magnetic Resonance Imaging 
4.4.5.1 Meniscus 
Magnetic resonance imaging was used to compare the structure of native 
and decellularised porcine medial meniscus.  Menisci (n = 2) were cut 
radially to produce 5 mm thick slices and imaged by performing a 3D FLASH 
sequence using a Bruker AVANCE II 400 MHz NMR system. A 
representative image is displayed in Figure 4.4.20.  Imaging of native 
menisci mainly highlighted structures that appeared to represent the 
vasculature which extended from the red zone all the way to the white zone.  
Blood vessels were larger in the red zone and diminished in size and number 
as they approached the white zone.  This correlated with collagen IV staining 
of native meniscus.  The distribution of vasculature through the native 
porcine meniscus is shown in Figure 4.4.20.  Larger vessels are seen 
emanating from the PMCP and spreading through the body of the meniscus.  
A smooth outer layer was also visible surrounding the entire meniscus which 
may have been the synovial membrane.  This layer was not seen on the 
decellularised meniscus instead a rough boundary layer was seen.  The 
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structures, presumed to be blood vessels in native meniscus were not 
apparent following decellularisation of the meniscus however a clear 
difference in signal intensity could be seen between the white zone and the 
rest of the meniscus. 
 
Figure 4.4.20: 2D image slices extracted from 3D MRI of native (right) and 
decellularised (left) porcine medial meniscus.  Representative image from n = 2 
menisci.   
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Figure 4.4.21: Collagen IV staining of native porcine medial meniscus showing 
distribution of vasculature throughout the immature meniscus. 
 
4.4.5.2 Bone 
MR images of bone were obtained using a 3D FLASH sequence on entire 
bone blocks.  Samples (n = 2) of native and decellularised bone were placed 
in a universal and scanned for ~56 hours to obtain a 3D representation of 
the sample.  Images of native porcine bone blocks (Figure 4.4.22) displayed 
the different regions clearly.  The 3D flash sequence allowed clear distinction 
of the regions.  Good signal was displayed from cartilage and tendon with 
collagen structures visible in the meniscal attachments.  The mineralised 
matrix was displayed through an absence of signal due to the surrounding 
marrow which is water-rich therefore resulting in a strong signal.  This 
consisted of the cortical bone, just underneath the cartilage surface of the 
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tibial plateau and the transition to trabecular bone.  The epiphyseal plate 
could also be seen towards the bottom of the bone block.     
 
Figure 4.4.22:  MRI of native porcine bone block.  Representative image from n = 2 
bone blocks. 
Structures were more clearly visible in MR images of decellularised bone 
blocks due to better contrast between different components (Figure 4.4.23).  
Again, all regions from the cartilage surface to the epiphyseal plate were 
displayed.  Slight changes in the depth of tibial cartilage were seen with a 
slightly thicker layer visible on decellularised bone blocks.  The attachment 
also appeared to be looser in structure and swollen when compared to the 
native attachment. 
Growth plate 
Attachment 
Cartilage 
Enthesis 
Trabecular 
bone 
156 
 
 
Figure 4.4.23:  MRI of decellularised porcine bone block.  Representative image from 
n = 2 bone blocks. 
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4.5 Discussion 
The work presented in this chapter aimed to determine whether the process 
developed in Chapter 3 to decellularise the porcine bone-meniscus –bone 
preserved the extracellular matrix composition and structure.  The duration 
and nature of the protocol required for effective decellularisation suggested 
that there would be changes to the extracellular matrix.  Since the collagen 
structure within the meniscus is vital to its function it was desirable to retain 
as much of this as possible.  Ionic detergents, such as sodium dodecyl 
sulfate (SDS), solubilise cell and nucleic membranes and can denature 
proteins.  SDS has been shown to effectively remove cell and nuclear 
material but can also remove GAGs and growth factors, and damage 
collagen (Reing et al., 2007; Lumpkins et al., 2008; Stapleton et al., 2008; 
Deeken et al., 2011).  Native and decellularised bone-meniscus-bone 
samples were evaluated for major matrix constituents both qualitatively and 
quantitatively. 
As mentioned in Chapter 3, H&E staining of meniscus revealed the loss of 
the synovial membrane post-decellularisation.  This is not deemed critical as 
it has been shown that migrating cells reform the synovial membrane 
(Arnoczky et al., 1992).  H&E staining also highlighted the formation of 
spaces in the extracellular matrix.  This may have been due to the freeze-
thaw cycles incorporated in the protocol and/or from the removal of cells and 
other matrix components.  The organised collagen structure was retained 
allowing the different regions to be clearly distinguished with radial tie-fibers 
visible throughout the tissue. 
Proteoglycans were visualised using safranin O with intense staining present 
in the inner region of native menisci and very little if any present in the outer.  
Decellularised samples displayed no safranin O staining suggesting 
complete removal of proteoglycans by the decellularisation protocol.  
However, safranin O has been shown to be limited when staining tissue 
where GAGs have been heavily depleted as antibodies were still able to 
detect the presence of GAGs (Camplejohn & Allard, 1988).  Therefore, 
DMMB assay was used to verify these results and confirmed that all GAGs 
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were lost from the outer and attachment regions of decellularised meniscus.  
However, some GAGs remained in the inner region post-decellularisation, 
which has a GAG content 3-fold higher than in the outer region and 6-fold 
higher than in the attachment.  This may be because the inner region has 
higher collagen II content, with higher proportion of hydroxylysine as well as 
glucosyl and galactosyl residues, which interact with proteoglycans (Mayne, 
1989).  The loss of GAGs may have an effect on the function of the tissue 
since GAGs retard fluid flow in the meniscus allowing the fluid phase to bear 
load before it is transmitted to the solid phase.  The effect on the 
biomechanical properties of the tissue will need to be determined. 
Qualitative analysis of the types of collagen present within bone-meniscus-
bone and changes to this composition perpetrated by decellularisation was 
carried out using immunohistochemical staining.  Collagen I is the major 
constituent of meniscal ECM.  It forms a complex network of fibril bundles 
that provide the tensile properties.  Intense staining was present throughout 
the native meniscus, attachment site and bone attachments.  This was 
replicated in decellularised bone-meniscus-bone however collagen I staining 
intensity was weaker in the inner region and highlighted the loss of collagen 
structure in the attachment with relaxation of the characteristic crimp.  This 
may have been due to the intentional mechanical disruption of the 
attachment to enhance diffusion of decellularisation reagents into the 
enthesis.  Collagen II staining assumed a similar pattern to collagen I with 
staining throughout the meniscus; however intensity was greatest in the 
inner meniscus and localised to cells both in the bone and meniscus.  
Collagen III is incorporated into collagen I fibrils during development where 
it prevents the lateral growth of type I collagen (Birk and Mayne, 1997) and 
also plays a role in the remodelling response (Sodersten et al., 2013).  
Uniform staining was present throughout with weak staining visible in the 
bone, mainly localised to cells.  Staining intensity was decreased in the 
decellularised attachment and bone however as collagen III is deposited 
within 2-5 days of injury.  It is hypothesised that following implantation in vivo, 
migrating host cells would replenish lost collagen III.  Collagen IV is found in 
the pericellular matrix and has been shown to be absent in osteoarthritic 
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meniscus (Foldager et al., 2014).  Collagen IV in native meniscus was seen 
localized to the vasculature exposing an extensive network extending into 
the white zone of the meniscus.  This was expected as the meniscus is 
known to be vascularised during development, becoming increasingly 
avascular with age (Clark and Ogden, 1981).  A complete removal of 
collagen IV was seen in decellularised bone-meniscus-bone.  Investigations 
in the lab have shown that this is caused by peracetic acid (Wilshaw et al., 
2014) and so an alternative sterilisation method may have to be developed.  
However, as the meniscus is largely avascular and studies have shown 
migration of cells into the meniscus it is not known whether the loss of 
collagen IV is critical to the in vivo function of decellularised bone-meniscus-
bone.  Type VI collagen is usually found in the pericellular matrix surrounding 
cells along with fibronectin and GAGs.  Collagen VI anchors the cell 
membrane to the ECM (Sardone et al., 2013) where it provides protection 
from compressive loading and is involved in cell-matrix signalling (Fraser et 
al., 2006).  Collagen VI has also been found in bone growth plates 
(Alexopoulos et al., 2009) and plays a role in remodelling (Keene et al., 
1991).  Immunohistochemical staining of collagen VI in bone-meniscus-bone 
confirmed its presence in meniscus and tibial bone with strong staining 
present localized to cells and on the meniscal surface.  Some staining was 
also present in the ECM especially surrounding the vasculature.  A decrease 
in collagen VI staining intensity was seen in decellularised samples with 
staining intensity increasing towards the centre of the meniscus.  This 
suggested physical removal of collagen VI by hydrostatic pressure as 
opposed to chemical removal by process reagents.  Osteocalcin is the most 
abundant non-collagenous protein present in bone (Hauschka et al., 1989) 
and has been shown to be a determinant of bone formation as its absence 
leads to increased bone formation (Ducy et al., 1996).  
Immunohistochemistry of native bone blocks using anti-osteocalcin 
antibodies revealed positive staining localised to cells in all regions including 
the attachment and marrow, while there was also some staining present on 
the bone matrix.  A similar intensity of staining was seen in decellularised 
bone suggesting the retention of matrix-associated osteocalcin.  Osteocalcin 
160 
 
has been shown to play a role in osteochondrocytic differentiation (Idelevich 
et al., 2011) and so may influence integration of bone blocks once implanted.  
Calcium, in the form of calcium phosphate, is a major component of bone 
where it provides strength and structure.  The strength of bone is dependent 
on its mass and geometry however it is also dependent on its composition.  
Therefore, the calcium content of decellularised bone was determined and 
compared to native bone using inductively coupled plasma mass 
spectrometry (ICP-MS).  ICP-MS allows the determination of elements within 
an atomic mass range of 7 to 250 by ionising samples with inductively 
coupled plasma and then quantifying using a mass spectrometer.  This 
analysis was carried out at the U.K. Centre for Tissue Engineering at the 
University of Liverpool.  Results showed a significant reduction in calcium 
content of decellularised bone (~50%) when compared to native bone.  This 
may adversely impact the mechanical properties in vivo with the implanted 
bone initially unable to withstand compressive forces to the same extent as 
native bone.  Removal of the inorganic mineral may however, prove to be 
beneficial as studies have shown that demineralised bone matrix, allograft 
bone that has had the mineral removed, through the exposure of bone 
morphogenetic proteins displays osteoinductive and osteoconductive 
properties, thus promoting a healing response (Reddi, 1975; Glowacki and 
Mulliken, 1985). 
Several methods were investigated in the determination of calcium content 
in porcine bone.  Initially a colorimetric assay utilising Arsenazo III was 
attempted.  Arsenazo III is a calcium-sensitive dye that has been used for 
the determination of calcium in serum (Morgan et al., 1993).  This proved to 
be unsuccessful as estimations of calcium content did not match values 
obtained from the literature.  Atomic absorption spectroscopy (AAS) was 
then investigated as a method for detection of calcium.  AAS utilises a flame 
to atomise samples which are then excited causing the electrons in the 
atomised sample to absorb a defined quantity of energy.  The wavelength of 
this absorption is specific to a particular electron transition in a specific 
element and is then measured using a detector.  Total calcium values 
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obtained using this method were similar to the colorimetric method however 
the proportional difference between native and decellularised samples was 
similar to that obtained using ICP-MS.  It is unknown why these methods 
were unable to correctly estimate total calcium content as samples were 
within the sensitivity limits of each method.  It is hypothesised that other 
elements present within the samples may have interfered with these 
measurement techniques. 
Thermal analysis of decellularised bone-meniscus-bone was undertaken 
using DSC and compared to that of native tissue.  DSC can be used to detect 
structural changes in samples as they are heated.  Samples were 
dehydrated prior to analysis as hydration of collagen has been shown to 
influence the denaturation temperature (Miles and Gelashvilli, 1999).  Due to 
the differing compositions between regions present within bone-meniscus-
bone five regions were chosen.  The white zone is composed of dense 
hyaline-like cartilage while the red-white, red and meniscal attachments are 
composed of fibrocartilage.  In the bone two distinct regions exist: the dense 
enthesis and the trabecular bone.  DSC revealed no significant differences 
between denaturation temperatures of native and decellularised samples 
except for in the attachment where there was a reduction in denaturation 
temperature.  This may be due to the disruption of collagen structures during 
the decellularisation process as incisions were made in this region to 
improve access of reagents into the enthesis.  Although there was a 
significant difference between the denaturation temperatures of native and 
decellularised attachment, the TD of decellularised attachment was not 
significantly different to native samples from all other regions suggesting 
retention of collagen organisation.   
Magnetic resonance imaging was utilised to provide a rapid comparison of 
meniscus and bone block structure.  A 3D-FLASH scan was able to reveal 
detailed images of major meniscal and bone architecture.  Interpretation of 
images proved to be difficult as the MRI was unable to differentiate between 
the various types of tissue present within bone-meniscus-bone.  Hence, 
morphological analysis was undertaken and compared to histology to 
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determine structures.  MR images of native meniscus displayed a branched 
network of structures emanating from the PMCP and terminating in the white 
zone.  These structures appeared to resemble those seen with collagen IV 
staining of native menisci, with large branches appearing from the red zone 
and terminating in the white zone.  Menisci were obtained from skeletally 
immature pigs (~ 6 months old) and this explains the vascularised meniscus 
present on the MR images and collagen IV staining.  MR signal intensity is 
dependent on numerous factors but mainly proton density.  In collagenous 
samples, signal intensity is affected by fibre orientation and hydration.  Blood 
vessels contain proportionally more water than ECM due to the presence of 
blood and high cellularity of the endothelial layer and perivascular cells.  It is 
suggested that the loss of these cells from decellularised menisci and hence 
equilibration of the water to the surrounding matrix resulted in the loss of 
these structures from MR images of decellularised menisci.  Positive staining 
in histological images of decellularised menisci also discouraged the notion 
that these structures may have been radial tie fibres.  MRI of bone revealed 
retention of major architecture however structures were more clearly 
displayed on decellularised bone samples.  This may have been due to 
improved hydration of decellularised samples with residual PBS post-
decellularisation.  Images of native bone contained areas of poor signal 
possibly owing to localised dehydration or interference from marrow.  
Cartilage present on the tibial surface also appeared rough which may be 
have been due to degradation and shrinkage over the extended scan time 
as samples were not fixed. 
Characterisation of decellularised meniscus revealed retention of geometry 
and structure.  Major collagens in both meniscus and bone were retained but 
collagen IV was completely removed.  A complete loss of GAGs was also 
seen with meniscus and bone maintaining thermal stability except for in the 
attachment region.  The impact of these compositional changes on the 
biomechanical properties and biocompatibility of bone-meniscus-bone are 
described in the next chapter. 
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Chapter 5. Assessment of the biocompatibility 
and function of decellularised porcine 
bone-meniscus-bone 
5.1 Introduction 
The previous chapter described compositional changes to porcine bone-
meniscus-bone as a result of the decellularisation process.  It was important 
to investigate whether any changes to the extracellular matrix of the porcine 
bone-meniscus-bone had any impact on the biomechanical properties and 
biocompatibility of the tissue which would potentially influence the in vivo 
function of decellularised bone-meniscus-bone.  The meniscus plays a 
critical role in knee joint mechanical stability through the transmission of load, 
shock absorption and lubrication.  Therefore, the ability of decellularised 
bone-meniscus-bone to provide these functions comparably to native 
meniscus will be paramount to future clinical translation.  Decellularised 
menisci have been shown to maintain mechanical properties (Maier et al., 
2007; Stapleton et al., 2008; Sandmann et al., 2009; Azhim et al., 2013) 
however other tissues have displayed changes in stiffness post-
decellularisation (Liao et al., 2008; Williams et al., 2009).  
It was also important to determine whether the decellularised bone-
meniscus-bone was biocompatible, in particular as SDS was utilised in the 
decellularisation protocol, verification of its removal during the wash 
procedures was important since SDS has been shown to be cytotoxic to cells 
and prevent cell attachment and infiltration into tissues (Kasimir et al., 2003; 
Rieder et al., 2004).  Pig to primate organ transplantation can result in 
hyperacute rejection (Galili et al., 1997; McPherson et al., 2000) as lower 
mammals have the Galactosyl-α(1,3)galactose (α-gal) epitope present on 
cell membranes.  Large titres of anti- α-gal are produced by humans and 
these cause thrombosis via complement-mediated hyperacute rejection.  
Incomplete decellularisation can lead to hyperacute rejection (Raeder et al., 
2002; Kasimir et al., 2005). 
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5.2 Aims and Objectives 
5.2.1 Aims 
The aim of the work presented in this chapter was to investigate the 
biocompatibility and material properties of the decellularised porcine bone-
meniscus bone. 
5.2.2 Objectives 
• To determine material properties of native and decellularised bone-
meniscus-bone using indentation, tensile, and compression tests 
• To assess the potential cytotoxicity imparted by decellularised bone-
meniscus-bone and by residual soluble components 
• To quantify any SDS remaining within decellularised bone-meniscus-
bone post-decellularisation 
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5.3 Materials and Methods 
5.3.1 Experimental approach 
To complete the studies described in this chapter it was necessary to dissect 
and decellularise a further 16 porcine bone-meniscus-bone samples. These 
were utilised as indicated below. It was also necessary to dissect a further 9 
bone-meniscus bone samples for biomechanical testing of fresh tissue. Six 
of these were used for indentation testing of the meniscus and compression 
testing of the bone and three for tensile testing.  
• Six porcine bone-meniscus bone samples were decellularised using 
the method described in Chapter (3) Section 3.3.1.5. These were then 
utilised for indentation testing of the meniscus tissue (n=6) and for 
compressive testing of the bone blocks (n=6).  Decellularised bone-
meniscus-bone was stored on PBS-soaked filter paper at -20 °C prior 
to testing.  
• Three porcine bone-meniscus-bone samples were decellularised 
using the method described in Chapter (3) Section 3.3.1.5.  
Decellularised bone-meniscus-bone was stored on PBS-soaked filter 
paper at -20 °C prior to testing.  These samples were utilised for 
tensile testing of the meniscus tissue.  Due to the nature of the 
sampling method, it was not possible to obtain meniscus tissue for 
both indentation and tensile testing from the same samples.  
• Three porcine bone-meniscus-bone samples were prepared 
aseptically for in vitro cytotoxicity assays. The samples were 
decellularised as described in Chapter (3) Section 3.3.1.5 with the 
exception that all steps after PAA sterilisation were undertaken in a 
Class II safety cabinet using sterile reagents.  Decellularised bone-
meniscus-bone was then stored in sterile containers at -20 °C until 
testing. 
• Four porcine bone-meniscus-bone samples were decellularised for 
quantification of residual SDS. These samples were processed 
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separately since it was necessary to utilise 14C radio-labelled SDS in 
the decellularisation process  
 
5.3.2 Mechanical testing of bone-meniscus-bone 
5.3.2.1 Indentation of meniscus 
Indentation testing was carried out on a custom designed indentation rig to 
assess the behaviour of native and decellularised porcine meniscus in 
unconfined compression.  Samples of meniscus (n = 6) 6 mm in diameter 
and 1.5 mm thickness were obtained from the middle region of menisci using 
a biopsy punch and loaded using a flat indenter (diameter = 2.5 mm; load = 
0.22 N) over the course of an hour.  Samples were attached to the base of 
the sample holder using cyanoacrylate glue to prevent slipping and 
submerged in PBS at room temperature to maintain hydration.  The sample 
holder was then raised until the indenter tip was <1 mm above the sample 
and the indenter lowered to contact the sample.  An oil-filled dashpot 
reduced the speed of the indenter shaft and hence the initial impact.  
Deformation was measured using a linear variable differential transducer 
(LVDT) and the force measured by a piezo-electric force transformer.  Data 
was collected using Lab View 8 software.  The experimental set up is shown 
in Figure 5.3.1.  Displacement values were converted to deformation using 
the sample height with the deformation at various time points arcsine 
transformed prior to statistical analysis and back transformed prior to 
presentation. 
The LVDT was calibrated using a series of standard stainless steel step 
heights placed under the indenter and the measured voltage used to create 
a standard curve.  Linear regression was then performed to obtain the 
calibration factor (Figure 5.3.2).  The force transducer was calibrated by 
loading known masses incrementally and noting the subsequent voltage 
readings.  Linear regression was performed to convert voltage to Newtons 
(Figure 5.3.3).  Displacement values were converted from LVDT readings 
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and converted to percentage deformation using the sample height.  
Percentage deformation was arcsine transformed for statistical analysis. 
 
Figure 5.3.1:  Indentation apparatus and experimental set up 
 
Figure 5.3.2: An example calibration of the LVDT 
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Figure 5.3.3:  An example calibration of the force transducer 
 
5.3.2.2 Finite element modelling 
Deformation curves generated using the method described in Section 5.3.2.1 
were used to obtain the aggregate modulus of native and decellularised 
porcine meniscus using a finite element model.  The aggregate modulus is 
a measure of the stiffness of a material at equilibrium once all fluid has 
ceased to flow from within it.  High values denote stiffer materials, and vice 
versa.  The aggregate modulus can be determined via confined compression 
employing a porous indenter to allow flow of fluid out of the tissue or via 
unconfined compression using a non-porous indenter as fluid flow is not 
restricted.  The aggregate modulus of porcine meniscus has been 
determined using creep indentation apparatus and ranged from 0.13 to 0.27 
MPa depending on sample location (Sweigart et al., 2004).  The model 
employed in this study was developed by Mow et al. (1989) for derivation of 
the material properties of cartilage.  Assumptions made by the model include 
that cartilage is an isotropic, homogeneous material and conditions of 
infinitesimal strain and a frictionless indenter tip were also set.   
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5.3.2.3 Tensile testing of meniscus 
Uniaxial tensile testing of native and decellularised porcine meniscus (n = 3) 
was undertaken to compare their material properties under tension.  Initial 
testing on meniscus was carried out on straight specimens measuring 3 mm 
in width to negate the impact of matrix heterogeneity (McDermott et al., 
2008a).  This proved unsuccessful as failure occurred at the grips where the 
sample was weakened due to the force required to tighten the grips in order 
to prevent the sample from slipping.  Tissue paper was used between the 
grips and sample to reduce the contact force exerted on the sample by the 
grip teeth.  This resulted in successful testing of some native samples with 
failure occurring in the gauge length however consistency could not be 
achieved.  This method was also unsuccessful when used with 
decellularised meniscus with samples slipping or failing at the grips once 
again.  Hence, it was decided to proceed using dumbbell shaped samples in 
order to reduce the force required to achieve failure and prevent the sample 
slipping through wider distribution of pressure at the grip.  Cross-sections of 
meniscus ~ 1 mm thick were obtained using a specially designed cutter 
employing two one-sided blades (Figure 5.3.4).  This cross-section was then 
placed onto a cold block and another cutter used in conjunction with a lever 
press to obtain dumbbell shaped samples for testing (Figure 5.3.5).  Sample 
widths were 1 mm with gauge lengths of 5 mm.  Samples were then placed 
in custom grips (Figure 5.3.6 and Figure 5.3.7) with tissue paper to prevent 
slipping and alignment of the sample.  A pre-load of 0.02 N was applied to 
ensure the gauge length was maintained and samples tested to failure on an 
Instron 3365 at a strain rate of 0.02.  Data were collected using Bluehill 3 
software.  Raw data was exported from BlueHill 3 software to Microsoft Excel 
2007 for analysis and derivation of engineering stress (σ) and engineering 
strain (ε) for each run.  The applied force was put into the following 
calculation to determine stress: 
σ𝑒𝑒𝑒𝑒𝑒𝑒 = 𝐹𝐹𝐴𝐴 
170 
 
where, F is the applied force and A is the cross-sectional area of the 
specimen in mm2.  A Poisson’s ratio of zero was set as changes to the 
sample cross-sectional area during loading were assumed to be negligible.  
The measured extension of the sample from the original length was used to 
calculate the strain: 
ε𝑒𝑒𝑒𝑒𝑒𝑒 = ∆𝐿𝐿𝐿𝐿  
where, ΔL is the extension of the specimen in mm, and L is the specimen 
length (~5 mm) after the application of the pre-load (0.02 N).  The material 
properties that were derived from the stress-strain data were the tensile 
modulus, the ultimate tensile strength (UTS), and the failure strain.  Data 
presented are averages of n = 3 (± 95% C.I.) specimens and statistical 
analysis was performed using student’s t-test. 
 
 
Figure 5.3.4: Cutting device used to obtain cross-sections of porcine meniscus for 
tensile testing 
 
 
Figure 5.3.5:  Method for obtaining dumbbell shaped samples of porcine meniscus 
for tensile testing 
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Figure 5.3.6: Cross-section of grips displaying positioning of sample 
 
 
 
Figure 5.3.7:  Custom grips used for tensile testing of porcine meniscus 
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5.3.2.4 Compression of bone 
Native and decellularised bone was tested to failure under unconfined 
compression to determine material properties.  Cylinders (diameter = ~6.5 
mm, height = ~5.5 mm) of bone (n = 6) were obtained from each block using 
a metal corer and electrical drill (Figure 5.3.8).  Cartilage was removed from 
the bone plugs using a scalpel and bone plugs were then attached to the 
sample holder (Figure 5.3.9) using cyanoacrylate glue to prevent slipping.  
Samples were then compressed at a rate of 0.01 s-1 until failure on an Instron 
3365.  Data were collected using Bluehill 3 software.  BlueHill 3 software was 
used to determine engineering stress (σ) and strain (ε) for each run as well 
as ultimate compressive strength and compressive modulus.   
The material properties that were derived from the stress-strain data were 
the ultimate compressive strength (UTS), and the failure strain ().  Data 
presented are averages of n = 6 (± 95% C.I.) specimens and statistical 
analysis was performed using student’s t-test. 
 
Figure 5.3.8:  Method for obtaining samples for unconfined compression 
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Figure 5.3.9:  Experimental set up for unconfined compression testing of bone  
 
5.3.3 Cytotoxicity assays 
5.3.3.1 Contact cytotoxicity assay 
Cytotoxicity occurring from decellularised bone-meniscus-bone components 
was assessed using a contact cytotoxicity assay.  Using aseptic technique 
in a class II safety cabinet, samples (n = 3) of decellularised meniscus and 
bone from the white, red/red-white, attachment and bone measuring ~5 mm 
x 5 mm x 1 mm were attached to 6-well tissue culture treated plates using a 
single steri strip (3M, Minnesota, US).  Samples were then washed three 
times with sterile PBS containing calcium and magnesium and seeded with 
BHK and 3T3 cells (Section 2.1.3) to achieve confluence after 48 hours.  The 
positive control used in this study was cyanoacrylate glue (n = 3) and the 
negative controls were either tissue culture plastic alone or a steri strip (n = 
3).  Following incubation, the culture medium was aspirated and the wells 
washed with sterile PBS containing calcium and magnesium.  Cells were 
then fixed using 10% (v/v) NBF for 10 minutes and stained using 2 mL of 
Giemsa solution for 5 minutes.  The stain was washed away by repeatedly 
rinsing using distilled water after which plates were allowed to air dry for 3 
hours and visualised under light microscopy. 
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5.3.3.2 Extract cytotoxicity assay 
Potentially cytotoxicity from compounds leaching out of decellularised 
meniscus was investigated using an extract cytotoxicity assay.  Using 
aseptic technique in a Class II safety cabinet, decellularised bone and 
meniscus was cut into ~1 mm3 pieces using a scalpel and weighed.  DMEM 
(3 mL.mg-1) was added to bone and meniscus and the samples were 
incubated at 37 °C for 72 hours with agitation.  Samples were then 
centrifuged at 500 g for 15 minutes and the supernatant retained for assay.  
A sterility check was performed by streaking extracts onto agar plates 
(nutrient, fresh blood and Sabauroud) and incubating nutrient and fresh 
blood plates at 37 °C and Sabauroud plates at 27 °C in an incubator.  Plates 
were checked for colonies after 48 hours.  BHK and 3T3 cells were seeded 
onto 96-well tissue culture treated plates at a concentration deemed suitable 
to yield confluency after 24 hours.  Once cells had attached (~3 hours) the 
medium was aspirated and 100 µL cell culture medium containing double 
strength FBS (DMEM, 20% (v/v) FBS, 200 µg.L-1 penicillin, 200 U.mL-1 
streptomycin, and 2 mM L-Glutamine) was added to each well followed by 
100 µL of test extract and plates incubated at 37 °C in an atmosphere of 5% 
(v/v) CO2 in air for 24 hours.  Controls utilised in this study were 40% (v/v) 
DMSO in DMEM (positive) and DMEM alone (negative).  Following 
incubation an ATPLite-M assay was performed to determine cellular 
adenosine triphosphate content (Section 5.3.3.3). 
5.3.3.3 ATPLite-M assay 
Reagents (Section 2.1.2) were allowed to equilibrate to room temperature 
prior to use.  The culture medium was aspirated from wells and fresh DMEM 
(100 µL) and cell lysis solution (50 µL) were added.  The plate was shaken 
at 700 rpm for two minutes on a plate shaker at room temperature after which 
the contents of each well were transferred to corresponding wells of a 96-
well Optiplate.  Substrate solution (50 µl) was added to each well and the 
plate shaken for a further five minutes at 700 rpm.  Optiplates were then 
placed into Top Count, allowed to equilibrate to the dark for 10 minutes prior 
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to measurement of the luminescence. Data was recorded in counts per 
second.  
 
5.3.4 Detection of α-gal epitope on porcine meniscus 
Native and decellularised meniscus (n = 3) were prepared for 
immunohistochemistry as described in Sections 2.2.3.1, 2.2.4.1-2.2.4.3.  
Sections of meniscus were then incubated using anti-α-gal antibody, no 
antibody (negative control) or an isotype control antibody to detect non-
specific staining (Section 2.2.7).  Once the secondary antibody had been 
applied and colouration reaction had been terminated, sections were 
dehydrated and mounted (Section 2.2.4.4) for visualisation using light 
microscopy. 
 
5.3.5 Determination of residual SDS 
Decellularised bone-meniscus-bone was tested for residual SDS using 14C 
radio-labelled SDS.  Reagents containing SDS in the decellularisation 
protocol were spiked with 5 µCi of 14C radio-labelled SDS and used during 
decellularisation of bone-meniscus-bone.  During decellularisation, the 
solutions obtained at the end of each stage of the process were collected 
and assayed for SDS as described below.   
After the decellularisation was complete the bone-mensicus-bone was 
collected and separated into white, red-white, attachment, and bone regions.  
Tissue from each region was cut into ~1 mm3 pieces and 40 mg (n = 4) 
placed into a well of a 96-well Optiplate.  To this, 200 µL of micro-scint 20 
was added and the plate was read for 20 minutes using Top Count.  Samples 
of decellularisation solution were read in the same way with 40 µL of sample 
(n = 4) and 160 µL of micro-scint used.  A standard curve of 0, 50, 100, 200, 
500 and 1000 µg.mL-1 of 14C spiked SDS was produced and linear 
regression performed to obtain the concentration of SDS in each sample.  
Values obtained for the tissues were then converted to absolute weights of 
SDS per weight of tissue.  
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5.4 Results 
5.4.1 Mechanical testing 
5.4.1.1 Indentation testing of meniscus 
The deformation of meniscus under applied load was assessed using 
indentation testing.  The deformation of native and decellularised meniscus 
under load over one hour is shown in Figure 5.4.1.  Native meniscus 
deformed gradually up to a peak deformation of ~22% after one hour, 
whereas the initial deformation of decellularised meniscus was more rapid 
and reached a higher value, ~33%, after one hour.  From these curves it was 
possible to obtain the aggregate modulus (Figure 5.4.2), a measure of the 
material’s stiffness, using a finite element model developed at the University 
of Leeds.  Modelling was carried out by Dr. Abdellatif Abdelgaied (iMBE, 
University of Leeds).  This resulted in an aggregate modulus of 0.123 MPa 
for native meniscus and 0.100 MPa for decellularised meniscus.  The values 
obtained were not significantly different (p > 0.05). 
 
Figure 5.4.1:  Deformation of native and decellularised meniscus over time.  Data 
presented as mean (n = 6) ± 95% C.I.   The data was arc sine transformed and analysed 
using a two-way ANOVA which revealed a significant difference (p < 0.01). 
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Figure 5.4.2:  Aggregate modulus of native and decellularised meniscus obtained 
using finite element modelling.  The data is presented as the mean (n = 6) ± 95% CI. The 
data was analysed using students t-test which revealed no significant difference (p = 0.061). 
 
5.4.1.2 Tensile testing of meniscus 
The material properties of native and decellularised meniscus under tension 
were investigated using uniaxial tensile testing.  Dumbbell-shaped 
specimens were obtained from the red-white zone and tested to failure.  
Stress-strain behaviour of native meniscus is shown in Figure 5.4.3 and 
decellularised meniscus is shown in Figure 5.4.4.  There was no significant 
difference between the tensile modulus, ultimate tensile strength and failure 
strain of native and decellularised meniscus.  There was a decrease in the 
ultimate tensile strength of decellularised meniscus with an 18% drop from 
70.2 MPa to 57.5 MPa however this was not significant (Figure 5.4.5).  The 
tensile modulus was virtually identical between native and decellularised 
meniscus at 140.6 MPa and 139.6 MPa (Figure 5.4.5).  The failure strain of 
native meniscus was 48% and for decellularised meniscus was 50% (Figure 
5.4.6). 
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Figure 5.4.3: Stress-strain behaviour of native meniscus under uniaxial tensile 
testing.  Each line represents an individual sample tested to failure. 
 
 
Figure 5.4.4: Stress-strain behaviour of decellularised meniscus under uniaxial 
tensile testing.  Each line represents an individual sample tested to failure. 
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Figure 5.4.5:  Ultimate tensile strength (UTS) and tensile modulus of native and 
decellularised meniscus.  Data presented as mean (n = 3) ± 95% C.I.  Statistical analysis 
performed using student’s t-test (p > 0.05) which revealed no significant differences. 
 
Figure 5.4.6:  Failure strain of native and decellularised meniscus.  Data presented as 
mean (n = 3) ± 95% C.I.  Statistical analysis performed using student’s t-test (p = 0.34) 
which revealed no significant differences. 
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Native and decellularised bone was tested under unconfined compression to 
determine compressive strength.  The yield point was clearly visible for 
native bone samples (Figure 5.4.7), however this was not true for 
decellularised bone where no obvious failure point was seen (Figure 5.4.8).  
Therefore, an offset of 0.02 was applied parallel to the elastic slope in order 
to obtain values for compressive load at yield and deformation at yield 
(Figure 5.4.9) as this value correlated well with the actual yield point for 
native samples.  There was a significant difference between the mean 
compressive load at yield for native bone (Figure 5.4.10), which was 160.46 
N (± 38.23 N, 95% C.I.), and decellularised bone which was 50.66 N (± 27.65 
N, 95% C.I.).  These values resulted in a mean compressive modulus of 
103.0 MPa (± 26.4 MPa, 95% C.I.) for native porcine bone and 12.7 MPa (± 
7.5 MPa, 95% C.I.) for decellularised porcine bone (Figure 5.4.11).  
 
Figure 5.4.7:  Representative load-extension plot showing compression of native 
porcine bone at a strain rate of 0.01 s-1.  Point where gradient is equal to zero signifies 
yield point (X). 
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Figure 5.4.8:  Representative load-extension plot showing compression of 
decellularised porcine bone at a strain rate of 0.01 s-1.  There is no point where the 
gradient is zero. 
 
 
Figure 5.4.9:  Load-Extension plot displaying offset method used to obtain 
compressive load at yield.  The triangle on the left denotes actual yield point and the 
triangle on the right denotes the estimated yield point using an offset of 0.02% strain. 
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Figure 5.4.10:  Compressive load at yield of native and decellularised bone tested 
under unconfined compression at a strain rate of 0.01 s-1.  Data presented as mean (n 
= 6) ± 95% C.I.  Statistical analysis performed using student’s t-test (* p<0.05). 
 
 
Figure 5.4.11:  Compressive modulus of native and decellularised bone tested under 
unconfined compression at a strain rate of 0.01 s-1.  Data presented as mean (n = 6) ± 
95% C.I.  Statistical analysis performed using student’s t-test (* p<0.05). 
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5.4.2 Cytotoxicity assays 
5.4.2.1 Extract cytotoxicity 
Extracts produced from the different regions of decellularised porcine bone-
meniscus-bone were used to test the potential cytotoxicity of residual soluble 
components on 3T3 and BHK cells.  The relative ATP content of cells is 
shown in Figure 5.4.12 and Figure 5.4.13.  The positive control samples 
(cells cultured in DMSO) had significantly lower ATP contents compared to 
the negative control for both cell types.  There was no significant difference 
observed between the cellular ATP content of cells cultured in extracts from 
all other regions when compared to their negative control of cells cultured in 
medium alone (p > 0.05). 
 
 
Figure 5.4.12:  Relative cellular ATP content of BHK cells cultured in extracts from 
different regions of decellularised porcine bone-meniscus-bone.  Data presented as 
mean ± 95% C.I. (n = 3).  Data was analysed using one way ANOVA (p > 0.05 when 
compared to Media only controls). 
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Figure 5.4.13:  Relative cellular ATP content of 3T3 cells cultured in extracts from 
different regions of decellularised porcine bone-meniscus-bone.  Data presented as 
mean ± 95% C.I. (n = 3).  Data was analysed using one way ANOVA (p > 0.05 when 
compared to Media only controls). 
 
5.4.2.2 Contact cytotoxicity 
Potential cytotoxicity from insoluble components of decellularised porcine 
bone-meniscus-bone was assessed by culturing cells directly in contact with 
samples of decellularised bone-meniscus-bone.  Controls (Figure 5.4.14) 
utilised in this study were tissue culture plastic alone (negative), a steri strip 
(negative), and cyanoacrylate glue (positive for cytotoxicity).  Both BHK and 
3T3 cells were seen to grow up to and in contact with steri strips (Figure 
5.4.14 A and C), however for cyanoacrylate glue a clear boundary was 
visible surrounding the glue where cells did not grow (Figure 5.4.14 B and 
D).  Cells grew normally on tissue culture plastic.  Images of Giemsa stained 
3T3 and BHK cells (Figure 5.4.15) showed that both cell lines grew up to and 
in contact with samples taken from all regions of decellularised bone-
meniscus-bone. 
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Figure 5.4.14:  Controls used for contact cytotoxicity study stained using Giemsa.  A) 
3T3 cells in contact with steri strip, B) BHK cells in contact with steri strip, C) 3T3 cells in 
contact with cyanoacrylate glue, D) BHK cells in contact with cyanoacrylate glue.  
Representative images from n = 3, 40x magnification. 
 
5.4.3 Detection of α-gal epitope on porcine meniscus 
Controls showed no positive staining, verifying specificity of the antibody 
(Appendix A).  Staining of native meniscus revealed positive staining 
localised to the vasculature, specifically the vascular cells (Figure 5.4.16 A, 
C, E and G).   Positive colouration could be seen in the red, superficial and 
red-white zone; however no staining was detected in the white zone.  
Decellularised meniscus displayed no positive staining throughout the entire 
tissue (Figure 5.4.16 B, D, F and H). 
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Figure 5.4.15:  Contact cytotoxicity assay using 3T3 and BHK cells stained with Giemsa.  A) 3T3 cells in contact with attachment, B) BHK cells in contact 
with attachment, C) 3T3 cells in contact with white meniscus, D) BHK cells in contact with white meniscus, E) 3T3 cells in contact with  bone, F) BHK cells in 
contact with bone, G) 3T3 cells in contact with red-white meniscus, H) BHK cells in contact with red-white meniscus.  Images representative of n = 3 bone-
meniscus-bone.  Magnification 100x unless stated. 
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Figure 5.4.16:  Immunohistochemical staining of radial sections of native and decellularised meniscus using antibody against α-gal.  A) Native 
meniscus red zone B) Decellularised meniscus red zone C) Native meniscus superior surface D) Decellularised meniscus superior surface E) Native meniscus 
red-white zone F) Decellularised meniscus red-white zone G) Native meniscus white zone H) Decellularised meniscus white zone.  Magnification 100x unless 
stated.  Images are representative of the results obtained from n = 3 menisci. 
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5.4.4 Determination of residual SDS in decellularisation 
solutions and decellularised tissues 
The residual SDS content of decellularised bone-meniscus-bone was 
assessed using 14C radio-labelled SDS.  There was a linear relationship 
between the concentrations of 14C radio-labelled SDS used as standards and 
the counts per minute (Figure 5.4.17), as well as between the absolute SDS 
weights and the counts per minute (Figure 5.4.18).  Determination of SDS in 
decellularisation process reagents (Figure 5.4.19) showed the highest 
concentration of SDS was present in the final SDS wash which was 975 
µg.mL-1 (0.0975% w/v).  Since the initial concentration of SDS in this solution 
was 0.1% w/v, this suggested that some SDS had remained within the bone-
meniscus-bone. The SDS concentrations in subsequent solutions from the 
process showed a gradual decrease as decellularisation progressed, with 
the final PBS step displaying no SDS content, or possibly falling under the 
detection limit of the assay.  Residual SDS content of decellularised porcine 
bone-meniscus-bone (Figure 5.4.20) was very low with the attachment and 
bone displaying slightly higher concentrations of 0.34 µg.mg-1 and 0.32 
µg.mg-1, respectively, compared to 0.23 and 0.21 µg.mg-1 for white and red-
white meniscus, respectively. 
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Figure 5.4.17:  Relationship between SDS concentration and counts per minute 
readings on Top Count 
 
Figure 5.4.18:  Relationship between absolute weight of SDS and counts per minute 
readings on Top Count 
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Figure 5.4.19:  SDS concentration of reagents after use during decellularisation of 
porcine bone-meniscus-bone.  Data presented as mean (n = 4) ± 95% C.I. 
 
 
Figure 5.4.20:  Residual SDS content of decellularised porcine bone-meniscus-bone.  
Data presented as mean (n = 4) ± 95% C.I.  Value for cytotoxicity limit obtained from 
Gratzer et al., 2006. 
  
0
200
400
600
800
1000
1200
Final
Hypotonic
Final SDS Pre-Nuclease
Wash
Hypertonic Final PBS
S
D
S
, μ
g.
m
L-
1
w
et
 w
ei
gh
t
0
2
4
6
8
10
12
White Red-white Attachment Bone Cytotoxicity Limit
SD
S
μg
.m
g-
1
w
et
 w
ei
gh
t
191 
 
5.5 Discussion 
Having characterised the changes in the porcine bone-meniscus-bone after 
decellularisation it was necessary to determine the biomechanical properties 
of the decellularised tissues compared to native tissues and to determine the 
biocompatibility of the processed tissue.  
The primary function of the meniscus is mechanical and so indentation and 
tensile testing of the meniscus and compressive testing of the bone were 
undertaken to determine material properties.  Indentation showed an 
increase in the percentage deformation, and hence a decrease in the 
stiffness, of decellularised meniscus compared to native meniscus however 
this was not significant (p > 0.05).  This change may be attributable to the 
loss of GAGs from the tissue as the GAGs play a critical role in the biphasic 
behaviour of meniscus.   
Anchoring of the meniscus at the horns converts vertical compressive forces 
into circumferential tensile forces as the meniscus is radial displaced.  This 
results in the dissipation of load through the generation of hoop stresses.  
The orientation of collagen fibres in the red-white and red zones provides 
this tensile strength.  Tensile testing of native and decellularised meniscus 
revealed no significant differences in the tensile modulus, ultimate tensile 
strength and failure strain.  Stress-strain behaviour was characteristic of 
collagenous tissue with a low modulus elastin phase and a high modulus 
collagen phase.  Values obtained for the young’s modulus and ultimate 
tensile strength were comparable to those obtained in the literature for native 
human meniscus (Fithian et al., 1990; Lechner et al., 2000) however 
literature on porcine meniscus is limited.  Maintenance of the tensile 
properties of decellularised meniscus suggests that the decellularisation 
protocol does not damage meniscal ECM, and specifically collagen I which 
is responsible for the tensile strength. 
Compressive testing of native and decellularised bone revealed a decrease 
of compressive strength in decellularised bone.  An ultimate compressive 
strength of ~160 MPa was determined for native bone and ~50 MPa for 
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decellularised bone.  Values obtained for the ultimate compressive strength 
of native bone corresponded well with other studies where testing of human 
and bovine compact bone was performed at 0.01 s-1 strain (McElhaney and 
Byars, 1965; Crowninshield and Pope, 1974; Carter and Hayes, 1976).  The 
reduction in compressive strength of decellularised bone may hinder the 
fixation of bone to the tibia in patients and so should be further investigated.  
The Poisson’s ratio was assumed to be zero for this study and so all stress 
values calculated did not consider the potential barrelling of samples under 
compression.  It should also be noted that in vivo decellularised bone will be 
confined and so the material properties may be different to those established 
in this study using unconfined compression. 
Rejection is an issue when transplanting tissue from xenogeneic sources to 
humans.  This usually occurs in the form of hyperacute rejection brought on 
by an immune response to α-gal (Galili et al., 1997).  The α-gal epitope is 
present on cell membrane glycolipids and glycoproteins of lower mammals 
but not in humans, apes or Old World monkeys.  Humans naturally produce 
large titres of antibody against α-gal and so it was important to ensure the 
removal of the α-gal epitope from decellularised bone-meniscus-bone.  
Immunohistochemical staining revealed the absence of α-gal from 
decellularised meniscus.  It is postulated that the mechanism of removal of 
collagen IV (Section 4.4.2.4) is also responsible for the removal of α-gal as 
α-gal has been shown to be localised to the basement membrane (McKenzie 
et al., 1994).  This occurs during the PAA sterilisation step (Section 3.3.1.5) 
as shown by Wilshaw et al. (2014).  Only staining of the meniscus was 
possible as issues with procurement of the antibody meant detection of α-
gal in bone could not be attempted.  However, given the loss of collagen IV 
seen in decellularised bone (Figure 4.4.9) it is hypothesised that α-gal will 
also be removed from decellularised bone.   
Qualitative contact cytotoxicity assays were undertaken using 3T3 and BHK 
cells to assess potential cytotoxic effects from decellularised bone-
meniscus-bone.  Results indicated no cytotoxic effects from any region 
including both deep and superficial areas, with cells growing up to and in 
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contact with decellularised bone-meniscus-bone and appearing to maintain 
normal morphology.  Extract cytotoxicity assays were also undertaken to 
investigate possible cytotoxic effects from soluble components of 
decellularised bone-meniscus-bone.  The mean ATP content of cells was 
measured by ATPLite-M assay, revealing no significant differences between 
cells cultured using extracts and the negative control (cell culture medium).  
Another source of potential cytotoxicity is SDS remaining from 
decellularisation with studies showing that removal of SDS is essential for 
recellularisation of decellularised matrices (Kim et al., 2002; Rieder et al., 
2004).  SDS was quantified in decellularised bone-meniscus-bone and wash 
solutions using 14C radio-labelled SDS.  Results revealed a small quantity of 
SDS was still present within decellularised bone-meniscus-bone.  Gratzer et 
al. (2006) showed that the lower cytotoxicity threshold for residual SDS in 
tissue is 10 µg per mg of tissue, whereas the mean SDS content of 
decellularised bone-meniscus-bone was 0.28 µg per mg of tissue.  Results 
from extract and contact cytotoxicity assays consolidated this finding by 
demonstrating a lack of cytotoxicity. 
In conclusion, decellularised bone-meniscus-bone was shown to be non-
cytotoxic to BHK and 3T3 cells with only a small quantity of SDS remaining 
within the matrix and complete removal of the immunogenic α-gal epitope.  
Mechanical testing revealed retention of meniscal material properties under 
tension however significant differences were seen for both decellularised 
meniscus and bone under compression. 
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Chapter 6. Discussion 
6.1 Discussion 
The aim of this study was to use xenogeneic tissue to develop an 
immunologically inert meniscal replacement with a view to future clinical 
translation incorporating bone blocks to aid fixation.  Porcine bone-
meniscus-bone was decellularised using physical, chemical and enzymatic 
methods.  Histology revealed the complete removal of porcine cellular 
material and analysis of DNA demonstrated >90% reduction in total DNA as 
well as an absence of functional DNA.  Investigations also revealed retention 
of matrix architecture and constituents however there was a loss of GAGs, a 
~50% reduction in calcium content of bone as well as depletion of collagen 
IV.  Biomechanical testing demonstrated significantly different behaviour of 
the decellularised meniscus compared to the native tissue under indentation 
however finite element modelling showed that decellularised meniscus was 
not significantly stiffer than native meniscus.  Decellularised meniscus was 
not significantly different to native meniscus under tensile testing however 
compressive properties of decellularised bone were diminished.  
Biocompatibility was assessed using cytotoxicity assays which 
demonstrated a lack of cytotoxicity. 
A real clinical need exists for a meniscal replacement owing to the current 
and ever increasing incidence of meniscal injury and lack of long term 
treatment options.  Approximately 1.5 million procedures related to the 
meniscus are performed each year and many of these are secondary 
surgeries burdening health service providers and patients.  Meniscal injury 
can be incurred through sport, accounting for the majority of injury in younger 
people, or other non-sporting activities, usually occurring later in life (Drosos 
and Pozo, 2004).  Injury usually reveals itself through various symptoms 
including pain and swelling (Choi and Victoroff, 2006), which impair quality 
of life.  The meniscus is largely avascular and so a limited healing response 
is activated resulting in the formation of mechanically inferior repair tissue 
(Roeddecker et al., 1994).  Prognosis is best with injury to the red zone 
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(Brindle et al., 2001) however repair may not be possible depending on the 
type of injury, location of the injury and other factors associated with the 
patient and in some cases will not heal (Adams et al., 2005) and in these 
cases resection of the meniscus is chosen to alleviate symptoms.  Resection 
of the meniscus in this way preserves the load distribution characteristics of 
the meniscus (Messner and Gao, 1998) however degeneration still proceeds 
and is proportional to the amount of tissue removed (Andersson-Molina et 
al., 2002).  Therefore, various tissue engineering strategies have been 
investigated for the repair or replacement of the meniscus.  These include 
both natural and synthetic biomaterials in conjunction with cells and growth 
factors to restore mechanical function and promote regeneration of the 
meniscus.  The different types of biomaterial offer various advantages and 
disadvantages, with synthetic materials offering reproducible production and 
customisation but lack natural signalling cues and can impart a foreign body 
response, whereas natural materials are less toxic however batch to batch 
variability is greater.  Success has been limited with these approaches as 
the meniscus is a highly complex structure composed of multiple 
components and cell types which are critical to its function and challenging 
to replicate using current techniques.  Therefore the approach used in this 
study was to use readily available xenogeneic tissue, already comprising the 
highly complex matrix and natural cell signalling cues, and remove all 
potentially immunogenic components leaving an immunologically inert 
natural scaffold capable of restoring mechanical function and regeneration.   
Decellularisation of tissues should leave a nontoxic, acellular scaffold 
capable of supporting cell repopulation and inducing a regenerative 
response whilst maintaining the biomechanical properties required of the 
replacement.  Decellularised matrices have been used clinically in the form 
of porcine small intestinal submucosa (Surgisis, Cook Biotech Inc), heart 
valves and dermis (Tissue Regenix plc) with further decellularised tissues 
undergoing development (Ingram et al., 2007; Partington et al., 2013).  
Porcine tissue is readily available from abattoirs and porcine meniscus is 
anatomically similar to human meniscus.  Issues with differences in 
geometry can be overcome by size matching of replacement tissue using 
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magnetic resonance imaging (MRI) techniques already employed in the 
clinic.  Studies have shown how effective size matching of meniscal 
replacements can improve outcomes (Verdonk et al., 2006).  The medial 
meniscus is smaller (McDermott et al., 2004) and less mobile (Vedi et al., 
1999) than the lateral meniscus resulting in an increase in the incidence of 
injury (Boyd and Myers, 2003).  The medial meniscal attachments can be 
more easily accessed than the lateral meniscal attachments and so surgical 
fixation is less problematic.  Bone blocks provide a simple yet effective 
method of fixation with bone to bone healing showing superior mechanical 
properties after 24 weeks when compared to bone to soft tissue fixation 
(Leung et al., 2002).  It has also been suggested that suture fixation of soft 
tissue allows the meniscus to extrude altering the load distribution profile as 
the meniscal horns are not anchored as well as when bone plugs used 
(Alhalki et al., 1999).  Various protocols are in development to produce 
decellularised meniscus however to date there are none that incorporate a 
bone element for fixation.   
Strategies have shifted from devitalized grafts (Arnoczky et al., 1992; Peretti 
et al., 2004; Yamasaki et al., 2008) to decellularised grafts (Maier et al., 
2007; Stapleton et al., 2008; Sandmann et al., 2009; Stabile et al., 2010).  
This shift may have occurred due to the unfavourable results produced using 
devitalised meniscus with degeneration similar to meniscectomised knees 
reported.  Decellularisation of meniscus has been undertaken using tissue 
from various sources including murine, ovine, porcine and human.  Various 
protocols have been developed usually incorporating a detergent wash or 
enzymatic digestion.  Trypsin has been used to decellularise meniscus 
resulting in removal of xenogeneic cells and generation of a biocompatible 
scaffold however trypsin treatment resulted in loss of GAGs and extensive 
damage to the matrix (Maier et al., 2007).  Stabile et al. (2010) had more 
success using a lower concentration of trypsin (0.05% compared to 0.25%) 
on ovine meniscus resulting in the generation of a biocompatible scaffold 
with retention of material properties, however only a ~55% reduction in total 
DNA was achieved.  SDS has been used widely to decellularise tissues with 
concentrations ranging from 0.1-1% (w/v) used to decellularise meniscus 
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(Stapleton et al., 2008; Sandmann et al., 2009).  Higher concentrations of 
SDS have been shown to damage ECM proteins (Bodnar et al., 1986; 
Courtman et al., 1994), although it has also been suggested that damage to 
ECM is caused by endogenous proteases released as cells are lysed and 
not SDS (Booth et al., 2002).   
Work leading to the current study was completed by Stapleton et al. (2008) 
in which porcine menisci were successfully decellularised using a protocol 
utilising physical, chemical and enzymatic methods.  The protocol was based 
on the process developed by Booth et al. (2002) to decellularise porcine 
heart valves.  Menisci were prepared by creating spaces in the extracellular 
matrix using freeze-thaw cycles.  Hypotonic solutions were used in 
conjunction with SDS to cause cell lysis and solubilise cellular material with 
protease inhibitors included to prevent damage to the matrix from 
endogenous proteases (Booth et al., 2002).  Subsequently released nucleic 
acids were digested using nucleases to prevent potential sites of calcification 
associated with phosphate groups (Schoen and Levy, 2005) and a 
hypertonic buffer wash step was added to aid removal of hydrophobic 
proteins.  The method developed by Stapleton et al. (2008) for decellularising 
porcine menisci was able to produce a biocompatible acellular scaffold 
retaining biochemical, structural and biomechanical properties of the native 
tissue.  Whole porcine medial menisci were subjected to three dry freeze-
thaw cycles followed by three freeze-thaw cycles in hypotonic buffer.  
Menisci were then treated using hypotonic buffer at 4 °C for 24 hours, 
hypotonic buffer at 37 °C for 24 hours, followed by two incubations in 0.1% 
(w/v) SDS at 45 °C for 24 hours each with all steps containing aprotinin and 
EDTA as protease inhibitors.  This cycle was repeated twice more before 
washing in PBS containing aprotinin three times for 12 hours each.  After 
washing, menisci were treated thrice using nuclease solution containing 
DNase and RNase for three hours each at 37 °C.  A hypertonic wash was 
then employed prior to another PBS wash at room temperature for 24 hours.  
This was followed by a sterilisation step in 0.1% (v/v) peracetic acid for three 
hours and final washing in PBS five times at 45 °C, 37 °C and 4 °C for 24 
hours each.  This protocol resulted in a decellularised scaffold which retained 
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biochemical, structural and biomechanical properties when compared to 
native menisci and was biocompatible. 
Initial investigations by Stapleton et al. (2008) into decellularisation of bone-
meniscus-bone resulted in decalcification of bone blocks owing to the 
inclusion of EDTA in wash solutions and incomplete decellularisation of the 
enthesis region of the bone blocks.  Therefore, for the current study EDTA 
was removed from all decellularisation solutions.  Other changes that were 
required to aid decellularisation were physical manipulation of the 
attachment site to improve diffusion of reagents into the enthesis, increases 
in sample processing volumes owing to the increased size and weight of 
bone-meniscus-bone compared to meniscus alone, processing at only 4 °C 
or 42 °C to reduce the potential of bio burden build up, removal of bone 
marrow from bone blocks to prevent clotting which could prevent 
decellularisation solutions from penetrating the bone, and increased wash 
buffer changes prior to the nuclease step to prevent inactivation of nucleases 
by SDS.  To the authors knowledge the current study represents the first 
known example of successful decellularisation of tissue with both soft and 
hard components.  Given the dense nature of the meniscus it is conceivable 
that the current process would successfully decellularise similar tissue from 
a variety of sources to produce bone-tendon and bone-ligament grafts. 
Decellularisation of porcine bone-meniscus-bone resulted in complete 
removal of whole cells and nuclei as evidenced by histology and analysis of 
residual DNA.  Initial assessment of decellularisation in bone was not 
attempted using traditional histological tissue preparation techniques as 
decalcification prior to paraffin embedding may result in decellularisation as 
mineralised matrix is removed.  Therefore resin embedding was chosen as 
the desired method for histological analysis of bone as this preserves the 
tissue in its absolute state eradicating the possibility of a false negative.  As 
histological techniques may not be suitable or lack the sensitivity to detect 
all residual DNA, DNA from decellularised bone-meniscus-bone was 
extracted using a DNeasy kit and quantified by spectrophotometry as well as 
assessed for functional genes using PCR and gel electrophoresis.  All 
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techniques employed revealed an absence of functional DNA or whole DNA 
fragments.  It has been suggested that decellularised matrices should 
contain no more than 50 ng.mg-1 of dsDNA (Crapo et al., 2011) as phosphate 
groups present on DNA can result in calcification (Schoen and Levy, 2005).  
Decellularised meniscus contained 26.7 ng.mg-1 of total DNA whereas 
decellularised bone contained 124.9 ng.mg-1 of total DNA.  As these values 
represent total DNA which includes both double stranded and single 
stranded DNA the actual content of dsDNA will be much lower.  Even though 
the total DNA content of bone was above the definition, calcification within 
the bone would not be detrimental, whereas calcification in the soft tissue 
could affect mechanical function.  It has been suggested that DNA fragment 
length is related to the host response to decellularised grafts (Keane et al., 
2012).  Larger fragments (>500 bp) have been associated with an 
inflammatory response whereas smaller fragments (<500 bp) correlated with 
a remodelling response.  It should be noted, however, that this effect may be 
attributable to different degrees of decellularisation as alternative sources of 
antigenicity were not determined.  Gel electrophoresis of DNA extracted from 
decellularised bone-meniscus-bone and amplified using PCR for three 
genes ubiquitous in this type of tissue failed to reveal the presence of large 
fragments of DNA.  This may have been because there was not enough total 
DNA of that size to be visible as the concentration of DNA extracted from 
native and decellularised tissue was different.  To counteract this and 
prevent extracted DNA samples falling below the detection limit of the 
spectrophotometer increased amounts of decellularised tissue were 
digested compared to native tissue for DNA extraction.  Decellularised bone-
meniscus-bone was also absent of functional DNA suggesting digestion of 
nuclear material by nucleases during the process.  This along with 
solubilisation and removal of cells should prevent the transfer of latent viral 
DNA to the host, although insertion of porcine endogenous retroviral DNA 
has been shown to be inefficient at best and otherwise non-existent in in vitro 
studies (Bisset et al., 2007). 
The general structure and geometry of native and decellularised bone 
meniscus bone was assessed using 9.4T MRI.  Non-destructive imaging of 
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tissues in three dimensions whilst preserving the native form is valuable as 
the impact of tribological testing can be investigated.  Images obtained 
allowed clear distinction between the different regions and tissue types 
present within porcine bone and meniscus.  The 3D FLASH sequence used 
allowed visualisation of the internal structures of bone and meniscus in any 
plane.  The main differences seen between native and decellularised 
meniscus were the loss of the synovium and vasculature in decellularised 
meniscus, and changes to the structure of the attachment site in bone.  
These changes correlated well with histological and immunohistochemical 
studies.  Loss of the synovium is not seen as critical as it is hypothesised 
that cells infiltrating from the synovium will regenerate a new synovium 
(Rodeo et al., 2000).  Porcine bone-meniscus-bone was obtained from 
young pigs (~6 months) in which the meniscus is not fully developed and 
remains largely vascularised with vessels extending into the white zone.  
Loss of the vasculature may prove beneficial as the channels that remain 
span the entire meniscus and may improve access for infiltrating cells into 
the deep portions of the meniscus, thereby accelerating the remodelling 
response. 
The extracellular matrix (ECM) was characterised using histology, 
immunohistochemistry and biochemical assays.  The collagen structure is 
responsible for the function of the meniscus with circumferential fibres 
dissipating compressive load through the generation of hoop stresses.  
Histology and biochemical assays showed retention collagen and 
maintenance of structure whilst immunohistochemistry revealed changes to 
the composition of meniscal ECM.  Collagen I, II and III were unchanged in 
decellularised meniscus however collagen IV was completely removed and 
some collagen VI was removed.  This may be because collagen I, II and II 
are structural collagens which form organised fibres and so are more 
resistant to washing out.  Studies in our laboratory have demonstrated how 
the removal of collagen IV is a chemical process (Wilshaw et al., 2014 - 
publication in progress) whereas removal of collagen VI appeared to be a 
more physical process with a boundary visible towards the periphery of the 
meniscus inside which collagen VI staining remained comparable to native 
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meniscus.  GAGs contribute to the biphasic nature of the meniscus by 
retarding the flow of water molecules leaving the matrix on application of 
load, thereby creating the Donnan osmotic pressure which bears the initial 
portion of the load, and attracting water back into the matrix once the 
meniscus is unloaded.  Histology suggested a complete loss of GAGs from 
the meniscus and this was verified by DMMB assay.  This may have been 
due to the immaturity of the tissue as well as the effect of SDS on ECM 
constituents (Reing et al., 2007; Lumpkins et al., 2008; Stapleton et al., 2008; 
Deeken et al., 2011).  Compositional changes to the bone post-
decellularisation followed a similar pattern to the meniscus.  Major collagens 
I, II and III were all unchanged with complete loss of collagen IV once more 
and a decrease in collagen VI staining intensity.  Osteocalcin, the most 
abundant non-collagenous protein in bone, was also stained for as a bone-
specific target.  Staining of osteocalcin was mainly localised to cells and so 
with the removal of cells the level of staining decreased however staining 
intensity in the bone matrix remained unchanged.  The calcium content of 
bone was determined using inductively coupled plasma mass spectrometry 
(ICPMS).  Calcium content was ~50% lower in decellularised bone when 
compared to native bone.  Studies have shown that removal of the 
mineralised matrix exposes bone morphogenetic proteins which promote a 
healing response (Reddi, 1975; Glowacki and Mulliken, 1985) and so this 
may not necessarily be detrimental to clinical success.   
Mechanical testing of meniscus and bone was undertaken to determine the 
impact of changes in matrix composition on material properties.  Indentation 
and tensile testing were performed on meniscus and compressive testing 
was performed on bone.  DMMB assay on the different regions of meniscus 
revealed the highest concentration of GAGs in the white zone however owing 
to the size of the meniscus repeatable sampling for indentation tests could 
only be carried out in the red zone.  Ideally testing should be performed on 
the whole meniscus in order to fully understand the mechanisms by which 
the meniscus functions mechanically.  Indentation testing revealed a 
significant difference between the deformation profiles of native and 
decellularised meniscus.  This can be attributed to the loss of GAGs from the 
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tissue.  Finite element modelling of meniscus was undertaken to determine 
the material properties of meniscus.  A low load was used (0.22 N) to prevent 
deformation exceeding 50% as the model does not permit such high 
deformations due to mesh alterations near the corner of the plane ended 
indenter.  Modelling did not reveal a significant difference between the 
aggregate modulus of native and decellularised meniscus however this may 
be because the model used was developed for cartilage and given sampling 
of meniscus occurred in the fibrocartilaginous zone and not the hyaline-like 
white zone alterations may be required to ensure the model is suitable for 
determining meniscal material properties.  Also, peak deformations were 
relatively high (~30%) and it is recommended that low deformations (5-10%) 
are used with the model. 
Tensile testing of meniscus was undertaken to investigate the effect of 
decellularisation on the tensile properties of meniscus.  Compressive forces 
are converted to circumferential hoop stresses by the radial displacement of 
the meniscus as it is anchored at the horns.  No significant differences were 
found for the ultimate tensile strength, failure strain or Young’s modulus of 
native and decellularised meniscus.  Studies on human menisci in the 
literature where similar sample dimensions were used obtained values 
ranging from 83 to 129 MPa for the Young’s modulus (Tissakht and Ahmed, 
1995; Lechner et al., 2000) which is comparable to the value obtained in this 
study.  However, further investigations should be undertaken using a 
standard testing method and sample geometry in order to obtain a true 
comparison between decellularised porcine meniscus and native human 
meniscus.  Retention of the complex collagen structure is advantageous over 
artificially produced replacements as randomly organised natural and/or 
synthetic polymers are unable to confer the requisite mechanical strength of 
native meniscus. 
The reduction in the calcium content of decellularised bone alluded to a 
decrease in mechanical strength of the bone.  Unconfined compression of 
bone revealed significant differences for the compressive load at yield and 
the compressive modulus between native and decellularised bone.  As the 
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graft will be confined once implanted the material properties under 
compression may be different.  Fixation of the bone blocks is crucial to the 
success of the decellularised graft.  Fixation needs to be secure in order to 
anchor the meniscus in place and prevent excessive displacement of the 
meniscus as this can lead to extrusion and altered load distribution within the 
knee (Costa et al., 2004; Lerer et al., 2004).  Future studies should 
investigate the effect the reduction in mechanical strength of decellularised 
bone blocks has on integration and meniscal load transmission using 
clinically relevant fixation techniques. 
Depletion of GAGs will no doubt impact the response of the meniscus under 
loading in vivo, however the success of the bone-meniscus-bone implant will 
depend on the extent of these effects.  As already discussed in this section, 
a significant difference was seen in the response of decellularised meniscus 
under compressive load and this can be attributed to the loss of GAGs.  
Collagen gels with bound GAGs and cultured with fibroblasts were shown to 
have reduced biomechanical properties when compared to gels without cells 
(Saddiq et al., 2005).  This may be due to the remodelling response initiated 
by the fibroblasts as they populate and proliferate in the collagen matrix, 
degrading the matrix prior to rebuilding it.  Once decellularised bone-
meniscus-bone is implanted into the knee, cells infiltrating the meniscus and 
bone will begin to remodel the construct as they respond to tensile and 
compressive forces exerted on them.  The success of decellularised bone-
meniscus-bone as a meniscal replacement will depend on its ability to direct 
this remodelling response to prevent resorption while providing mechanical 
function.  Mechanical testing of aortic valve cusps with GAGs depleted 
displayed altered viscoelastic properties however stiffness of the tissue was 
not changed (Borghi et al., 2013).  Tensile properties of the meniscus have 
not been affected by decellularisation therefore the decellularised construct 
should provide mechanical function within the patient knee.  CMI, comprised 
of an unorganised collagen I matrix, has been extensively used as a 
meniscal replacement with varying degrees of success, suggesting a 
replacement with the varied composition and complex matrix organisation 
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present within native meniscus should provide improved mechanical 
properties. 
Bone forms through three basic processes: synthesis of extracellular matrix, 
mineralisation, and remodelling.  Healing in long bones, such as the tibia, 
occurs through endochondral ossification where bone growth occurs from an 
underlying cartilage model.  Removal of calcium through decellularisation 
retains the extracellular matrix and some mineral content potentially allowing 
more rapid mineralisation and remodelling as extensive resorption does not 
need to occur.  Retention of bone structures may also allow infiltration of 
cells from the marrow through Haversian canals facilitating the healing 
response.  Bone is constantly being remodelled to prevent accumulation of 
microdamage (Turner, 1998).  Loss of mechanical strength due to the loss 
of calcium should not be detrimental to the success of decellularised bone-
meniscus-bone as compressive loading of the tibia at the attachment site is 
minimal with the meniscus bearing the majority of the load (Walker and 
Erkman, 1975).  A point of concern may be the ability to properly fix 
decellularised bone blocks into the tibia without forces generated during 
activity causing bone blocks to be damaged and dislodge.  A study 
conducted in the group on porcine bone decellularised using the method 
described in Section 3.3.1.5 was implanted into murine tibia and fixed in 
place using sutures and allowed to heal.  Bone displayed good integration to 
the native tissue with no adverse reactions noted (data not published).  This 
displays bio- and immune-compatibility of decellularised bone, which 
contained higher residual DNA content than meniscus, in a non-homologous 
animal model, providing a good basis for predicting that porcine meniscus 
produced in the same method will also prove biocompatible.  An appropriate 
rehabilitation programme can also be employed to minimise potential 
damage to the knee and meniscus to allow repopulation and replenishment 
of GAGs by patient cells and healing and integration of bone to the tibia. 
It is clear that in vivo investigations are required in order to fully elucidate the 
effect of GAG and calcium depletion from decellularised bone-meniscus-
bone as well as inform the remodelling response initiated by the 
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decellularised graft.  Tensile properties have been maintained suggesting 
strategies can be applied to reduce the impact of increased deformation of 
decellularised meniscus under load.  These could be in the form of a 
physiotherapy and rehabilitation regime where loading on the knee is 
reduced to minimise excessive stress on the meniscus, or introduction of a 
cell population prior to implantation to accelerate cell infiltration and 
population of the graft thereby promoting the replenishment of the meniscus 
with GAGs and initiating the remodelling response.  Any cells used in this 
way should be autologous and minimally manipulated to maintain process 
simplicity and reduce the regulatory burden. 
Biocompatibility of the decellularised porcine bone-meniscus-bone has to be 
determined prior to clinical use.  The current study focussed on the removal 
of the immunogenic α-gal epitope and removal of SDS as well as in vitro 
biocompatibility assays using BHK and 3T3 cells to assess soluble and 
contact cytotoxicity.  Immunohistochemical evaluation revealed an absence 
of α-gal in decellularised meniscus however studies on bone could not be 
completed due to issues in procuring the antibody.  It is postulated that α-gal 
is removed chemically along with collagen IV by PAA (Wilshaw et al., 2014 
– manuscript under review) and, as it is located on cells, during washing out 
of cell fragments by SDS.  As mentioned previously, SDS is known to 
damage proteins and has been shown to be cytotoxic at increased 
concentrations (Zorn-Kruppa et al., 2004).  Residual SDS was quantified 
using 14C radio-labelled SDS resulting in a mean SDS content of 0.28 µg.mg-
1 in decellularised bone-meniscus-bone.  This was well below the cytotoxicity 
threshold defined by Gratzer et al. (2006) of 10 µg.mg-1 suggesting bone-
meniscus-bone would not be cytotoxic to cells.  Contact and extract 
cytotoxicity assays corroborated this finding as BHK and 3T3 cells grew 
normally up to and in contact with decellularised bone-meniscus-bone with 
no evidence of cytotoxicity. 
It is paramount that decellularised bone-meniscus-bone is sterilised prior to 
implantation to prevent the transmission of viruses and other infectious 
agents.  Exposure to porcine endogenous retrovirus (PERV) is unavoidable 
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as these viruses are a permanent part of the mammalian genome (Blusch et 
al., 2002) however transmission rate is low and replication of endogenous 
retroviruses does not usually occur (Patience et al., 1997).  As mentioned 
earlier, decellularisation renders all nuclear material replication incompetent 
and so retroviral transmission should not occur.  The current protocol used 
0.1% (v/v) PAA as a terminal sterilisation step.  No sign of contamination was 
seen during cytotoxicity assays suggesting PAA is an effective method of 
sterilisation.  PAA has been used extensively to disinfect biomaterials and 
has been shown to inactivate viruses, spores and mycoplasma (Sprossig et 
al., 1976; Pruss et al., 1999) while also leaving biologically active growth 
factors behind (Hodde et al., 2007).  However, PAA sterilisation has been 
shown to inhibit remodelling of ACL allografts (Scheffler et al., 2008) 
although other studies have shown PAA does not affect repopulation of 
decellularised matrices (Bolland et al., 2007).  Alternative methods of 
sterilisation should be investigated to circumvent this as well as studies 
assessing recellularisation of decellularised bone-meniscus-bone sterilised 
using the current method.  Gamma irradiation and ethylene oxide treatment 
are two options that are available.  Gamma irradiation has been shown to 
weaken cortical bone whereas ethylene oxide does not (Zhou et al., 2011). 
The current study has described a process for obtaining acellular, 
biocompatible porcine bone-meniscus-bone which retains the geometry and 
collagen organisation of native meniscus and displays excellent potential as 
a meniscal replacement.  Future studies should focus on in vivo performance 
and optimisation of surgical techniques for fixation.  Consideration should 
also be given to large-scale manufacture of decellularised bone-meniscus-
bone using scale-up rather than scale-out methodologies and optimisation 
of tissue harvest procedures. 
 
6.2 Future work 
Further in vitro testing needs to be undertaken in order to ascertain the 
potential utility of decellularised bone-meniscus-bone.  The tensile testing 
207 
 
described in Section 5.3.2.3 should be completed by bringing the number of 
native and decellularised samples tested to 6 each.  This will allow accurate 
determination of the tensile performance of decellularised bone.  The α-gal 
content of decellularised bone-meniscus-bone should also be quantified 
using an ELISA, as even though immunohistochemical staining revealed an 
absence in decellularised tissue a quantitative method provides a more 
comprehensive method of determination. 
The ability of decellularised bone-meniscus-bone to support a cell population 
also needs to be evaluated.  This can be done by seeding the decellularised 
construct using mesenchymal stem cells.  It will be interesting to see the 
response of these cells to mechanical stimulation, tension and/or 
compression, in bioreactors currently available in the group (TenCell II and 
ComCell).  Constructs should be cultured for 28 days prior to removal and 
assessment of infiltration and cell phenotype using histology and 
immunocytochemistry.  If longer term culture is possible then possible 
conditioning of decellularised meniscus should be investigated using 
mechanical testing methods described in Section 5.3.2. 
To complete the product development cycle and market decellularised bone-
meniscus-bone as a class III medical device a set of further investigations 
need to take place.  This should begin with characterisation of human 
meniscus and comparison of structure, composition and biomechanical 
properties in order to compare to decellularised meniscus and reveal areas 
for development.  Evaluation of alternative sterilisation techniques, such as 
ethylene oxide, should then be undertaken in order to prevent detrimental 
changes to the matrix owing to PAA sterilisation.  Safety and fixation 
techniques can then be assessed in a large animal study, e.g. sheep, and 
should take approximately one month to complete.  Size matching of grafts 
can be investigated using MRI techniques with histology and 
immunohistochemistry used to assess the host response.  Once these have 
been determined a longer term study investigating the integration of the 
decellularised graft to the knee joint should be carried out with explants also 
analysed for the type of immune response elicited.  Longer term studies for 
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clinical efficacy, i.e. biomechanical function and regeneration, can then occur 
which will conclude the initial phase of development.  The secondary phase 
should focus on development of a suitable bioprocess that adheres to GMP 
in order to obtain a market authorisation for decellularised bone-meniscus-
bone.  Design of experiments (DoE) should be used to fully understand the 
decellularisation process and obtain critical process parameters.  Once this 
process is finalised, bone-meniscus-bone produced using this optimised 
protocol will have to be investigated in a large animal study to demonstrate 
safety and also where comparisons to the previous study can be made.  This 
should then be followed by a first-in-man study comprising 20-30 patients to 
assess the safety of the GMP product, successful completion of which will 
enable CE marking of the product in Europe and FDA approval in the US. 
 
6.3 Conclusion 
In conclusion, this study represents the first time decellularisation has been 
successfully achieved in grafts comprising both bone and a soft tissue 
component.  No cell nuclei were visible on inspection and total DNA was 
reduced by >90% in the decellularised graft.  Further investigation into the 
impact of compositional changes on potential clinical utility need to be 
undertaken prior to progression of developmental activities. 
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Appendix A – Supplementary Material 
 
Antibody controls 
Representative images of negative controls (isotype and antibody 
omission) used in Chapter 4, Section 4.4.2 and Chapter 5, Section 5.4.3 
are shown here.  All anti-collagen antibodies were IgG’s, anti-osteocalcin 
antibody was IgG2a and anti-α-gal was IgM. 
 
Figure A1:  Representative images from n = 3 menisci/bone of negative controls 
used for immunohistochemistry.  All controls were negative for staining. 
 
Animation of 3D FLASH MRI sequence 
A CD is included with this study and contains an animation of MRI images 
showing the entire stack of images captured during scanning native and 
decellularised bone-meniscus-bone. 
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